Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Alzheimer's Disease

  Free Subscription


Articles published in J Alzheimers Dis

Retrieve available abstracts of 820 articles:
HTML format
Text format



Single Articles


    October 2018
  1. INNES KE, Selfe TK, Brundage K, Montgomery C, et al
    Effects of Meditation and Music-Listening on Blood Biomarkers of Cellular Aging and Alzheimer's Disease in Adults with Subjective Cognitive Decline: An Exploratory Randomized Clinical Trial.
    J Alzheimers Dis. 2018 Oct 11. pii: JAD180164. doi: 10.3233/JAD-180164.
    PubMed     Text format     Abstract available


  2. WENG YC, Hsiao IT, Huang CY, Huang KL, et al
    Progress of Brain Amyloid Deposition in Familial Alzheimer's Disease with Taiwan D678H APP Mutation.
    J Alzheimers Dis. 2018 Oct 9. pii: JAD180824. doi: 10.3233/JAD-180824.
    PubMed     Text format     Abstract available


  3. DE MATOS MR, Ferreira C, Herukka SK, Soininen H, et al
    Quantitative Genetics Validates Previous Genetic Variants and Identifies Novel Genetic Players Influencing Alzheimer's Disease Cerebrospinal Fluid Biomarkers.
    J Alzheimers Dis. 2018 Oct 9. pii: JAD180512. doi: 10.3233/JAD-180512.
    PubMed     Text format     Abstract available


  4. ELIAS A, Cummins T, Tyrrell R, Lamb F, et al
    Risk of Alzheimer's Disease in Obstructive Sleep Apnea Syndrome: Amyloid-beta and Tau Imaging.
    J Alzheimers Dis. 2018 Oct 8. pii: JAD180640. doi: 10.3233/JAD-180640.
    PubMed     Text format     Abstract available


  5. COUSINS CC, Alosco ML, Cousins HC, Chua A, et al
    Nailfold Capillary Morphology in Alzheimer's Disease Dementia.
    J Alzheimers Dis. 2018 Oct 6. pii: JAD180658. doi: 10.3233/JAD-180658.
    PubMed     Text format     Abstract available


  6. BAIRD A, Brancatisano O, Gelding R, Thompson WF, et al
    Characterization of Music and Photograph Evoked Autobiographical Memories in People with Alzheimer's Disease.
    J Alzheimers Dis. 2018 Oct 6. pii: JAD180627. doi: 10.3233/JAD-180627.
    PubMed     Text format     Abstract available


  7. ZHANG F, Wei J, Li X, Ma C, et al
    Early Candidate Urine Biomarkers for Detecting Alzheimer's Disease Before Amyloid-beta Plaque Deposition in an APP (swe)/PSEN1dE9 Transgenic Mouse Model.
    J Alzheimers Dis. 2018 Oct 6. pii: JAD180412. doi: 10.3233/JAD-180412.
    PubMed     Text format     Abstract available


  8. MULLER-EHRENBERG L, Riphagen JM, Verhey FRJ, Sack AT, et al
    Alzheimer's Disease Biomarkers Have Distinct Associations with Specific Hippocampal Subfield Volumes.
    J Alzheimers Dis. 2018 Oct 5. pii: JAD180676. doi: 10.3233/JAD-180676.
    PubMed     Text format     Abstract available


    September 2018
  9. STELLA TURCHETTA C, Perri R, Fadda L, Caruso G, et al
    Forgetting Rate on the Recency Portion of a Word List Differentiates Mild to Moderate Alzheimer's Disease from Other Forms of Dementi.
    J Alzheimers Dis. 2018 Sep 29. pii: JAD180690. doi: 10.3233/JAD-180690.
    PubMed     Text format     Abstract available


  10. SONG YN, Wang P, Xu W, Li JQ, et al
    Risk Factors of Rapid Cognitive Decline in Alzheimer's Disease and Mild Cognitive Impairment: A Systematic Review and Meta-Analysis.
    J Alzheimers Dis. 2018 Sep 29. pii: JAD180476. doi: 10.3233/JAD-180476.
    PubMed     Text format     Abstract available


  11. KROLAK-SALMON P, Dubois B, Sellal F, Delabrousse-Mayoux JP, et al
    France Will No More Reimburse Available Symptomatic Drugs Against Alzheimer's Disease.
    J Alzheimers Dis. 2018 Sep 28. pii: JAD180843. doi: 10.3233/JAD-180843.
    PubMed     Text format     Abstract available


  12. LOMIGUEN C, Vidal L, Kozlowski P, Prancan A, et al
    Possible Role of Chitin-Like Proteins in the Etiology of Alzheimer's Disease.
    J Alzheimers Dis. 2018 Sep 28. pii: JAD180326. doi: 10.3233/JAD-180326.
    PubMed     Text format     Abstract available


  13. FRANK L, Wesson Ashford J, Bayley P, Borson S, et al
    Genetic Risk of Alzheimer's Disease: Three Wishes Now That the Genie is Out of the Bottle.
    J Alzheimers Dis. 2018 Sep 27. pii: JAD180629. doi: 10.3233/JAD-180629.
    PubMed     Text format     Abstract available


  14. FIORINI M, Bongianni M, Donata Benedetti M, Monaco S, et al
    Reappraisal of Abeta40 and Abeta42 Peptides Measurements in Cerebrospinal Fluid of Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2018 Sep 26. pii: JAD180616. doi: 10.3233/JAD-180616.
    PubMed     Text format     Abstract available


  15. R ZAMMIT A, B Hall C, J Katz M, Muniz-Terrera G, et al
    Class-Specific Incidence of All-Cause Dementia and Alzheimer's Disease: A Latent Class Approach.
    J Alzheimers Dis. 2018 Sep 26. pii: JAD180604. doi: 10.3233/JAD-180604.
    PubMed     Text format     Abstract available


  16. SARYCHEVA T, Taipale H, Lavikainen P, Tiihonen J, et al
    Incidence and Prevalence of Antiepileptic Medication Use in Community-Dwelling Persons with and without Alzheimer's Disease.
    J Alzheimers Dis. 2018 Sep 26. pii: JAD180594. doi: 10.3233/JAD-180594.
    PubMed     Text format     Abstract available


  17. GRIZZANTI J, Corrigan R, Casadesus G
    Neuroprotective Effects of Amylin Analogues on Alzheimer's Disease Pathogenesis and Cognition.
    J Alzheimers Dis. 2018 Sep 26. pii: JAD180433. doi: 10.3233/JAD-180433.
    PubMed     Text format     Abstract available


  18. PANAGAKI T, Gengler S, Holscher C
    The Novel DA-CH3 Dual Incretin Restores Endoplasmic Reticulum Stress and Autophagy Impairments to Attenuate Alzheimer-Like Pathology and Cognitive Decrements in the APPSWE/PS1DeltaE9 Mouse Model.
    J Alzheimers Dis. 2018 Sep 25. pii: JAD180584. doi: 10.3233/JAD-180584.
    PubMed     Text format     Abstract available


  19. MINN YK, Hye Choi S, Ju Suh Y, Hyang Jeong J, et al
    Effect of Physical Activity on the Progression of Alzheimer's Disease: The Clinical Research Center for Dementia of South Korea Study.
    J Alzheimers Dis. 2018 Sep 25. pii: JAD180333. doi: 10.3233/JAD-180333.
    PubMed     Text format     Abstract available


  20. J DOIG A
    Positive Feedback Loops in Alzheimer's Disease: The Alzheimer's Feedback Hypothesis.
    J Alzheimers Dis. 2018 Sep 24. pii: JAD180583. doi: 10.3233/JAD-180583.
    PubMed     Text format     Abstract available


  21. BERA G, Migliaccio R, Michelin T, Lamari F, et al
    Parietal Involvement in the Semantic Variant of Primary Progressive Aphasia with Alzheimer's Disease Cerebrospinal Fluid Profile.
    J Alzheimers Dis. 2018 Sep 24. pii: JAD180087. doi: 10.3233/JAD-180087.
    PubMed     Text format     Abstract available


  22. AVILA-VILLANUEVA M, Maestu F, Fernandez-Blazquez MA
    Internal Consistency Over Time of Subjective Cognitive Decline: Drawing Preclinical Alzheimer's Disease Trajectories.
    J Alzheimers Dis. 2018 Sep 19. pii: JAD180307. doi: 10.3233/JAD-180307.
    PubMed     Text format     Abstract available


  23. NAGATA T, Shinagawa S, Nakajima S, Mimura M, et al
    Association between Neuropsychiatric Improvement and Neurocognitive Change in Alzheimer's Disease: Analysis of the CATIE-AD Study.
    J Alzheimers Dis. 2018 Sep 18. pii: JAD180304. doi: 10.3233/JAD-180304.
    PubMed     Text format     Abstract available


  24. EMMERZAAL TL, Rodenburg RJ, Tanila H, Verweij V, et al
    Age-Dependent Decrease of Mitochondrial Complex II Activity in a Familial Mouse Model for Alzheimer's Disease.
    J Alzheimers Dis. 2018 Sep 15. pii: JAD180337. doi: 10.3233/JAD-180337.
    PubMed     Text format     Abstract available


  25. LAUGISCH O, Johnen A, Maldonado A, Ehmke B, et al
    Periodontal Pathogens and Associated Intrathecal Antibodies in Early Stages of Alzheimer's Disease.
    J Alzheimers Dis. 2018 Sep 11. pii: JAD180620. doi: 10.3233/JAD-180620.
    PubMed     Text format     Abstract available


  26. EHRENBERG AJ, Suemoto CK, de Paula Franca Resende E, Petersen C, et al
    Neuropathologic Correlates of Psychiatric Symptoms in Alzheimer's Disease.
    J Alzheimers Dis. 2018 Sep 7. pii: JAD180688. doi: 10.3233/JAD-180688.
    PubMed     Text format     Abstract available


  27. KOYCHEV I, Galna B, Zetterberg H, Lawson J, et al
    Abeta42/Abeta40 and Abeta42/Abeta38 Ratios Are Associated with Measures of Gait Variability and Activities of Daily Living in Mild Alzheimer's Disease: A Pilot Study.
    J Alzheimers Dis. 2018 Sep 4. pii: JAD180622. doi: 10.3233/JAD-180622.
    PubMed     Text format     Abstract available


  28. O'BRYANT SE, Zhang F, Johnson LA, Hall J, et al
    A Precision Medicine Model for Targeted NSAID Therapy in Alzheimer's Disease.
    J Alzheimers Dis. 2018 Sep 4. pii: JAD180619. doi: 10.3233/JAD-180619.
    PubMed     Text format     Abstract available


    August 2018
  29. HUAN T, Tran T, Zheng J, Sapkota S, et al
    Metabolomics Analyses of Saliva Detect Novel Biomarkers of Alzheimer's Disease.
    J Alzheimers Dis. 2018 Aug 28. pii: JAD180711. doi: 10.3233/JAD-180711.
    PubMed     Text format     Abstract available


  30. BLOCH K, Gil-Ad I, Vanichkin A, Hornfeld SH, et al
    Intracranial Transplantation of Pancreatic Islets Attenuates Cognitive and Peripheral Metabolic Dysfunctions in a Rat Model of Sporadic Alzheimer's Disease.
    J Alzheimers Dis. 2018 Aug 28. pii: JAD180623. doi: 10.3233/JAD-180623.
    PubMed     Text format     Abstract available


  31. HEDDERICH DM, Spiro JE, Goldhardt O, Kaesmacher J, et al
    Increasing Diagnostic Accuracy of Mild Cognitive Impairment due to Alzheimer's Disease by User-Independent, Web-Based Whole-Brain Volumetry.
    J Alzheimers Dis. 2018 Aug 27. pii: JAD180532. doi: 10.3233/JAD-180532.
    PubMed     Text format     Abstract available


  32. WANG B, Miao L, Niu Y, Cao R, et al
    Abnormal Functional Brain Networks in Mild Cognitive Impairment and Alzheimer's Disease: A Minimum Spanning Tree Analysis.
    J Alzheimers Dis. 2018 Aug 23. pii: JAD180603. doi: 10.3233/JAD-180603.
    PubMed     Text format     Abstract available


  33. YUMOTO S, Kakimi S, Ishikawa A
    Colocalization of Aluminum and Iron in Nuclei of Nerve Cells in Brains of Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2018 Aug 23. pii: JAD171108. doi: 10.3233/JAD-171108.
    PubMed     Text format     Abstract available


  34. RAMANAN VK, Przybelski SA, Graff-Radford J, Castillo AM, et al
    Statins and Brain Health: Alzheimer's Disease and Cerebrovascular Disease Biomarkers in Older Adults.
    J Alzheimers Dis. 2018 Aug 22. pii: JAD180446. doi: 10.3233/JAD-180446.
    PubMed     Text format     Abstract available


  35. YUAN H, Yang W
    Genetically Determined Serum Uric Acid and Alzheimer's Disease Risk.
    J Alzheimers Dis. 2018 Aug 21. pii: JAD180538. doi: 10.3233/JAD-180538.
    PubMed     Text format     Abstract available


  36. HOLDEN JG, Cosnard A, Laurens B, Asselineau J, et al
    Prodromal Alzheimer's Disease Demonstrates Increased Errors at a Simple and Automated Anti-Saccade Task.
    J Alzheimers Dis. 2018 Aug 21. pii: JAD180082. doi: 10.3233/JAD-180082.
    PubMed     Text format     Abstract available


  37. JAVANSHIRI K, Waldo ML, Friberg N, Sjovall F, et al
    Atherosclerosis, Hypertension, and Diabetes in Alzheimer's Disease, Vascular Dementia, and Mixed Dementia: Prevalence and Presentation.
    J Alzheimers Dis. 2018 Aug 20. pii: JAD180644. doi: 10.3233/JAD-180644.
    PubMed     Text format     Abstract available


  38. BUSS SS, Padmanabhan J, Saxena S, Pascual-Leone A, et al
    Atrophy in Distributed Networks Predicts Cognition in Alzheimer's Disease and Type 2 Diabetes.
    J Alzheimers Dis. 2018 Aug 20. pii: JAD180570. doi: 10.3233/JAD-180570.
    PubMed     Text format     Abstract available


  39. ALBANI D, Marizzoni M, Ferrari C, Fusco F, et al
    Plasma Abeta42 as Biomarker of Prodromal Alzheimer's Disease Progression in Patients with Amnestic Mild Cognitive Impairment: Evidence from the PharmaCog/E-ADNI Study.
    J Alzheimers Dis. 2018 Aug 20. pii: JAD180321. doi: 10.3233/JAD-180321.
    PubMed     Text format     Abstract available


  40. OLIVEIRA FF, Almeida SS, Chen ES, Smith MC, et al
    Lifetime Risk Factors for Functional and Cognitive Outcomes in Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2018 Aug 20. pii: JAD180303. doi: 10.3233/JAD-180303.
    PubMed     Text format     Abstract available


  41. LIANG JW, Fang ZY, Huang Y, Liuyang ZY, et al
    Application of Weighted Gene Co-Expression Network Analysis to Explore the Key Genes in Alzheimer's Disease.
    J Alzheimers Dis. 2018 Aug 16. pii: JAD180400. doi: 10.3233/JAD-180400.
    PubMed     Text format     Abstract available


  42. VICENTE MC, Almeida MC, Bicego KC, Carrettiero DC, et al
    Hypercapnic and Hypoxic Respiratory Response During Wakefulness and Sleep in a Streptozotocin Model of Alzheimer's Disease in Rats.
    J Alzheimers Dis. 2018 Aug 14. pii: JAD180397. doi: 10.3233/JAD-180397.
    PubMed     Text format     Abstract available


  43. BENVENUTTO A, Giusiano B, Koric L, Gueriot C, et al
    Imaging Biomarkers of Neurodegeneration in Alzheimer's Disease: Distinct Contributions of Cortical MRI Atrophy and FDG-PET Hypometabolism.
    J Alzheimers Dis. 2018 Aug 13. pii: JAD180292. doi: 10.3233/JAD-180292.
    PubMed     Text format     Abstract available


  44. E BAKER J, Ying Lim Y, Jaeger J, Ames D, et al
    Episodic Memory and Learning Dysfunction Over an 18-Month Period in Preclinical and Prodromal Alzheimer's Disease.
    J Alzheimers Dis. 2018 Aug 9. pii: JAD180344. doi: 10.3233/JAD-180344.
    PubMed     Text format     Abstract available


  45. DOMINGUEZ-PRIETO M, Velasco A, Tabernero A, Medina JM, et al
    Endocytosis and Transcytosis of Amyloid-beta Peptides by Astrocytes: A Possible Mechanism for Amyloid-beta Clearance in Alzheimer's Disease.
    J Alzheimers Dis. 2018 Aug 7. pii: JAD180332. doi: 10.3233/JAD-180332.
    PubMed     Text format     Abstract available


  46. BULK M, Kenkhuis B, Graaf LMV, Goeman JJ, et al
    Postmortem T2*- Weighted MRI Imaging of Cortical Iron Reflects Severity of Alzheimer's Disease.
    J Alzheimers Dis. 2018 Aug 7. pii: JAD180317. doi: 10.3233/JAD-180317.
    PubMed     Text format     Abstract available


  47. RITCHIE K, Carriere I, Howett D, Su L, et al
    Allocentric and Egocentric Spatial Processing in Middle-Aged Adults at High Risk of Late-Onset Alzheimer's Disease: The PREVENT Dementia Study.
    J Alzheimers Dis. 2018 Aug 4. pii: JAD180432. doi: 10.3233/JAD-180432.
    PubMed     Text format     Abstract available


  48. DUINKERKEN EV, Farme J, Landeira-Fernandez J, Dourado MC, et al
    Medical and Research Consent Decision-Making Capacity in Patients with Alzheimer's Disease: A Systematic Review.
    J Alzheimers Dis. 2018 Aug 3. pii: JAD180311. doi: 10.3233/JAD-180311.
    PubMed     Text format     Abstract available


  49. ZALETEL I, Schwirtlich M, Perovic M, Jovanovic M, et al
    Early Impairments of Hippocampal Neurogenesis in 5xFAD Mouse Model of Alzheimer's Disease Are Associated with Altered Expression of SOXB Transcription Factors.
    J Alzheimers Dis. 2018 Aug 3. pii: JAD180277. doi: 10.3233/JAD-180277.
    PubMed     Text format     Abstract available


  50. LIZIO R, Babiloni C, Percio CD, Losurdo A, et al
    Different Abnormalities of Cortical Neural Synchronization Mechanisms in Patients with Mild Cognitive Impairment due to Alzheimer's and Chronic Kidney Diseases: An EEG Study.
    J Alzheimers Dis. 2018 Aug 3. pii: JAD180245. doi: 10.3233/JAD-180245.
    PubMed     Text format     Abstract available


  51. SCHELTENS NME, Tijms BM, Heymans MW, Rabinovici GD, et al
    Prominent Non-Memory Deficits in Alzheimer's Disease Are Associated with Faster Disease Progression.
    J Alzheimers Dis. 2018 Aug 3. pii: JAD171088. doi: 10.3233/JAD-171088.
    PubMed     Text format     Abstract available


    July 2018
  52. KERET O, Shochat T, Steiner I, Glik A, et al
    Non-Ashkenazi Jewish Origin is Associated with Early Onset Alzheimer's Disease.
    J Alzheimers Dis. 2018 Jul 30. pii: JAD180331. doi: 10.3233/JAD-180331.
    PubMed     Text format     Abstract available


  53. ZOLOCHEVSKA O, Bjorklund N, Woltjer R, Wiktorowicz JE, et al
    Postsynaptic Proteome of Non-Demented Individuals with Alzheimer's Disease Neuropathology.
    J Alzheimers Dis. 2018 Jul 30. pii: JAD180179. doi: 10.3233/JAD-180179.
    PubMed     Text format     Abstract available


  54. SLEGERS A, Filiou RP, Montembeault M, Brambati SM, et al
    Connected Speech Features from Picture Description in Alzheimer's Disease: A Systematic Review.
    J Alzheimers Dis. 2018 Jul 30. pii: JAD170881. doi: 10.3233/JAD-170881.
    PubMed     Text format     Abstract available


  55. KONTAXOPOULOU D, Beratis IN, Fragkiadaki S, Pavlou D, et al
    Exploring the Profile of Incidental Memory in Patients with Amnestic Mild Cognitive Impairment and Mild Alzheimer's Disease.
    J Alzheimers Dis. 2018 Jul 27. pii: JAD180328. doi: 10.3233/JAD-180328.
    PubMed     Text format     Abstract available


  56. LEE J, Cho H, Jeon S, Jin Kim H, et al
    Sex-Related Reserve Hypothesis in Alzheimer's Disease: Changes in Cortical Thickness with a Five-Year Longitudinal Follow-Up.
    J Alzheimers Dis. 2018 Jul 26. pii: JAD180049. doi: 10.3233/JAD-180049.
    PubMed     Text format     Abstract available


  57. MANUEL GORRIZ J, Iglesias-Gonzalez E, Ramirez J
    Multivariate Approaches in Neuroimaging: Assessing the Connectome of Alzheimer's Disease.
    J Alzheimers Dis. 2018 Jul 21. pii: JAD180654. doi: 10.3233/JAD-180654.
    PubMed     Text format    


  58. BOHLKEN J, Kostev K
    Relevance of Coded Prodromal Mild Cognitive Impairment in the Routine Treatment of Patients with Dementia in Germany.
    J Alzheimers Dis. 2018 Jul 21. pii: JAD180567. doi: 10.3233/JAD-180567.
    PubMed     Text format     Abstract available


  59. GUERRIER L, Men JL, Gane A, Planton M, et al
    Involvement of the Cingulate Cortex in Anosognosia: A Multimodal Neuroimaging Study in Alzheimer's Disease Patients.
    J Alzheimers Dis. 2018 Jul 20. pii: JAD180324. doi: 10.3233/JAD-180324.
    PubMed     Text format     Abstract available


  60. DE LA RUBIA ORTI JE, Garcia-Pardo MRIP, Drehmer E, Cantus DS, et al
    Improvement of Main Cognitive Functions in Patients with Alzheimer's Disease after Treatment with Coconut Oil Enriched Mediterranean Diet: A Pilot Study.
    J Alzheimers Dis. 2018 Jul 20. pii: JAD180184. doi: 10.3233/JAD-180184.
    PubMed     Text format     Abstract available


  61. JIN H, Guan S, Wang R, Fang X, et al
    The Distribution of Urinary Alzheimer-Associated Neuronal Thread Protein and Its Association with Common Chronic Diseases in the General Population.
    J Alzheimers Dis. 2018 Jul 19. pii: JAD180441. doi: 10.3233/JAD-180441.
    PubMed     Text format     Abstract available


  62. RAIKWAR SP, Thangavel R, Dubova I, Ejaz Ahmed M, et al
    Neuro-Immuno-Gene- and Genome-Editing-Therapy for Alzheimer's Disease: Are We There Yet?
    J Alzheimers Dis. 2018 Jul 19. pii: JAD180422. doi: 10.3233/JAD-180422.
    PubMed     Text format     Abstract available


  63. STEFFEN J, Stenzel J, Ibrahim S, Pahnke J, et al
    Short-Term Effects of Microglia-Specific Mitochondrial Dysfunction on Amyloidosis in Transgenic Models of Alzheimer's Disease.
    J Alzheimers Dis. 2018 Jul 19. pii: JAD180395. doi: 10.3233/JAD-180395.
    PubMed     Text format     Abstract available


  64. MCDERMOTT B, Porter E, Hughes D, McGinley B, et al
    Gamma Band Neural Stimulation in Humans and the Promise of a New Modality to Prevent and Treat Alzheimer's Disease.
    J Alzheimers Dis. 2018 Jul 19. pii: JAD180391. doi: 10.3233/JAD-180391.
    PubMed     Text format     Abstract available


  65. SCOTT TM, Bhadelia RA, Qiao Qiu W, Folstein MF, et al
    Small Vessel Cerebrovascular Pathology Identified by Magnetic Resonance Imaging Is Prevalent in Alzheimer's Disease and Mild Cognitive Impairment: A Potential Target for Intervention.
    J Alzheimers Dis. 2018 Jul 18. pii: JAD180366. doi: 10.3233/JAD-180366.
    PubMed     Text format     Abstract available


  66. AGUAYO S, Schuh CMAP, Vicente B, Aguayo LG, et al
    Association between Alzheimer's Disease and Oral and Gut Microbiota: Are Pore Forming Proteins the Missing Link?
    J Alzheimers Dis. 2018 Jul 18. pii: JAD180319. doi: 10.3233/JAD-180319.
    PubMed     Text format     Abstract available


  67. YAO F, Hong X, Li S, Zhang Y, et al
    Urine-Based Biomarkers for Alzheimer's Disease Identified Through Coupling Computational and Experimental Methods.
    J Alzheimers Dis. 2018 Jul 18. pii: JAD180261. doi: 10.3233/JAD-180261.
    PubMed     Text format     Abstract available


  68. SOBOL NA, Have Dall C, Hgh P, Hoffmann K, et al
    Change in Fitness and the Relation to Change in Cognition and Neuropsychiatric Symptoms After Aerobic Exercise in Patients with Mild Alzheimer's Disease.
    J Alzheimers Dis. 2018 Jul 18. pii: JAD180253. doi: 10.3233/JAD-180253.
    PubMed     Text format     Abstract available


  69. MERCORIO R, Pergoli L, Galimberti D, Favero C, et al
    PICALM Gene Methylation in Blood of Alzheimer's Disease Patients Is Associated with Cognitive Decline.
    J Alzheimers Dis. 2018 Jul 18. pii: JAD180242. doi: 10.3233/JAD-180242.
    PubMed     Text format     Abstract available


  70. CRUZ-RIVERA YE, Perez-Morales J, Santiago YM, Gonzalez VM, et al
    A Selection of Important Genes and Their Correlated Behavior in Alzheimer's Disease.
    J Alzheimers Dis. 2018 Jul 18. pii: JAD170799. doi: 10.3233/JAD-170799.
    PubMed     Text format     Abstract available


  71. WATAD A, Bragazzi NL, Tiosano S, Yavne Y, et al
    Alzheimer's Disease in Systemic Sclerosis Patients: A Nationwide Population-Based Cohort Study.
    J Alzheimers Dis. 2018 Jul 17. pii: JAD180516. doi: 10.3233/JAD-180516.
    PubMed     Text format     Abstract available


  72. PANDAREESH MD, Chauhan V, Chauhan A
    Walnut Supplementation in the Diet Reduces Oxidative Damage and Improves Antioxidant Status in Transgenic Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2018 Jul 17. pii: JAD180361. doi: 10.3233/JAD-180361.
    PubMed     Text format     Abstract available


  73. ROCHA NP, Toledo A, Corgosinho LTS, Souza LC, et al
    Cerebrospinal Fluid Levels of Angiotensin-Converting Enzyme Are Associated with Amyloid-beta42 Burden in Alzheimer's Disease.
    J Alzheimers Dis. 2018 Jul 17. pii: JAD180282. doi: 10.3233/JAD-180282.
    PubMed     Text format     Abstract available


  74. GUZMAN-VELEZ E, Jaimes S, Aguirre-Acevedo DC, Norton DJ, et al
    A Three-Factor Structure of Cognitive Functioning Among Carriers and Non-Carriers of Autosomal-Dominant Alzheimer's Disease.
    J Alzheimers Dis. 2018 Jul 17. pii: JAD180078. doi: 10.3233/JAD-180078.
    PubMed     Text format     Abstract available


  75. SHAO Y, Jiang H, Wei Y, Shi Y, et al
    Visualization of Focal Thinning of the Ganglion Cell- Inner Plexiform Layer in Patients with Mild Cognitive Impairment and Alzheimer's Disease.
    J Alzheimers Dis. 2018 Jul 17. pii: JAD180070. doi: 10.3233/JAD-180070.
    PubMed     Text format     Abstract available


  76. PITON M, Hirtz C, Desmetz C, Milhau J, et al
    Alzheimer's Disease: Advances in Drug Development.
    J Alzheimers Dis. 2018 Jul 16. pii: JAD180145. doi: 10.3233/JAD-180145.
    PubMed     Text format     Abstract available


  77. PADOVANI A, Benussi A, Cantoni V, Dell'Era V, et al
    Diagnosis of Mild Cognitive Impairment Due to Alzheimer's Disease with Transcranial Magnetic Stimulation.
    J Alzheimers Dis. 2018 Jul 13. pii: JAD180293. doi: 10.3233/JAD-180293.
    PubMed     Text format     Abstract available


  78. SMAILAGIC N, Lafortune L, Kelly S, Hyde C, et al
    18F-FDG PET for Prediction of Conversion to Alzheimer's Disease Dementia in People with Mild Cognitive Impairment: An Updated Systematic Review of Test Accuracy.
    J Alzheimers Dis. 2018 Jul 13. pii: JAD171125. doi: 10.3233/JAD-171125.
    PubMed     Text format     Abstract available


  79. BRENDEL M, Sauerbeck J, Greven S, Kotz S, et al
    Serotonin Selective Reuptake Inhibitor Treatment Improves Cognition and Grey Matter Atrophy but not Amyloid Burden During Two-Year Follow-Up in Mild Cognitive Impairment and Alzheimer's Disease Patients with Depressive Symptoms.
    J Alzheimers Dis. 2018 Jul 13. pii: JAD170387. doi: 10.3233/JAD-170387.
    PubMed     Text format     Abstract available


  80. CASAMITJANA A, Petrone P, Tucholka A, Falcon C, et al
    MRI-Based Screening of Preclinical Alzheimer's Disease for Prevention Clinical Trials.
    J Alzheimers Dis. 2018 Jul 12. pii: JAD180299. doi: 10.3233/JAD-180299.
    PubMed     Text format     Abstract available


  81. NI H, Xu M, Zhan GL, Fan Y, et al
    The GWAS Risk Genes for Depression May Be Actively Involved in Alzheimer's Disease.
    J Alzheimers Dis. 2018 Jul 12. pii: JAD180276. doi: 10.3233/JAD-180276.
    PubMed     Text format     Abstract available


  82. E WHITSON H, G Potter G, A Feld J, L Plassman B, et al
    Dual-Task Gait and Alzheimer's Disease Genetic Risk in Cognitively Normal Adults: A Pilot Study.
    J Alzheimers Dis. 2018 Jul 12. pii: JAD180016. doi: 10.3233/JAD-180016.
    PubMed     Text format     Abstract available


  83. MUSAEUS CS, Engedal K, Hgh P, Jelic V, et al
    EEG Theta Power Is an Early Marker of Cognitive Decline in Dementia due to Alzheimer's Disease.
    J Alzheimers Dis. 2018 Jul 6. pii: JAD180300. doi: 10.3233/JAD-180300.
    PubMed     Text format     Abstract available


  84. KENT BA, Strittmatter SM, Nygaard H
    Sleep and EEG Power Spectral Analysis in Three Transgenic Mouse Models of Alzheimer's Disease: APP/PS1, 3xTgAD, and Tg2576.
    J Alzheimers Dis. 2018 Jul 6. pii: JAD180260. doi: 10.3233/JAD-180260.
    PubMed     Text format     Abstract available


  85. THYGESEN C, Metaxas A, Larsen MR, Finsen B, et al
    Age-Dependent Changes in the Sarkosyl-Insoluble Proteome of APPSWE/PS1DeltaE9 Transgenic Mice Implicate Dysfunctional Mitochondria in the Pathogenesis of Alzheimer's Disease.
    J Alzheimers Dis. 2018 Jul 6. pii: JAD180197. doi: 10.3233/JAD-180197.
    PubMed     Text format     Abstract available


  86. LYU J, Zhang J, Mu H, Li W, et al
    The Effects of Music Therapy on Cognition, Psychiatric Symptoms, and Activities of Daily Living in Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2018 Jul 6. pii: JAD180183. doi: 10.3233/JAD-180183.
    PubMed     Text format     Abstract available


    June 2018
  87. SAO T, Yoshino Y, Yamazaki K, Ozaki Y, et al
    TREM1 mRNA Expression in Leukocytes and Cognitive Function in Japanese Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2018 Jun 28. pii: JAD180418. doi: 10.3233/JAD-180418.
    PubMed     Text format     Abstract available


  88. SAHOO A, Benjanin A, Murray ME, Tosakulwong N, et al
    TDP-43 and Alzheimer's Disease Pathologic Subtype in Non-Amnestic Alzheimer's Disease Dementia.
    J Alzheimers Dis. 2018 Jun 28. pii: JAD180169. doi: 10.3233/JAD-180169.
    PubMed     Text format     Abstract available


  89. R BEAM C, Kaneshiro C, Yun Jang J, A Reynolds C, et al
    Differences Between Women and Men in Incidence Rates of Dementia and Alzheimer's Disease.
    J Alzheimers Dis. 2018 Jun 27. pii: JAD180141. doi: 10.3233/JAD-180141.
    PubMed     Text format     Abstract available


  90. FEMMINELLA GD, Taylor-Davies G, Scott J, Edison P, et al
    Do Cardiometabolic Risk Factors Influence Amyloid, Tau, and Neuronal Function in APOE4 Carriers and Non-Carriers in Alzheimer's Disease Trajectory?
    J Alzheimers Dis. 2018 Jun 23. pii: JAD180365. doi: 10.3233/JAD-1803656.
    PubMed     Text format     Abstract available


  91. RITCHIE CW, Khandker RK, Pike J, Black CM, et al
    Real-World, Multinational, Retrospective Observational Survey of the ADAS-Cog and Associations with Healthcare Resource Utilization in Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2018 Jun 23. pii: JAD180306. doi: 10.3233/JAD-180306.
    PubMed     Text format     Abstract available


  92. CHEN Y, Lim P, Rogers KA, Rutt BK, et al
    In Vivo MRI of Amyloid Plaques in a Cholesterol-Fed Rabbit Model of Alzheimer's Disease.
    J Alzheimers Dis. 2018 Jun 23. pii: JAD180207. doi: 10.3233/JAD-180207.
    PubMed     Text format     Abstract available


  93. SCHARTMANN E, Schemmert S, Niemietz N, Honold D, et al
    In Vitro Potency and Preclinical Pharmacokinetic Comparison of All-D-Enantiomeric Peptides Developed for the Treatment of Alzheimer's Disease.
    J Alzheimers Dis. 2018 Jun 23. pii: JAD180165. doi: 10.3233/JAD-180165.
    PubMed     Text format     Abstract available


  94. PILLAI JA, Appleby BS, Safar J, Leverenz JB, et al
    Rapidly Progressive Alzheimer's Disease in Two Distinct Autopsy Cohorts.
    J Alzheimers Dis. 2018 Jun 23. pii: JAD180155. doi: 10.3233/JAD-180155.
    PubMed     Text format     Abstract available


  95. DERK J, Bermudez Hernandez K, Rodriguez M, He M, et al
    Diaphanous 1 (DIAPH1) is Highly Expressed in the Aged Human Medial Temporal Cortex and Upregulated in Myeloid Cells During Alzheimer's Disease.
    J Alzheimers Dis. 2018 Jun 23. pii: JAD180088. doi: 10.3233/JAD-180088.
    PubMed     Text format     Abstract available


  96. BARTOS A, Fialova L, Svarcova J
    Lower Serum Antibodies Against Tau Protein and Heavy Neurofilament in Alzheimer's Disease.
    J Alzheimers Dis. 2018 Jun 23. pii: JAD180039. doi: 10.3233/JAD-180039.
    PubMed     Text format     Abstract available


  97. RUIZ E, Ramirez J, Gorriz JM, Casillas J, et al
    Alzheimer's Disease Computer-Aided Diagnosis: Histogram-Based Analysis of Regional MRI Volumes for Feature Selection and Classification.
    J Alzheimers Dis. 2018 Jun 23. pii: JAD170514. doi: 10.3233/JAD-170514.
    PubMed     Text format     Abstract available


  98. LARSSON SC, Markus HS
    Does Treating Vascular Risk Factors Prevent Dementia and Alzheimer's Disease? A Systematic Review and Meta-Analysis.
    J Alzheimers Dis. 2018 Jun 9. pii: JAD180288. doi: 10.3233/JAD-180288.
    PubMed     Text format     Abstract available


  99. AKHTER H, Huang WT, van Groen T, Kuo HC, et al
    A Small Molecule Inhibitor of Plasminogen Activator Inhibitor-1 Reduces Brain Amyloid-beta Load and Improves Memory in an Animal Model of Alzheimer's Disease.
    J Alzheimers Dis. 2018 Jun 9. pii: JAD180241. doi: 10.3233/JAD-180241.
    PubMed     Text format     Abstract available


  100. HAAPALA EA, Paananen J, Hiltunen M, Lakka TA, et al
    Associations of Genetic Susceptibility to Alzheimer's Disease with Adiposity and Cardiometabolic Risk Factors among Children in a 2-Year Follow-up Study.
    J Alzheimers Dis. 2018 Jun 9. pii: JAD180216. doi: 10.3233/JAD-180216.
    PubMed     Text format     Abstract available


  101. CROTEAU E, Castellano CA, Richard MA, Fortier M, et al
    Ketogenic Medium Chain Triglycerides Increase Brain Energy Metabolism in Alzheimer's Disease.
    J Alzheimers Dis. 2018 Jun 9. pii: JAD180202. doi: 10.3233/JAD-180202.
    PubMed     Text format     Abstract available


  102. MARIZZONI M, Ferrari C, Jovicich J, Albani D, et al
    Predicting and Tracking Short Term Disease Progression in Amnestic Mild Cognitive Impairment Patients with Prodromal Alzheimer's Disease: Structural Brain Biomarkers.
    J Alzheimers Dis. 2018 Jun 9. pii: JAD180152. doi: 10.3233/JAD-180152.
    PubMed     Text format     Abstract available


  103. LEOUTSAKOS JS, Yan H, Anderson WS, Asaad WF, et al
    Deep Brain Stimulation Targeting the Fornix for Mild Alzheimer Dementia (the ADvance Trial): A Two Year Follow-up Including Results of Delayed Activation.
    J Alzheimers Dis. 2018 Jun 9. pii: JAD180121. doi: 10.3233/JAD-180121.
    PubMed     Text format     Abstract available


  104. TEIPEL SJ, Metzger C, Brosseron F, Buerger K, et al
    Multicenter Resting State Functional Connectivity in Prodromal and Dementia Stages of Alzheimer's Disease.
    J Alzheimers Dis. 2018 Jun 9. pii: JAD180106. doi: 10.3233/JAD-180106.
    PubMed     Text format     Abstract available


  105. HUTTON CP, Lemon JA, Sakic B, Rollo CD, et al
    Early Intervention with a Multi-Ingredient Dietary Supplement Improves Mood and Spatial Memory in a Triple Transgenic Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2018 Jun 9. pii: JAD170921. doi: 10.3233/JAD-170921.
    PubMed     Text format     Abstract available


  106. GIIL LM, Aarsland D, Hellton K, Lund A, et al
    Antibodies to Multiple Receptors are Associated with Neuropsychiatric Symptoms and Mortality in Alzheimer's Disease: A Longitudinal Study.
    J Alzheimers Dis. 2018 Jun 9. pii: JAD170882. doi: 10.3233/JAD-170882.
    PubMed     Text format     Abstract available


  107. CHALATSA I, Arvanitis DA, Mikropoulou EV, Giagini A, et al
    Beneficial Effects of Sideritis scardica and Cichorium spinosum against Amyloidogenic Pathway and Tau Misprocessing in Alzheimer's Disease Neuronal Cell Culture Models.
    J Alzheimers Dis. 2018 Jun 9. pii: JAD170862. doi: 10.3233/JAD-170862.
    PubMed     Text format     Abstract available


  108. BARNES J, Bartlett JW, Wolk DA, van der Flier WM, et al
    Disease Course Varies According to Age and Symptom Length in Alzheimer's Disease.
    J Alzheimers Dis. 2018 Jun 9. pii: JAD170841. doi: 10.3233/JAD-170841.
    PubMed     Text format     Abstract available


  109. BROOKES KJ, McConnell G, Williams K, Chaudhury S, et al
    Genotyping of the Alzheimer's Disease Genome-Wide Association Study Index Single Nucleotide Polymorphisms in the Brains for Dementia Research Cohort.
    J Alzheimers Dis. 2018 Jun 8. pii: JAD180191. doi: 10.3233/JAD-180191.
    PubMed     Text format     Abstract available


  110. FURCILA D, DeFelipe J, Alonso-Nanclares L
    A Study of Amyloid-beta and Phosphotau in Plaques and Neurons in the Hippocampus of Alzheimer's Disease Patients.
    J Alzheimers Dis. 2018 Jun 8. pii: JAD180173. doi: 10.3233/JAD-180173.
    PubMed     Text format     Abstract available


  111. JARVINEN H, Taipale H, Koponen M, Tanskanen A, et al
    Hospitalization after Oral Antibiotic Initiation in Finnish Community Dwellers with and without Alzheimer's Disease: Retrospective Register-Based Cohort Study.
    J Alzheimers Dis. 2018 Jun 8. pii: JAD180125. doi: 10.3233/JAD-180125.
    PubMed     Text format     Abstract available


  112. MADSEN JB, Folke J, Pakkenberg B
    Stereological Quantification of Plaques and Tangles in Neocortex from Alzheimer's Disease Patients.
    J Alzheimers Dis. 2018 Jun 8. pii: JAD180105. doi: 10.3233/JAD-180105.
    PubMed     Text format     Abstract available


  113. MARTINEZ-SANCHEZ F, Meilan JJG, Carro J, Ivanova O, et al
    A Prototype for the Voice Analysis Diagnosis of Alzheimer's Disease.
    J Alzheimers Dis. 2018 Jun 8. pii: JAD180037. doi: 10.3233/JAD-180037.
    PubMed     Text format     Abstract available


  114. SCHIRINZI T, Di Lorenzo F, Sancesario GM, Di Lazzaro G, et al
    Amyloid-Mediated Cholinergic Dysfunction in Motor Impairment Related to Alzheimer's Disease.
    J Alzheimers Dis. 2018 Jun 8. pii: JAD171166. doi: 10.3233/JAD-171166.
    PubMed     Text format     Abstract available


  115. SALLOWAY SP, Sperling R, Fox NC, Sabbagh MN, et al
    Long-Term Follow Up of Patients with Mild-to-Moderate Alzheimer's Disease Treated with Bapineuzumab in a Phase III, Open-Label, Extension Study.
    J Alzheimers Dis. 2018 Jun 8. pii: JAD171157. doi: 10.3233/JAD-171157.
    PubMed     Text format     Abstract available


  116. KAWANISHI S, Takata K, Itezono S, Nagayama H, et al
    Bone-Marrow-Derived Microglia-Like Cells Ameliorate Brain Amyloid Pathology and Cognitive Impairment in a Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2018 Jun 8. pii: JAD170994. doi: 10.3233/JAD-170994.
    PubMed     Text format     Abstract available


  117. RUIZ M, Arias A, Sanchez-Llanos E, Gil MP, et al
    Minor Hallucinations in Alzheimer's Disease.
    J Alzheimers Dis. 2018 Jun 4. pii: JAD180234. doi: 10.3233/JAD-180234.
    PubMed     Text format     Abstract available


    May 2018
  118. LI H, Jia J, Wang W, Hou T, et al
    Honokiol Alleviates Cognitive Deficits of Alzheimer's Disease (PS1V97L) Transgenic Mice by Activating Mitochondrial SIRT3.
    J Alzheimers Dis. 2018 May 31. pii: JAD180126. doi: 10.3233/JAD-180126.
    PubMed     Text format     Abstract available


  119. SCHMOLE AC, Lundt R, Toporowski G, Hansen JN, et al
    Cannabinoid Receptor 2-Deficiency Ameliorates Disease Symptoms in a Mouse Model with Alzheimer's Disease-Like Pathology.
    J Alzheimers Dis. 2018 May 28. pii: JAD180230. doi: 10.3233/JAD-180230.
    PubMed     Text format     Abstract available


  120. TIEPOLT S, Schafer A, Rullmann M, Roggenhofer E, et al
    Quantitative Susceptibility Mapping of Amyloid-beta Aggregates in Alzheimer's Disease with 7T MR.
    J Alzheimers Dis. 2018 May 28. pii: JAD180118. doi: 10.3233/JAD-180118.
    PubMed     Text format     Abstract available


  121. BARANOWSKI BJ, Hayward GC, Fajardo VA, MacPherson REK, et al
    Increased Prevalence of Obesity/Type 2 Diabetes and Lower Levels of Lithium in Rural Texas Counties May Explain Greater Alzheimer's Disease Risk.
    J Alzheimers Dis. 2018 May 28. pii: JAD171150. doi: 10.3233/JAD-171150.
    PubMed     Text format     Abstract available


  122. POSPORELIS S, David AS, Ashkan K, Shotbolt P, et al
    Deep Brain Stimulation of the Memory Circuit: Improving Cognition in Alzheimer's Disease.
    J Alzheimers Dis. 2018 May 26. pii: JAD180212. doi: 10.3233/JAD-180212.
    PubMed     Text format     Abstract available


  123. TAN MS, Zhu JX, Cao XP, Yu JT, et al
    Rare Variants in PLD3 Increase Risk for Alzheimer's Disease in Han Chinese.
    J Alzheimers Dis. 2018 May 26. pii: JAD180205. doi: 10.3233/JAD-180205.
    PubMed     Text format     Abstract available


  124. LLORENTE-OVEJERO A, Manuel I, Lombardero L, Giralt MT, et al
    Endocannabinoid and Muscarinic Signaling Crosstalk in the 3xTg-AD Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2018 May 26. pii: JAD180137. doi: 10.3233/JAD-180137.
    PubMed     Text format     Abstract available


  125. KAMINARI A, Tsilibary EC, Tzinia A
    A New Perspective in Utilizing MMP-9 as a Therapeutic Target for Alzheimer's Disease and Type 2 Diabetes Mellitus.
    J Alzheimers Dis. 2018 May 26. pii: JAD180035. doi: 10.3233/JAD-180035.
    PubMed     Text format     Abstract available


  126. LANE DJR, Ayton S, Bush AI
    Iron and Alzheimer's Disease: An Update on Emerging Mechanisms.
    J Alzheimers Dis. 2018 May 26. pii: JAD179944. doi: 10.3233/JAD-179944.
    PubMed     Text format     Abstract available


  127. SIGURDSSON EM
    Tau Immunotherapies for Alzheimer's Disease and Related Tauopathies: Progress and Potential Pitfalls.
    J Alzheimers Dis. 2018 May 26. pii: JAD179937. doi: 10.3233/JAD-179937.
    PubMed     Text format     Abstract available


  128. GULISANO W, Maugeri D, Baltrons MA, Fa M, et al
    Role of Amyloid-beta and Tau Proteins in Alzheimer's Disease: Confuting the Amyloid Cascade.
    J Alzheimers Dis. 2018 May 26. pii: JAD179935. doi: 10.3233/JAD-179935.
    PubMed     Text format     Abstract available


  129. EDISON P, Brooks DJ
    Role of Neuroinflammation in the Trajectory of Alzheimer's Disease and in vivo Quantification Using PET.
    J Alzheimers Dis. 2018 May 26. pii: JAD179929. doi: 10.3233/JAD-179929.
    PubMed     Text format     Abstract available


  130. VOS SJB, Visser PJ
    Preclinical Alzheimer's Disease: Implications for Refinement of the Concept.
    J Alzheimers Dis. 2018 May 23. pii: JAD179943. doi: 10.3233/JAD-179943.
    PubMed     Text format     Abstract available


  131. SCHERR M, Pasquini L, Benson G, Nuttall R, et al
    Decoupling of Local Metabolic Activity and Functional Connectivity Links to Amyloid in Alzheimer's Disease.
    J Alzheimers Dis. 2018 May 19. pii: JAD180022. doi: 10.3233/JAD-180022.
    PubMed     Text format     Abstract available


  132. ALOSCO ML, Sugarman MA, Besser LM, Tripodis Y, et al
    A Clinicopathological Investigation of White Matter Hyperintensities and Alzheimer's Disease Neuropathology.
    J Alzheimers Dis. 2018 May 19. pii: JAD180017. doi: 10.3233/JAD-180017.
    PubMed     Text format     Abstract available


  133. ADAMS SL, Benayoun L, Tilton K, Mellott TJ, et al
    Immunohistochemical Analysis of Activin Receptor-Like Kinase 1 (ACVRL1/ALK1) Expression in the Rat and Human Hippocampus: Decline in CA3 During Progression of Alzheimer's Disease.
    J Alzheimers Dis. 2018 May 18. pii: JAD171065. doi: 10.3233/JAD-171065.
    PubMed     Text format     Abstract available


  134. STEENLAND K, Zhao L, John SE, Goldstein FC, et al
    A 'Framingham-like' Algorithm for Predicting 4-Year Risk of Progression to Amnestic Mild Cognitive Impairment or Alzheimer's Disease Using Multidomain Information.
    J Alzheimers Dis. 2018 May 18. pii: JAD170769. doi: 10.3233/JAD-170769.
    PubMed     Text format     Abstract available


  135. COSTA M, Horrillo R, Ortiz AM, Perez A, et al
    Increased Albumin Oxidation in Cerebrospinal Fluid and Plasma from Alzheimer's Disease Patients.
    J Alzheimers Dis. 2018 May 16. pii: JAD180243. doi: 10.3233/JAD-180243.
    PubMed     Text format     Abstract available


  136. BOURGIN J, Guyader N, Chauvin A, Juphard A, et al
    Early Emotional Attention is Impacted in Alzheimer's Disease: An Eye-Tracking Study.
    J Alzheimers Dis. 2018 May 16. pii: JAD180170. doi: 10.3233/JAD-180170.
    PubMed     Text format     Abstract available


  137. MA FC, Wang HF, Cao XP, Tan CC, et al
    Meta-Analysis of the Association between Variants in ABCA7 and Alzheimer's Disease.
    J Alzheimers Dis. 2018 May 16. pii: JAD180107. doi: 10.3233/JAD-180107.
    PubMed     Text format     Abstract available


  138. CAI Z, Qiao PF, Wan CQ, Cai M, et al
    Role of Blood-Brain Barrier in Alzheimer's Disease.
    J Alzheimers Dis. 2018 May 16. pii: JAD180098. doi: 10.3233/JAD-180098.
    PubMed     Text format     Abstract available


  139. ANDRADE A, Bubu OM, Varga AW, Osorio RS, et al
    The Relationship between Obstructive Sleep Apnea and Alzheimer's Disease.
    J Alzheimers Dis. 2018 May 16. pii: JAD179936. doi: 10.3233/JAD-179936.
    PubMed     Text format     Abstract available


  140. MORMINO EC, Papp KV
    Amyloid Accumulation and Cognitive Decline in Clinically Normal Older Individuals: Implications for Aging and Early Alzheimer's Disease.
    J Alzheimers Dis. 2018 May 16. pii: JAD179928. doi: 10.3233/JAD-179928.
    PubMed     Text format     Abstract available


  141. BESSI V, Mazzeo S, Padiglioni S, Piccini C, et al
    From Subjective Cognitive Decline to Alzheimer's Disease: The Predictive Role of Neuropsychological Assessment, Personality Traits, and Cognitive Reserve. A 7-Year Follow-Up Study.
    J Alzheimers Dis. 2018 May 16. pii: JAD171180. doi: 10.3233/JAD-171180.
    PubMed     Text format     Abstract available


  142. MIRON J, Picard C, Frappier J, Dea D, et al
    TLR4 Gene Expression and Pro-Inflammatory Cytokines in Alzheimer's Disease and in Response to Hippocampal Deafferentation in Rodents.
    J Alzheimers Dis. 2018 May 16. pii: JAD171160. doi: 10.3233/JAD-171160.
    PubMed     Text format     Abstract available


  143. NIEMANTSVERDRIET E, Ribbens A, Bastin C, Benoit F, et al
    A Retrospective Belgian Multi-Center MRI Biomarker Study in Alzheimer's Disease (REMEMBER).
    J Alzheimers Dis. 2018 May 16. pii: JAD171140. doi: 10.3233/JAD-171140.
    PubMed     Text format     Abstract available


  144. PAIRE-FICOUT L, Lafont S, Conte F, Coquillat A, et al
    Naturalistic Driving Study Investigating Self-Regulation Behavior in Early Alzheimer's Disease: A Pilot Study.
    J Alzheimers Dis. 2018 May 16. pii: JAD171031. doi: 10.3233/JAD-171031.
    PubMed     Text format     Abstract available


  145. MOUSTAFA AA, El Haj M
    Phenomenological Characteristics of Future Thinking in Alzheimer's Disease.
    J Alzheimers Dis. 2018 May 11. pii: JAD180182. doi: 10.3233/JAD-180182.
    PubMed     Text format     Abstract available


  146. ZHUANG ZQ, Shen LL, Li WW, Fu X, et al
    Gut Microbiome is Altered in Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2018 May 11. pii: JAD180176. doi: 10.3233/JAD-180176.
    PubMed     Text format     Abstract available


  147. QUINN J
    Lost in Translation? Finding Our Way To Effective Alzheimer's Disease Therapies.
    J Alzheimers Dis. 2018 May 11. pii: JAD179930. doi: 10.3233/JAD-179930.
    PubMed     Text format     Abstract available


  148. ZETTERBERG H, Blennow K
    From Cerebrospinal Fluid to Blood: The Third Wave of Fluid Biomarkers for Alzheimer's Disease.
    J Alzheimers Dis. 2018 May 11. pii: JAD179926. doi: 10.3233/JAD-179926.
    PubMed     Text format     Abstract available


  149. ROUDIL J, Deramecourt V, Dufournet B, Dubois B, et al
    Influence of Lewy Pathology on Alzheimer's Disease Phenotype: A Retrospective Clinico-Pathological Study.
    J Alzheimers Dis. 2018 May 11. pii: JAD170914. doi: 10.3233/JAD-170914.
    PubMed     Text format     Abstract available


    April 2018
  150. HONG YJ, Choi SH, Jeong JH, Park KW, et al
    Effectiveness of Anti-Dementia Drugs in Extremely Severe Alzheimer's Disease: A 12-Week, Multicenter, Randomized, Single-Blind Study.
    J Alzheimers Dis. 2018 Apr 28. pii: JAD180159. doi: 10.3233/JAD-180159.
    PubMed     Text format     Abstract available


  151. MAHAMAN YAR, Huang F, Wu M, Wang Y, et al
    Moringa Oleifera Alleviates Homocysteine-Induced Alzheimer's Disease-Like Pathology and Cognitive Impairments.
    J Alzheimers Dis. 2018 Apr 28. pii: JAD180091. doi: 10.3233/JAD-180091.
    PubMed     Text format     Abstract available


  152. GRILL JD, Hoang D, Gillen DL, Cox CG, et al
    Constructing a Local Potential Participant Registry to Improve Alzheimer's Disease Clinical Research Recruitment.
    J Alzheimers Dis. 2018 Apr 28. pii: JAD180069. doi: 10.3233/JAD-180069.
    PubMed     Text format     Abstract available


  153. PROSERPIO P, Arnaldi D, Nobili F, Nobili L, et al
    Integrating Sleep and Alzheimer's Disease Pathophysiology: Hints for Sleep Disorders Management.
    J Alzheimers Dis. 2018 Apr 28. pii: JAD180041. doi: 10.3233/JAD-180041.
    PubMed     Text format     Abstract available


  154. MENDEZ MF, Moheb N, Desarzant RE, Teng EH, et al
    The Progressive Acalculia Presentation of Parietal Variant Alzheimer's Disease.
    J Alzheimers Dis. 2018 Apr 28. pii: JAD180024. doi: 10.3233/JAD-180024.
    PubMed     Text format     Abstract available


  155. TYUMENTSEV MA, Stefanova NA, Muraleva NA, Rumyantseva YV, et al
    Mitochondrial Dysfunction as a Predictor and Driver of Alzheimer's Disease-Like Pathology in OXYS Rats.
    J Alzheimers Dis. 2018 Apr 27. pii: JAD180065. doi: 10.3233/JAD-180065.
    PubMed     Text format     Abstract available


  156. LEE JH, Jahrling JB, Denner L, Dineley KT, et al
    Targeting Insulin for Alzheimer's Disease: Mechanisms, Status and Potential Directions.
    J Alzheimers Dis. 2018 Apr 27. pii: JAD179923. doi: 10.3233/JAD-179923.
    PubMed     Text format     Abstract available


  157. HORVATH A, Szucs A, Hidasi Z, Csukly G, et al
    Prevalence, Semiology, and Risk Factors of Epilepsy in Alzheimer's Disease: An Ambulatory EEG Study.
    J Alzheimers Dis. 2018 Apr 27. pii: JAD170925. doi: 10.3233/JAD-170925.
    PubMed     Text format     Abstract available


  158. HUANG Y, Guo B, Shi B, Gao Q, et al
    Chinese Herbal Medicine Xueshuantong Enhances Cerebral Blood Flow and Improves Neural Functions in Alzheimer's Disease Mice.
    J Alzheimers Dis. 2018 Apr 27. pii: JAD170763. doi: 10.3233/JAD-170763.
    PubMed     Text format     Abstract available


  159. LEE WJ, Han CE, Aganj I, Seo SW, et al
    Distinct Patterns of Rich Club Organization in Alzheimer's Disease and Subcortical Vascular Dementia: A White Matter Network Study.
    J Alzheimers Dis. 2018 Apr 25. pii: JAD180027. doi: 10.3233/JAD-180027.
    PubMed     Text format     Abstract available


  160. CORTES N, Andrade V, Maccioni RB
    Behavioral and Neuropsychiatric Disorders in Alzheimer's Disease.
    J Alzheimers Dis. 2018 Apr 25. pii: JAD180005. doi: 10.3233/JAD-180005.
    PubMed     Text format     Abstract available


  161. SELLES MC, Oliveira MM, Ferreira ST
    Brain Inflammation Connects Cognitive and Non-Cognitive Symptoms in Alzheimer's Disease.
    J Alzheimers Dis. 2018 Apr 25. pii: JAD179925. doi: 10.3233/JAD-179925.
    PubMed     Text format     Abstract available


  162. WIMO A
    The End of the Beginning of the Alzheimer's Disease Nightmare: A Devil's Advocate's View.
    J Alzheimers Dis. 2018 Apr 25. pii: JAD179905. doi: 10.3233/JAD-179905.
    PubMed     Text format     Abstract available


  163. ABU-RUMEILEH S, Capellari S, Parchi P
    Rapidly Progressive Alzheimer's Disease: Contributions to Clinical-Pathological Definition and Diagnosis.
    J Alzheimers Dis. 2018 Apr 25. pii: JAD171181. doi: 10.3233/JAD-171181.
    PubMed     Text format     Abstract available


  164. SHI Y, Fang YY, Wei YP, Jiang Q, et al
    Melatonin in Synaptic Impairments of Alzheimer's Disease.
    J Alzheimers Dis. 2018 Apr 25. pii: JAD171178. doi: 10.3233/JAD-171178.
    PubMed     Text format     Abstract available


  165. MATSUOKA T, Imai A, Fujimoto H, Kato Y, et al
    Neural Correlates of Sleep Disturbance in Alzheimer's Disease: Role of the Precuneus in Sleep Disturbance.
    J Alzheimers Dis. 2018 Apr 25. pii: JAD171169. doi: 10.3233/JAD-171169.
    PubMed     Text format     Abstract available


  166. SEN A, Nelson TJ, Alkon DL, Hongpaisan J, et al
    Loss in PKC Epsilon Causes Downregulation of MnSOD and BDNF Expression in Neurons of Alzheimer's Disease Hippocampus.
    J Alzheimers Dis. 2018 Apr 25. pii: JAD171008. doi: 10.3233/JAD-171008.
    PubMed     Text format     Abstract available


  167. ALVAREZ XA, Alvarez I, Aleixandre M, Linares C, et al
    Severity-Related Increase and Cognitive Correlates of Serum VEGF Levels in Alzheimer's Disease ApoE4 Carriers.
    J Alzheimers Dis. 2018 Apr 25. pii: JAD160477. doi: 10.3233/JAD-160477.
    PubMed     Text format     Abstract available


  168. ARISPE N, De Maio A
    Memory Loss and the Onset of Alzheimer's Disease Could Be Under the Control of Extracellular Heat Shock Proteins.
    J Alzheimers Dis. 2018 Apr 17. pii: JAD180161. doi: 10.3233/JAD-180161.
    PubMed     Text format     Abstract available


  169. WADA M, Noda Y, Shinagawa S, Chung JK, et al
    Effect of Education on Alzheimer's Disease-Related Neuroimaging Biomarkers in Healthy Controls, and Participants with Mild Cognitive Impairment and Alzheimer's Disease: A Cross-Sectional Study.
    J Alzheimers Dis. 2018 Apr 17. pii: JAD171168. doi: 10.3233/JAD-171168.
    PubMed     Text format     Abstract available


  170. ANDRIUTA D, Roussel M, Barbay M, Despretz-Wannepain S, et al
    Differentiating between Alzheimer's Disease and Vascular Cognitive Impairment: Is the "Memory Versus Executive Function" Contrast Still Relevant?
    J Alzheimers Dis. 2018 Apr 17. pii: JAD171097. doi: 10.3233/JAD-171097.
    PubMed     Text format     Abstract available


  171. FANTONI ER, Chalkidou A, O' Brien JT, Farrar G, et al
    A Systematic Review and Aggregated Analysis on the Impact of Amyloid PET Brain Imaging on the Diagnosis, Diagnostic Confidence, and Management of Patients being Evaluated for Alzheimer's Disease.
    J Alzheimers Dis. 2018 Apr 16. pii: JAD171093. doi: 10.3233/JAD-171093.
    PubMed     Text format     Abstract available


  172. MAKOVAC E, Serra L, Di Domenico C, Marra C, et al
    Quantitative Magnetization Transfer of White Matter Tracts Correlates with Diffusion Tensor Imaging Indices in Predicting the Conversion from Mild Cognitive Impairment to Alzheimer's Disease.
    J Alzheimers Dis. 2018 Apr 16. pii: JAD170995. doi: 10.3233/JAD-170995.
    PubMed     Text format     Abstract available


  173. VOJDANI A, Vojdani E, Saidara E, Kharrazian D, et al
    Reaction of Amyloid-beta Peptide Antibody with Different Infectious Agents Involved in Alzheimer's Disease.
    J Alzheimers Dis. 2018 Apr 14. pii: JAD170961. doi: 10.3233/JAD-170961.
    PubMed     Text format     Abstract available


  174. HEYMANN P, Gienger R, Hett A, Muller S, et al
    Early Detection of Alzheimer's Disease Based on the Patient's Creative Drawing Process: First Results with a Novel Neuropsychological Testing Method.
    J Alzheimers Dis. 2018 Apr 14. pii: JAD170946. doi: 10.3233/JAD-170946.
    PubMed     Text format     Abstract available


  175. NOURIZIABARI B, Sarkar S, Tanninen SE, Dayton RD, et al
    Aberrant Cortical Event-Related Potentials During Associative Learning in Rat Models for Presymptomatic Stages of Alzheimer's Disease.
    J Alzheimers Dis. 2018 Apr 11. pii: JAD171033. doi: 10.3233/JAD-171033.
    PubMed     Text format     Abstract available


  176. KUEPER JK, Speechley M, Montero-Odasso M
    The Alzheimer's Disease Assessment Scale-Cognitive Subscale (ADAS-Cog): Modifications and Responsiveness in Pre-Dementia Populations. A Narrative Review.
    J Alzheimers Dis. 2018 Apr 11. pii: JAD170991. doi: 10.3233/JAD-170991.
    PubMed     Text format     Abstract available


  177. ROUCH I, Pongan E, Leveque Y, Tillmann B, et al
    Personality Modulates the Efficacy of Art Intervention on Chronic Pain in a Population of Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2018 Apr 11. pii: JAD170990. doi: 10.3233/JAD-170990.
    PubMed     Text format     Abstract available


  178. MEYER PF, Savard M, Poirier J, Labonte A, et al
    Bi-Directional Association of Cerebrospinal Fluid Immune Markers with Stage of Alzheimer's Disease Pathogenesis.
    J Alzheimers Dis. 2018 Apr 11. pii: JAD170887. doi: 10.3233/JAD-170887.
    PubMed     Text format     Abstract available


  179. WANG JH, Wu YJ, Tee BL, Lo RY, et al
    Medical Comorbidity in Alzheimer's Disease: A Nested Case-Control Study.
    J Alzheimers Dis. 2018 Apr 11. pii: JAD170786. doi: 10.3233/JAD-170786.
    PubMed     Text format     Abstract available


  180. MANDAL PK, Shukla D
    Brain Metabolic, Structural, and Behavioral Pattern Learning for Early Predictive Diagnosis of Alzheimer's Disease.
    J Alzheimers Dis. 2018 Apr 4. pii: JAD180063. doi: 10.3233/JAD-180063.
    PubMed     Text format     Abstract available


  181. VAN DEN BERG E, Geerlings MI, Biessels GJ, Nederkoorn PJ, et al
    White Matter Hyperintensities and Cognition in Mild Cognitive Impairment and Alzheimer's Disease: A Domain-Specific Meta-Analysis.
    J Alzheimers Dis. 2018 Apr 4. pii: JAD170573. doi: 10.3233/JAD-170573.
    PubMed     Text format     Abstract available


    March 2018
  182. D'AMELIO M, Serra L, Bozzali M
    Ventral Tegmental Area in Prodromal Alzheimer's Disease: Bridging the Gap between Mice and Humans.
    J Alzheimers Dis. 2018 Mar 30. pii: JAD180094. doi: 10.3233/JAD-180094.
    PubMed     Text format     Abstract available


  183. DE LA TORRE J
    The Vascular Hypothesis of Alzheimer's Disease: A Key to Preclinical Prediction of Dementia Using Neuroimaging.
    J Alzheimers Dis. 2018 Mar 29. pii: JAD180004. doi: 10.3233/JAD-180004.
    PubMed     Text format     Abstract available


  184. THORDARDOTTIR S, Graff C
    Findings from the Swedish Study on Familial Alzheimer's Disease Including the APP Swedish Double Mutation.
    J Alzheimers Dis. 2018 Mar 29. pii: JAD179922. doi: 10.3233/JAD-179922.
    PubMed     Text format     Abstract available


  185. KIDDLE SJ, Voyle N, Dobson RJB
    A Blood Test for Alzheimer's Disease: Progress, Challenges, and Recommendations.
    J Alzheimers Dis. 2018 Mar 29. pii: JAD179904. doi: 10.3233/JAD-179904.
    PubMed     Text format     Abstract available


  186. JULIAN A, Rioux-Bilan A, Ragot S, Krolak-Salmon P, et al
    Blood Inflammatory Mediators and Cognitive Decline in Alzheimer's Disease: A Two Years Longitudinal Study.
    J Alzheimers Dis. 2018 Mar 29. pii: JAD171131. doi: 10.3233/JAD-171131.
    PubMed     Text format     Abstract available


  187. KLOPPEL S, Kotschi M, Peter J, Egger K, et al
    Separating Symptomatic Alzheimer's Disease from Depression based on Structural MRI.
    J Alzheimers Dis. 2018 Mar 29. pii: JAD170964. doi: 10.3233/JAD-170964.
    PubMed     Text format     Abstract available


  188. FERNANDEZ G, Orozco D, Agamennoni O, Schumacher M, et al
    Visual Processing during Short-Term Memory Binding in Mild Alzheimer's Disease.
    J Alzheimers Dis. 2018 Mar 29. pii: JAD170728. doi: 10.3233/JAD-170728.
    PubMed     Text format     Abstract available


  189. RANSMAYR G, Hermann P, Sallinger K, Benke T, et al
    Caregiving and Caregiver Burden in Dementia Home Care: Results from the Prospective Dementia Registry (PRODEM) of the Austrian Alzheimer Society.
    J Alzheimers Dis. 2018 Mar 29. pii: JAD170657. doi: 10.3233/JAD-170657.
    PubMed     Text format     Abstract available


  190. MC ARDLE R, Morris R, Hickey A, Del Din S, et al
    Gait in Mild Alzheimer's Disease: Feasibility of Multi-Center Measurement in the Clinic and Home with Body-Worn Sensors: A Pilot Study.
    J Alzheimers Dis. 2018 Mar 28. pii: JAD171116. doi: 10.3233/JAD-171116.
    PubMed     Text format     Abstract available


  191. JIN H, Wang R, Liu Z, Jia Q, et al
    Some Methodological Characteristics of Alzheimer-Associated Urine Neuronal Thread Protein Detected by Enzyme-Linked Immunosorbent Assay.
    J Alzheimers Dis. 2018 Mar 28. pii: JAD171109. doi: 10.3233/JAD-171109.
    PubMed     Text format     Abstract available


  192. XIE L, Shinohara RT, Ittyerah R, Kuijf HJ, et al
    Automated Multi-Atlas Segmentation of Hippocampal and Extrahippocampal Subregions in Alzheimer's Disease at 3T and 7T: What Atlas Composition Works Best?
    J Alzheimers Dis. 2018 Mar 28. pii: JAD170932. doi: 10.3233/JAD-170932.
    PubMed     Text format     Abstract available


  193. HOU TT, Yang HY, Wang W, Wu QQ, et al
    Sulforaphane Inhibits the Generation of Amyloid-beta Oligomer and Promotes Spatial Learning and Memory in Alzheimer's Disease (PS1V97L) Transgenic Mice.
    J Alzheimers Dis. 2018 Mar 24. pii: JAD171110. doi: 10.3233/JAD-171110.
    PubMed     Text format     Abstract available


  194. KAMARA DM, Gangishetti U, Gearing M, Willis-Parker M, et al
    Cerebral Amyloid Angiopathy: Similarity in African-Americans and Caucasians with Alzheimer's Disease.
    J Alzheimers Dis. 2018 Mar 24. pii: JAD170954. doi: 10.3233/JAD-170954.
    PubMed     Text format     Abstract available


  195. CARDILLO GM, de-Paula VJ, Ikenaga EH, Costa LR, et al
    Chronic Lithium Treatment Increases Telomere Length in Parietal Cortex and Hippocampus of Triple-Transgenic Alzheimer's Disease Mice.
    J Alzheimers Dis. 2018 Mar 24. pii: JAD170838. doi: 10.3233/JAD-170838.
    PubMed     Text format     Abstract available


  196. URBANOVA BS, Schwabova JP, Magerova H, Jansky P, et al
    Reduced Cerebrovascular Reserve Capacity as a Biomarker of Microangiopathy in Alzheimer's Disease and Mild Cognitive Impairment.
    J Alzheimers Dis. 2018 Mar 24. pii: JAD170815. doi: 10.3233/JAD-170815.
    PubMed     Text format     Abstract available


  197. TEUNISSEN CE, Chiu MJ, Yang CC, Yang SY, et al
    Plasma Amyloid-beta (Abeta42) Correlates with Cerebrospinal Fluid Abeta42 in Alzheimer's Disease.
    J Alzheimers Dis. 2018 Mar 24. pii: JAD170784. doi: 10.3233/JAD-170784.
    PubMed     Text format     Abstract available


  198. SCHEININ NM, Gardberg M, Roytta M, Rinne JO, et al
    Negative 11C-PIB PET Predicts Lack of Alzheimer's Disease Pathology in Postmortem Examination.
    J Alzheimers Dis. 2018 Mar 24. pii: JAD170569. doi: 10.3233/JAD-170569.
    PubMed     Text format     Abstract available


  199. BURNS N, Watts A, Perales J, Montgomery RN, et al
    The Impact of Creative Arts in Alzheimer's Disease and Dementia Public Health Education.
    J Alzheimers Dis. 2018 Mar 23. pii: JAD180092. doi: 10.3233/JAD-180092.
    PubMed     Text format     Abstract available


  200. GALBIATI A, Carli G, Hensley M, Ferini-Strambi L, et al
    REM Sleep Behavior Disorder and Alzheimer's Disease: Definitely No Relationship?
    J Alzheimers Dis. 2018 Mar 23. pii: JAD171164. doi: 10.3233/JAD-171164.
    PubMed     Text format     Abstract available


  201. MARESOVA P, Dolejs J, Kuca K
    Call for a Uniform Strategy of Collecting Alzheimer's Disease Costs: A Review and Meta-Analysis.
    J Alzheimers Dis. 2018 Mar 23. pii: JAD171028. doi: 10.3233/JAD-171028.
    PubMed     Text format     Abstract available


  202. DE MARCO M, Venneri A
    Volume and Connectivity of the Ventral Tegmental Area are Linked to Neurocognitive Signatures of Alzheimer's Disease in Humans.
    J Alzheimers Dis. 2018 Mar 23. pii: JAD171018. doi: 10.3233/JAD-171018.
    PubMed     Text format     Abstract available


  203. AGOSTINI S, Mancuso R, Hernis A, Costa AS, et al
    HSV-1-Specific IgG Subclasses Distribution and Serum Neutralizing Activity in Alzheimer's Disease and in Mild Cognitive Impairment.
    J Alzheimers Dis. 2018 Mar 23. pii: JAD170966. doi: 10.3233/JAD-170966.
    PubMed     Text format     Abstract available


  204. POWELL F, Tosun D, Sadeghi R, Weiner M, et al
    Preserved Structural Network Organization Mediates Pathology Spread in Alzheimer's Disease Spectrum Despite Loss of White Matter Tract Integrity.
    J Alzheimers Dis. 2018 Mar 23. pii: JAD170798. doi: 10.3233/JAD-170798.
    PubMed     Text format     Abstract available


  205. YAN T, Wang L, Gao J, Siedlak SL, et al
    Rab10 Phosphorylation is a Prominent Pathological Feature in Alzheimer's Disease.
    J Alzheimers Dis. 2018 Mar 16. pii: JAD180023. doi: 10.3233/JAD-180023.
    PubMed     Text format     Abstract available


  206. HAMPEL H, Toschi N, Babiloni C, Baldacci F, et al
    Revolution of Alzheimer Precision Neurology Passageway of Systems Biology and Neurophysiology.
    J Alzheimers Dis. 2018 Mar 16. pii: JAD179932. doi: 10.3233/JAD-179932.
    PubMed     Text format     Abstract available


  207. GONG CX, Liu F, Iqbal K
    Multifactorial Hypothesis and Multi-Targets for Alzheimer's Disease.
    J Alzheimers Dis. 2018 Mar 16. pii: JAD179921. doi: 10.3233/JAD-179921.
    PubMed     Text format     Abstract available


  208. TEIXEIRA CM, Pallas-Bazarra N, Bolos M, Terreros-Roncal J, et al
    Untold New Beginnings: Adult Hippocampal Neurogenesis and Alzheimer's Disease.
    J Alzheimers Dis. 2018 Mar 16. pii: JAD179918. doi: 10.3233/JAD-179918.
    PubMed     Text format     Abstract available


  209. HERNANDEZ F, Llorens-Martin M, Bolos M, Perez M, et al
    New Beginnings in Alzheimer's Disease: The Most Prevalent Tauopathy.
    J Alzheimers Dis. 2018 Mar 16. pii: JAD179916. doi: 10.3233/JAD-179916.
    PubMed     Text format     Abstract available


  210. GUTIERREZ A, Vitorica J
    Toward a New Concept of Alzheimer's Disease Models: A Perspective from Neuroinflammation.
    J Alzheimers Dis. 2018 Mar 16. pii: JAD179914. doi: 10.3233/JAD-179914.
    PubMed     Text format     Abstract available


  211. MCGEER PL, McGeer E
    Conquering Alzheimer's Disease by Self Treatment.
    J Alzheimers Dis. 2018 Mar 16. pii: JAD179913. doi: 10.3233/JAD-179913.
    PubMed     Text format     Abstract available


  212. CLARKE JR, Ribeiro FC, Frozza RL, De Felice FG, et al
    Metabolic Dysfunction in Alzheimer's Disease: From Basic Neurobiology to Clinical Approaches.
    J Alzheimers Dis. 2018 Mar 16. pii: JAD179911. doi: 10.3233/JAD-179911.
    PubMed     Text format     Abstract available


  213. PARNETTI L, Eusebi P
    Cerebrospinal Fluid Biomarkers in Alzheimer's Disease: An Invaluable Tool for Clinical Diagnosis and Trial Enrichment.
    J Alzheimers Dis. 2018 Mar 16. pii: JAD179910. doi: 10.3233/JAD-179910.
    PubMed     Text format     Abstract available


  214. DRUMMOND E, Goni F, Liu S, Prelli F, et al
    Potential Novel Approaches to Understand the Pathogenesis and Treat Alzheimer's Disease.
    J Alzheimers Dis. 2018 Mar 16. pii: JAD179909. doi: 10.3233/JAD-179909.
    PubMed     Text format     Abstract available


  215. NISBET RM, Gotz J
    Amyloid-beta and Tau in Alzheimer's Disease: Novel Pathomechanisms and Non-Pharmacological Treatment Strategies.
    J Alzheimers Dis. 2018 Mar 16. pii: JAD179907. doi: 10.3233/JAD-179907.
    PubMed     Text format     Abstract available


  216. MECOCCI P, Baroni M, Senin U, Boccardi V, et al
    Brain Aging and Late-Onset Alzheimer's Disease: A Matter of Increased Amyloid or Reduced Energy?
    J Alzheimers Dis. 2018 Mar 16. pii: JAD179903. doi: 10.3233/JAD-179903.
    PubMed     Text format     Abstract available


  217. CUMMINGS J, Ritter A, Zhong K
    Clinical Trials for Disease-Modifying Therapies in Alzheimer's Disease: A Primer, Lessons Learned, and a Blueprint for the Future.
    J Alzheimers Dis. 2018 Mar 16. pii: JAD179901. doi: 10.3233/JAD-179901.
    PubMed     Text format     Abstract available


  218. STIPHO F, Jackson R, Sabbagh MN
    Pathologically Confirmed Alzheimer's Disease in APOE varepsilon2 Homozygotes is Rare but Does Occur.
    J Alzheimers Dis. 2018 Mar 16. pii: JAD171060. doi: 10.3233/JAD-171060.
    PubMed     Text format     Abstract available


  219. COURTEMANCHE H, Bigot E, Pichelin M, Guyomarch B, et al
    PCSK9 Concentrations in Cerebrospinal Fluid Are Not Specifically Increased in Alzheimer's Disease.
    J Alzheimers Dis. 2018 Mar 16. pii: JAD170993. doi: 10.3233/JAD-170993.
    PubMed     Text format     Abstract available


  220. BALMIK AA, Chinnathambi S
    Multi-Faceted Role of Melatonin in Neuroprotection and Amelioration of Tau Aggregates in Alzheimer's Disease.
    J Alzheimers Dis. 2018 Mar 16. pii: JAD170900. doi: 10.3233/JAD-170900.
    PubMed     Text format     Abstract available


  221. HIRANO S, Shinotoh H, Shimada H, Ota T, et al
    Voxel-Based Acetylcholinesterase PET Study in Early and Late Onset Alzheimer's Disease.
    J Alzheimers Dis. 2018 Mar 16. pii: JAD170749. doi: 10.3233/JAD-170749.
    PubMed     Text format     Abstract available


  222. PENNY W, Iglesias-Fuster J, Quiroz YT, Lopera FJ, et al
    Dynamic Causal Modeling of Preclinical Autosomal-Dominant Alzheimer's Disease.
    J Alzheimers Dis. 2018 Mar 16. pii: JAD170405. doi: 10.3233/JAD-170405.
    PubMed     Text format     Abstract available


  223. KWAK K, Yun HJ, Park G, Lee JM, et al
    Multi-Modality Sparse Representation for Alzheimer's Disease Classification.
    J Alzheimers Dis. 2018 Mar 16. pii: JAD170338. doi: 10.3233/JAD-170338.
    PubMed     Text format     Abstract available


  224. GAUTHIER S, Ng KP, Pascoal TA, Zhang H, et al
    Targeting Alzheimer's Disease at the Right Time and the Right Place: Validation of a Personalized Approach to Diagnosis and Treatment.
    J Alzheimers Dis. 2018 Mar 1. pii: JAD179924. doi: 10.3233/JAD-179924.
    PubMed     Text format     Abstract available


    February 2018
  225. CHETELAT G
    Multimodal Neuroimaging in Alzheimer's Disease: Early Diagnosis, Physiopathological Mechanisms, and Impact of Lifestyle.
    J Alzheimers Dis. 2018 Feb 28. pii: JAD179920. doi: 10.3233/JAD-179920.
    PubMed     Text format     Abstract available


  226. MARTINI AC, Forner S, Trujillo-Estrada L, Baglietto-Vargas D, et al
    Past to Future: What Animal Models Have Taught Us About Alzheimer's Disease.
    J Alzheimers Dis. 2018 Feb 28. pii: JAD179917. doi: 10.3233/JAD-179917.
    PubMed     Text format     Abstract available


  227. STOCKBURGER C, Eckert S, Eckert GP, Friedland-Leuner K, et al
    Mitochondrial Function, Dynamics, and Permeability Transition: A Complex Love Triangle as A Possible Target for the Treatment of Brain Aging and Alzheimer's Disease.
    J Alzheimers Dis. 2018 Feb 28. pii: JAD179915. doi: 10.3233/JAD-179915.
    PubMed     Text format     Abstract available


  228. BUTTERFIELD DA
    Perspectives on Oxidative Stress in Alzheimer's Disease and Predictions of Future Research Emphases.
    J Alzheimers Dis. 2018 Feb 28. pii: JAD179912. doi: 10.3233/JAD-179912.
    PubMed     Text format     Abstract available


  229. GOSZTYLA ML, Brothers HM, Robinson SR
    Alzheimer's Amyloid-beta is an Antimicrobial Peptide: A Review of the Evidence.
    J Alzheimers Dis. 2018 Feb 28. pii: JAD171133. doi: 10.3233/JAD-171133.
    PubMed     Text format     Abstract available


  230. GHIDONI R, Squitti R, Siotto M, Benussi L, et al
    Innovative Biomarkers for Alzheimer's Disease: Focus on the Hidden Disease Biomarkers.
    J Alzheimers Dis. 2018 Feb 28. pii: JAD170953. doi: 10.3233/JAD-170953.
    PubMed     Text format     Abstract available


    January 2018
  231. REDDY PH, Manczak M, Yin X, Reddy AP, et al
    Synergistic Protective Effects of Mitochondrial Division Inhibitor 1 and Mitochondria-Targeted Small Peptide SS31 in Alzheimer's Disease.
    J Alzheimers Dis. 2018 Jan 30. pii: JAD170988. doi: 10.3233/JAD-170988.
    PubMed     Text format     Abstract available


  232. SCHARRE DW, Weichart E, Nielson D, Zhang J, et al
    Deep Brain Stimulation of Frontal Lobe Networks to Treat Alzheimer's Disease.
    J Alzheimers Dis. 2018 Jan 30. pii: JAD170082. doi: 10.3233/JAD-170082.
    PubMed     Text format     Abstract available


  233. BOUTS MJRJ, Moller C, Hafkemeijer A, van Swieten JC, et al
    Single Subject Classification of Alzheimer's Disease and Behavioral Variant Frontotemporal Dementia Using Anatomical, Diffusion Tensor, and Resting-State Functional Magnetic Resonance Imaging.
    J Alzheimers Dis. 2018 Jan 24. pii: JAD170893. doi: 10.3233/JAD-170893.
    PubMed     Text format     Abstract available


  234. ZHANG Y, Guo O, Huo Y, Wang G, et al
    Amyloid-beta Induces AMPA Receptor Ubiquitination and Degradation in Primary Neurons and Human Brains of Alzheimer's Disease.
    J Alzheimers Dis. 2018 Jan 24. pii: JAD170879. doi: 10.3233/JAD-170879.
    PubMed     Text format     Abstract available


  235. GRASSI M, Perna G, Caldirola D, Schruers K, et al
    A Clinically-Translatable Machine Learning Algorithm for the Prediction of Alzheimer's Disease Conversion in Individuals with Mild and Premild Cognitive Impairment.
    J Alzheimers Dis. 2018 Jan 17. pii: JAD170547. doi: 10.3233/JAD-170547.
    PubMed     Text format     Abstract available


  236. ROBINSON M, Lee BY, Hanes FT
    Recent Progress in Alzheimer's Disease Research, Part 2: Genetics and Epidemiology.
    J Alzheimers Dis. 2018;61:459.
    PubMed     Text format    


  237. CHATTERJEE P, Roy D, Rathi N
    Epigenetic Drug Repositioning for Alzheimer's Disease Based on Epigenetic Targets in Human Interactome.
    J Alzheimers Dis. 2018;61:53-65.
    PubMed     Text format     Abstract available


  238. LAO PJ, Handen BL, Betthauser TJ, Mihaila I, et al
    Alzheimer-Like Pattern of Hypometabolism Emerges with Elevated Amyloid-beta Burden in Down Syndrome.
    J Alzheimers Dis. 2018;61:631-644.
    PubMed     Text format     Abstract available


  239. DODICH A, Cerami C, Cappa SF, Marcone A, et al
    Combined Socio-Behavioral Evaluation Improves the Differential Diagnosis Between the Behavioral Variant of Frontotemporal Dementia and Alzheimer's Disease: In Search of Neuropsychological Markers.
    J Alzheimers Dis. 2018;61:761-772.
    PubMed     Text format     Abstract available


  240. VALECH N, Tort-Merino A, Coll-Padros N, Olives J, et al
    Executive and Language Subjective Cognitive Decline Complaints Discriminate Preclinical Alzheimer's Disease from Normal Aging.
    J Alzheimers Dis. 2018;61:689-703.
    PubMed     Text format     Abstract available


  241. CHAI YL, Xing H, Chong JR, Francis PT, et al
    Mitochondrial Translocase of the Outer Membrane Alterations May Underlie Dysfunctional Oxidative Phosphorylation in Alzheimer's Disease.
    J Alzheimers Dis. 2018;61:793-801.
    PubMed     Text format     Abstract available


  242. SAKSIDA T, Koprivica I, Vujicic M, Stosic-Grujicic S, et al
    Impaired IL-17 Production in Gut-Residing Immune Cells of 5xFAD Mice with Alzheimer's Disease Pathology.
    J Alzheimers Dis. 2018;61:619-630.
    PubMed     Text format     Abstract available


  243. WHARTON W, Goldstein FC, Tansey MG, Brown AL, et al
    Rationale and Design of the Mechanistic Potential of Antihypertensives in Preclinical Alzheimer's (HEART) Trial.
    J Alzheimers Dis. 2018;61:815-824.
    PubMed     Text format     Abstract available


  244. JONVEAUX TR, Fescharek R
    When Art Meets Gardens: Does It Enhance the Benefits? The Nancy Hypothesis of Care for Persons with Alzheimer's Disease.
    J Alzheimers Dis. 2018;61:885-898.
    PubMed     Text format     Abstract available


  245. CHIZIANE E, Telemann H, Krueger M, Adler J, et al
    Free Heme and Amyloid-beta: A Fatal Liaison in Alzheimer's Disease.
    J Alzheimers Dis. 2018;61:963-984.
    PubMed     Text format     Abstract available


  246. TAKENOSHITA S, Terada S, Yokota O, Kutoku Y, et al
    Sally-Anne Test in Patients with Alzheimer's Disease Dementia.
    J Alzheimers Dis. 2018;61:1029-1036.
    PubMed     Text format     Abstract available


  247. FAN Y, Luo R, Su LY, Xiang Q, et al
    Does the Genetic Feature of the Chinese Tree Shrew (Tupaia belangeri chinensis) Support Its Potential as a Viable Model for Alzheimer's Disease Research?
    J Alzheimers Dis. 2018;61:1015-1028.
    PubMed     Text format     Abstract available


  248. ROZZINI L, Lanfranchi F, Pilotto A, Catalani S, et al
    Serum Non-Ceruloplasmin Non-Albumin Copper Elevation in Mild Cognitive Impairment and Dementia due to Alzheimer's Disease: A Case Control Study.
    J Alzheimers Dis. 2018;61:907-912.
    PubMed     Text format     Abstract available


  249. HEMACHANDRA REDDY P, Manczak M, Yin X, Grady MC, et al
    Protective Effects of Indian Spice Curcumin Against Amyloid-beta in Alzheimer's Disease.
    J Alzheimers Dis. 2018;61:843-866.
    PubMed     Text format     Abstract available


  250. LIU G, Zhang Y, Wang L, Xu J, et al
    Alzheimer's Disease rs11767557 Variant Regulates EPHA1 Gene Expression Specifically in Human Whole Blood.
    J Alzheimers Dis. 2018;61:1077-1088.
    PubMed     Text format     Abstract available


  251. SNIR JA, Suchy M, Bindseil GA, Kovacs M, et al
    An Aspartyl Cathepsin Targeted PET Agent: Application in an Alzheimer's Disease Mouse Model.
    J Alzheimers Dis. 2018;61:1241-1252.
    PubMed     Text format     Abstract available


  252. WANG H, Stewart T, Toledo JB, Ginghina C, et al
    A Longitudinal Study of Total and Phosphorylated alpha-Synuclein with Other Biomarkers in Cerebrospinal Fluid of Alzheimer's Disease and Mild Cognitive Impairment.
    J Alzheimers Dis. 2018;61:1541-1553.
    PubMed     Text format     Abstract available


  253. SERPENTE M, Fenoglio C, Cioffi SMG, Oldoni E, et al
    Profiling of Specific Gene Expression Pathways in Peripheral Cells from Prodromal Alzheimer's Disease Patients.
    J Alzheimers Dis. 2018;61:1289-1294.
    PubMed     Text format     Abstract available


  254. YANG CC, Chiu MJ, Chen TF, Chang HL, et al
    Assay of Plasma Phosphorylated Tau Protein (Threonine 181) and Total Tau Protein in Early-Stage Alzheimer's Disease.
    J Alzheimers Dis. 2018;61:1323-1332.
    PubMed     Text format     Abstract available


  255. SUZUKI A, Shinozaki J, Yazawa S, Ueki Y, et al
    Establishing a New Screening System for Mild Cognitive Impairment and Alzheimer's Disease with Mental Rotation Tasks that Evaluate Visuospatial Function.
    J Alzheimers Dis. 2018;61:1653-1665.
    PubMed     Text format     Abstract available


  256. PALEY EL, Merkulova-Rainon T, Faynboym A, Shestopalov VI, et al
    Geographical Distribution and Diversity of Gut Microbial NADH:Ubiquinone Oxidoreductase Sequence Associated with Alzheimer's Disease.
    J Alzheimers Dis. 2018;61:1531-1540.
    PubMed     Text format     Abstract available


  257. PORTACOLONE E, Johnson JK, Covinsky KE, Halpern J, et al
    The Effects and Meanings of Receiving a Diagnosis of Mild Cognitive Impairment or Alzheimer's Disease When One Lives Alone.
    J Alzheimers Dis. 2018;61:1517-1529.
    PubMed     Text format     Abstract available


  258. HALLIKAINEN I, Hongisto K, Valimaki T, Hanninen T, et al
    The Progression of Neuropsychiatric Symptoms in Alzheimer's Disease During a Five-Year Follow-Up: Kuopio ALSOVA Study.
    J Alzheimers Dis. 2018;61:1367-1376.
    PubMed     Text format     Abstract available


  259. CHE XQ, Zhao QH, Huang Y, Li X, et al
    Mutation Screening of the CHCHD2 Gene for Alzheimer's Disease and Frontotemporal Dementia in Chinese Mainland Population.
    J Alzheimers Dis. 2018;61:1283-1288.
    PubMed     Text format     Abstract available


  260. LU J, Shu R, Zhu Y
    Dysregulation and Dislocation of SFPQ Disturbed DNA Organization in Alzheimer's Disease and Frontotemporal Dementia.
    J Alzheimers Dis. 2018;61:1311-1321.
    PubMed     Text format     Abstract available


  261. PEDRINOLLA A, Venturelli M, Fonte C, Munari D, et al
    Exercise Training on Locomotion in Patients with Alzheimer's Disease: A Feasibility Study.
    J Alzheimers Dis. 2018;61:1599-1609.
    PubMed     Text format     Abstract available


  262. NAKAIZUMI K, Ouchi Y, Terada T, Yoshikawa E, et al
    In vivo Depiction of alpha7 Nicotinic Receptor Loss for Cognitive Decline in Alzheimer's Disease.
    J Alzheimers Dis. 2018;61:1355-1365.
    PubMed     Text format     Abstract available


  263. GOMEZ-TORTOSA E, Ruggiero M, Sainz MJ, Villarejo-Galende A, et al
    SORL1 Variants in Familial Alzheimer's Disease.
    J Alzheimers Dis. 2018;61:1275-1281.
    PubMed     Text format     Abstract available


  264. KIM J, Park S, Yoo H, Jang H, et al
    The Impact of APOE varepsilon4 in Alzheimer's Disease Differs According to Age.
    J Alzheimers Dis. 2018;61:1377-1385.
    PubMed     Text format     Abstract available


  265. TUCHOLKA A, Grau-Rivera O, Falcon C, Rami L, et al
    Structural Connectivity Alterations Along the Alzheimer's Disease Continuum: Reproducibility Across Two Independent Samples and Correlation with Cerebrospinal Fluid Amyloid-beta and Tau.
    J Alzheimers Dis. 2018;61:1575-1587.
    PubMed     Text format     Abstract available


  266. LIBARD S, Laurell K, Cesarini KG, Alafuzoff I, et al
    Progression of Alzheimer's Disease-Related Pathology and Cell Counts in a Patient with Idiopathic Normal Pressure Hydrocephalus.
    J Alzheimers Dis. 2018;61:1451-1462.
    PubMed     Text format     Abstract available


  267. GUREL B, Cansev M, Sevinc C, Kelestemur S, et al
    Early Stage Alterations in CA1 Extracellular Region Proteins Indicate Dysregulation of IL6 and Iron Homeostasis in the 5XFAD Alzheimer's Disease Mouse Model.
    J Alzheimers Dis. 2018;61:1399-1410.
    PubMed     Text format     Abstract available


  268. MAHADY L, Nadeem M, Malek-Ahmadi M, Chen K, et al
    Frontal Cortex Epigenetic Dysregulation During the Progression of Alzheimer's Disease.
    J Alzheimers Dis. 2018;62:115-131.
    PubMed     Text format     Abstract available


  269. REALE M, D'Angelo C, Costantini E, Di Nicola M, et al
    Expression Profiling of Cytokine, Cholinergic Markers, and Amyloid-beta Deposition in the APPSWE/PS1dE9 Mouse Model of Alzheimer's Disease Pathology.
    J Alzheimers Dis. 2018;62:467-476.
    PubMed     Text format     Abstract available


  270. ZHOU F, Chen S
    Effects of Gender and Other Confounding Factors on Leptin Concentrations in Alzheimer's Disease: Evidence from the Combined Analysis of 27 Case-Control Studies.
    J Alzheimers Dis. 2018;62:477-486.
    PubMed     Text format     Abstract available


  271. IHARA M, Washida K
    Linking Atrial Fibrillation with Alzheimer's Disease: Epidemiological, Pathological, and Mechanistic Evidence.
    J Alzheimers Dis. 2018;62:61-72.
    PubMed     Text format     Abstract available


  272. WEZYK M, Szybinska A, Wojsiat J, Szczerba M, et al
    Overactive BRCA1 Affects Presenilin 1 in Induced Pluripotent Stem Cell-Derived Neurons in Alzheimer's Disease.
    J Alzheimers Dis. 2018;62:175-202.
    PubMed     Text format     Abstract available


  273. XU L, Zhang W, Liu X, Zhang C, et al
    Circulatory Levels of Toxic Metals (Aluminum, Cadmium, Mercury, Lead) in Patients with Alzheimer's Disease: A Quantitative Meta-Analysis and Systematic Review.
    J Alzheimers Dis. 2018;62:361-372.
    PubMed     Text format     Abstract available


  274. VOGELGSANG J, Wedekind D, Bouter C, Klafki HW, et al
    Reproducibility of Alzheimer's Disease Cerebrospinal Fluid-Biomarker Measurements under Clinical Routine Conditions.
    J Alzheimers Dis. 2018;62:203-212.
    PubMed     Text format     Abstract available


  275. CORVOL A, Netter A, Campeon A, Somme D, et al
    Implementation of an Occupational Therapy Program for Alzheimer's Disease Patients in France: Patients' and Caregivers' Perspectives.
    J Alzheimers Dis. 2018;62:157-164.
    PubMed     Text format     Abstract available


  276. MULLAN K, Cardwell CR, McGuinness B, Woodside JV, et al
    Plasma Antioxidant Status in Patients with Alzheimer's Disease and Cognitively Intact Elderly: A Meta-Analysis of Case-Control Studies.
    J Alzheimers Dis. 2018;62:305-317.
    PubMed     Text format     Abstract available


  277. BABILONI C, Del Percio C, Lizio R, Noce G, et al
    Abnormalities of Resting State Cortical EEG Rhythms in Subjects with Mild Cognitive Impairment Due to Alzheimer's and Lewy Body Diseases.
    J Alzheimers Dis. 2018;62:247-268.
    PubMed     Text format     Abstract available


  278. BETTCHER BM, Johnson SC, Fitch R, Casaletto KB, et al
    Cerebrospinal Fluid and Plasma Levels of Inflammation Differentially Relate to CNS Markers of Alzheimer's Disease Pathology and Neuronal Damage.
    J Alzheimers Dis. 2018;62:385-397.
    PubMed     Text format     Abstract available


  279. HAAPALINNA F, Kokki M, Jaaskelainen O, Hallikainen M, et al
    Subtle Cognitive Impairment and Alzheimer's Disease-Type Pathological Changes in Cerebrospinal Fluid are Common Among Neurologically Healthy Subjects.
    J Alzheimers Dis. 2018;62:165-174.
    PubMed     Text format     Abstract available


  280. WATREMEZ W, Jackson J, Almari B, McLean SL, et al
    Stabilized Low-n Amyloid-beta Oligomers Induce Robust Novel Object Recognition Deficits Associated with Inflammatory, Synaptic, and GABAergic Dysfunction in the Rat.
    J Alzheimers Dis. 2018;62:213-226.
    PubMed     Text format     Abstract available


  281. SCHWEDA M, Kogel A, Bartels C, Wiltfang J, et al
    Prediction and Early Detection of Alzheimer's Dementia: Professional Disclosure Practices and Ethical Attitudes.
    J Alzheimers Dis. 2018;62:145-155.
    PubMed     Text format     Abstract available


  282. JESKO H, Lukiw WJ, Wilkaniec A, Cieslik M, et al
    Altered Expression of Urea Cycle Enzymes in Amyloid-beta Protein Precursor Overexpressing PC12 Cells and in Sporadic Alzheimer's Disease Brain.
    J Alzheimers Dis. 2018;62:279-291.
    PubMed     Text format     Abstract available


  283. MALPAS CB, Saling MM, Velakoulis D, Desmond P, et al
    Cerebrospinal Fluid Biomarkers are Differentially Related to Structural and Functional Changes in Dementia of the Alzheimer's Type.
    J Alzheimers Dis. 2018;62:417-427.
    PubMed     Text format     Abstract available


  284. STITES SD
    Cognitively Healthy Individuals Want to Know Their Risk for Alzheimer's Disease: What Should We Do?
    J Alzheimers Dis. 2018;62:499-502.
    PubMed     Text format     Abstract available


  285. DORNINGER F, Moser AB, Kou J, Wiesinger C, et al
    Alterations in the Plasma Levels of Specific Choline Phospholipids in Alzheimer's Disease Mimic Accelerated Aging.
    J Alzheimers Dis. 2018;62:841-854.
    PubMed     Text format     Abstract available


  286. LE GUENNEC K, Tubeuf H, Hannequin D, Wallon D, et al
    Biallelic Loss of Function of SORL1 in an Early Onset Alzheimer's Disease Patient.
    J Alzheimers Dis. 2018;62:821-831.
    PubMed     Text format     Abstract available


  287. HE XY, Isaacs C, Yang SY
    Roles of Mitochondrial 17beta-Hydroxysteroid Dehydrogenase Type 10 in Alzheimer's Disease.
    J Alzheimers Dis. 2018;62:665-673.
    PubMed     Text format     Abstract available


  288. TAO Q, Zhu H, Chen X, Stern RA, et al
    Pramlintide: The Effects of a Single Drug Injection on Blood Phosphatidylcholine Profile for Alzheimer's Disease.
    J Alzheimers Dis. 2018;62:597-609.
    PubMed     Text format     Abstract available


  289. ZADORI D, Veres G, Szalardy L, Klivenyi P, et al
    Alzheimer's Disease: Recent Concepts on the Relation of Mitochondrial Disturbances, Excitotoxicity, Neuroinflammation, and Kynurenines.
    J Alzheimers Dis. 2018;62:523-547.
    PubMed     Text format     Abstract available


  290. SAPKOTA S, Dixon RA
    A Network of Genetic Effects on Non-Demented Cognitive Aging: Alzheimer's Genetic Risk (CLU + CR1 + PICALM) Intensifies Cognitive Aging Genetic Risk (COMT + BDNF) Selectively for APOEvarepsilon4 Carriers.
    J Alzheimers Dis. 2018;62:887-900.
    PubMed     Text format     Abstract available


  291. SZABLEWSKI L
    Human Gut Microbiota in Health and Alzheimer's Disease.
    J Alzheimers Dis. 2018;62:549-560.
    PubMed     Text format     Abstract available


  292. WANG D, Schultz T, Novak GP, Baker S, et al
    Longitudinal Modeling of Functional Decline Associated with Pathologic Alzheimer's Disease in Older Persons without Cognitive Impairment.
    J Alzheimers Dis. 2018;62:855-865.
    PubMed     Text format     Abstract available


  293. D'IORIO A, Garramone F, Piscopo F, Baiano C, et al
    Meta-Analysis of Personality Traits in Alzheimer's Disease: A Comparison with Healthy Subjects.
    J Alzheimers Dis. 2018;62:773-787.
    PubMed     Text format     Abstract available


  294. CROZE ML, Zimmer L
    Ozone Atmospheric Pollution and Alzheimer's Disease: From Epidemiological Facts to Molecular Mechanisms.
    J Alzheimers Dis. 2018;62:503-522.
    PubMed     Text format     Abstract available


  295. DEL-AGUILA JL, Fernandez MV, Schindler S, Ibanez L, et al
    Assessment of the Genetic Architecture of Alzheimer's Disease Risk in Rate of Memory Decline.
    J Alzheimers Dis. 2018;62:745-756.
    PubMed     Text format     Abstract available


  296. ALEGRET M, Pereto M, Perez A, Valero S, et al
    The Role of Verb Fluency in the Detection of Early Cognitive Impairment in Alzheimer's Disease.
    J Alzheimers Dis. 2018;62:611-619.
    PubMed     Text format     Abstract available


  297. MILNE R, Bunnik E, Diaz A, Richard E, et al
    Perspectives on Communicating Biomarker-Based Assessments of Alzheimer's Disease to Cognitively Healthy Individuals.
    J Alzheimers Dis. 2018;62:487-498.
    PubMed     Text format     Abstract available


  298. BURNS CM, Kaszniak AW, Chen K, Lee W, et al
    Longitudinal Changes in Serum Glucose Levels are Associated with Metabolic Changes in Alzheimer's Disease Related Brain Regions.
    J Alzheimers Dis. 2018;62:833-840.
    PubMed     Text format     Abstract available


  299. FALSETTI L, Viticchi G, Buratti L, Grigioni F, et al
    Interactions between Atrial Fibrillation, Cardiovascular Risk Factors, and ApoE Genotype in Promoting Cognitive Decline in Patients with Alzheimer's Disease: A Prospective Cohort Study.
    J Alzheimers Dis. 2018;62:713-725.
    PubMed     Text format     Abstract available


  300. ZHANG W, Guo Y, Li B, Zhang Q, et al
    GDF11 Rejuvenates Cerebrovascular Structure and Function in an Animal Model of Alzheimer's Disease.
    J Alzheimers Dis. 2018;62:807-819.
    PubMed     Text format     Abstract available


  301. D'ONOFRIO G, Panza F, Sancarlo D, Addante F, et al
    Executive Dysfunction Detected with the Frontal Assessment Battery in Alzheimer's Disease Versus Vascular Dementia.
    J Alzheimers Dis. 2018;62:699-711.
    PubMed     Text format     Abstract available


  302. MARTINS RN, Villemagne V, Sohrabi HR, Chatterjee P, et al
    Alzheimer's Disease: A Journey from Amyloid Peptides and Oxidative Stress, to Biomarker Technologies and Disease Prevention Strategies-Gains from AIBL and DIAN Cohort Studies.
    J Alzheimers Dis. 2018;62:965-992.
    PubMed     Text format     Abstract available


  303. KEHOE PG
    The Coming of Age of the Angiotensin Hypothesis in Alzheimer's Disease: Progress Toward Disease Prevention and Treatment?
    J Alzheimers Dis. 2018;62:1443-1466.
    PubMed     Text format     Abstract available


  304. MOREIRA PI
    Sweet Mitochondria: A Shortcut to Alzheimer's Disease.
    J Alzheimers Dis. 2018;62:1391-1401.
    PubMed     Text format     Abstract available


  305. BOADA M, Santos-Santos MA, Rodriguez-Gomez O, Alegret M, et al
    Patient Engagement: The Fundacio ACE Framework for Improving Recruitment and Retention in Alzheimer's Disease Research.
    J Alzheimers Dis. 2018;62:1079-1090.
    PubMed     Text format     Abstract available


  306. BAAZAOUI N, Iqbal K
    A Novel Therapeutic Approach to Treat Alzheimer's Disease by Neurotrophic Support During the Period of Synaptic Compensation.
    J Alzheimers Dis. 2018;62:1211-1218.
    PubMed     Text format     Abstract available


  307. DE LA MONTE SM, Tong M, Wands JR
    The 20-Year Voyage Aboard the Journal of Alzheimer's Disease: Docking at 'Type 3 Diabetes', Environmental/Exposure Factors, Pathogenic Mechanisms, and Potential Treatments.
    J Alzheimers Dis. 2018;62:1381-1390.
    PubMed     Text format     Abstract available


  308. FORLONI G, Balducci C
    Alzheimer's Disease, Oligomers, and Inflammation.
    J Alzheimers Dis. 2018;62:1261-1276.
    PubMed     Text format     Abstract available


  309. BLENNOW K, Zetterberg H
    The Past and the Future of Alzheimer's Disease Fluid Biomarkers.
    J Alzheimers Dis. 2018;62:1125-1140.
    PubMed     Text format     Abstract available


  310. MECOCCI P, Boccardi V, Cecchetti R, Bastiani P, et al
    A Long Journey into Aging, Brain Aging, and Alzheimer's Disease Following the Oxidative Stress Tracks.
    J Alzheimers Dis. 2018;62:1319-1335.
    PubMed     Text format     Abstract available


  311. FENOGLIO C, Scarpini E, Serpente M, Galimberti D, et al
    Role of Genetics and Epigenetics in the Pathogenesis of Alzheimer's Disease and Frontotemporal Dementia.
    J Alzheimers Dis. 2018;62:913-932.
    PubMed     Text format     Abstract available


  312. MOLINUEVO JL, Minguillon C, Rami L, Gispert JD, et al
    The Rationale Behind the New Alzheimer's Disease Conceptualization: Lessons Learned During the Last Decades.
    J Alzheimers Dis. 2018;62:1067-1077.
    PubMed     Text format     Abstract available


  313. BJERKE M, Engelborghs S
    Cerebrospinal Fluid Biomarkers for Early and Differential Alzheimer's Disease Diagnosis.
    J Alzheimers Dis. 2018;62:1199-1209.
    PubMed     Text format     Abstract available


  314. GRINAN-FERRE C, Corpas R, Puigoriol-Illamola D, Palomera-Avalos V, et al
    Understanding Epigenetics in the Neurodegeneration of Alzheimer's Disease: SAMP8 Mouse Model.
    J Alzheimers Dis. 2018;62:943-963.
    PubMed     Text format     Abstract available


  315. ADLARD PA, Bush AI
    Metals and Alzheimer's Disease: How Far Have We Come in the Clinic?
    J Alzheimers Dis. 2018;62:1369-1379.
    PubMed     Text format     Abstract available


  316. BUTTERFIELD DA, Boyd-Kimball D
    Oxidative Stress, Amyloid-beta Peptide, and Altered Key Molecular Pathways in the Pathogenesis and Progression of Alzheimer's Disease.
    J Alzheimers Dis. 2018;62:1345-1367.
    PubMed     Text format     Abstract available


  317. SHI L, Baird AL, Westwood S, Hye A, et al
    A Decade of Blood Biomarkers for Alzheimer's Disease Research: An Evolving Field, Improving Study Designs, and the Challenge of Replication.
    J Alzheimers Dis. 2018;62:1181-1198.
    PubMed     Text format     Abstract available


  318. YANG H, Hou T, Wang W, Luo Y, et al
    The Effect of Chronic Cerebral Hypoperfusion on Amyloid-beta Metabolism in a Transgenic Mouse Model of Alzheimer's Disease (PS1V97L).
    J Alzheimers Dis. 2018;62:1609-1621.
    PubMed     Text format     Abstract available


  319. GU J, Jin N, Ma D, Chu D, et al
    Calpain I Activation Causes GLUT3 Proteolysis and Downregulation of O-GlcNAcylation in Alzheimer's Disease Brain.
    J Alzheimers Dis. 2018;62:1737-1746.
    PubMed     Text format     Abstract available


  320. PIACERI I, Imperiale D, Ghidoni E, Atzori C, et al
    Novel GRN Mutations in Alzheimer's Disease and Frontotemporal Lobar Degeneration.
    J Alzheimers Dis. 2018;62:1683-1689.
    PubMed     Text format     Abstract available


  321. TETZLOFF KA, Graff-Radford J, Martin PR, Tosakulwong N, et al
    Regional Distribution, Asymmetry, and Clinical Correlates of Tau Uptake on [18F]AV-1451 PET in Atypical Alzheimer's Disease.
    J Alzheimers Dis. 2018;62:1713-1724.
    PubMed     Text format     Abstract available



  322. PET Tau and Amyloid-beta Burden in Mild Alzheimer's Disease: Divergent Relationship with Age, Cognition, and Cerebrospinal Fluid Biomarkers.
    J Alzheimers Dis. 2018;63:407.
    PubMed     Text format    



  323. Patient Engagement: The Fundacio ACE Framework for Improving Recruitment and Retention in Alzheimer's Disease Research.
    J Alzheimers Dis. 2018;63:1207.
    PubMed     Text format    



  324. Gait in Mild Alzheimer's Disease: Feasibility of Multi-Center Measurement in the Clinic and Home with Body-Worn Sensors: A Pilot Study.
    J Alzheimers Dis. 2018;63:1557.
    PubMed     Text format    


  325. SAARI T, Hallikainen I, Hanninen T, Raty H, et al
    Relationships between Cognition and Activities of Daily Living in Alzheimer's Disease During a 5-Year Follow-Up: ALSOVA Study.
    J Alzheimers Dis. 2018;64:269-279.
    PubMed     Text format     Abstract available


  326. MANDAL PK, Shukla D
    Brain Metabolic, Structural, and Behavioral Pattern Learning for Early Predictive Diagnosis of Alzheimer's Disease.
    J Alzheimers Dis. 2018;64:669-670.
    PubMed     Text format    


  327. NOLAN JM, Mulcahy R, Power R, Moran R, et al
    Nutritional Intervention to Prevent Alzheimer's Disease: Potential Benefits of Xanthophyll Carotenoids and Omega-3 Fatty Acids Combined.
    J Alzheimers Dis. 2018;64:367-378.
    PubMed     Text format     Abstract available


  328. ZUSSO M, Barbierato M, Facci L, Skaper SD, et al
    Neuroepigenetics and Alzheimer's Disease: An Update.
    J Alzheimers Dis. 2018;64:671-688.
    PubMed     Text format     Abstract available


  329. SU L, Hayes L, Soteriades S, Williams G, et al
    Hippocampal Stratum Radiatum, Lacunosum, and Moleculare Sparing in Mild Cognitive Impairment.
    J Alzheimers Dis. 2018;61:415-424.
    PubMed     Text format     Abstract available



  330. Greg Kennedy, BSc (Hons), Recipient of the 2018 Alzheimer Award.
    J Alzheimers Dis. 2018;65:1-2.
    PubMed     Text format    


    December 2017
  331. RAHA-CHOWDHURY R, Henderson JW, Raha AA, Stott SRW, et al
    Erythromyeloid-Derived TREM2: A Major Determinant of Alzheimer's Disease Pathology in Down Syndrome.
    J Alzheimers Dis. 2017 Dec 16. pii: JAD170814. doi: 10.3233/JAD-170814.
    PubMed     Text format     Abstract available


  332. KONISHI K, Joober R, Poirier J, MacDonald K, et al
    Healthy versus Entorhinal Cortical Atrophy Identification in Asymptomatic APOE4 Carriers at Risk for Alzheimer's Disease.
    J Alzheimers Dis. 2017 Dec 16. pii: JAD170540. doi: 10.3233/JAD-170540.
    PubMed     Text format     Abstract available


  333. BOTCHWAY BOA, Moore MK, Akinleye FO, Iyer IC, et al
    Nutrition: Review on the Possible Treatment for Alzheimer's Disease.
    J Alzheimers Dis. 2017 Dec 15. pii: JAD170874. doi: 10.3233/JAD-170874.
    PubMed     Text format     Abstract available


  334. WANG SS, Jia J, Wang Z
    Mesenchymal Stem Cell-Derived Extracellular Vesicles Suppresses iNOS Expression and Ameliorates Neural Impairment in Alzheimer's Disease Mice.
    J Alzheimers Dis. 2017 Dec 15. pii: JAD170848. doi: 10.3233/JAD-170848.
    PubMed     Text format     Abstract available


  335. WEI EX, Oh ES, Harun A, Ehrenburg M, et al
    Vestibular Loss Predicts Poorer Spatial Cognition in Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2017 Dec 15. pii: JAD170751. doi: 10.3233/JAD-170751.
    PubMed     Text format     Abstract available


  336. GABRIEL AJ, Almeida MR, Ribeiro MH, Carneiro D, et al
    Influence of Butyrylcholinesterase in Progression of Mild Cognitive Impairment to Alzheimer's Disease.
    J Alzheimers Dis. 2017 Dec 15. pii: JAD170695. doi: 10.3233/JAD-170695.
    PubMed     Text format     Abstract available


  337. ELDHOLM RS, Barca ML, Persson K, Knapskog AB, et al
    Progression of Alzheimer's Disease: A Longitudinal Study in Norwegian Memory Clinics.
    J Alzheimers Dis. 2017 Dec 15. pii: JAD170436. doi: 10.3233/JAD-170436.
    PubMed     Text format     Abstract available


  338. ATANASOVA B, Mondon K, Dreyfuss L, Beaufils E, et al
    Hedonic Assessment of Odors: A Comparison of Two Sensory Scales for Use with Alzheimer's Disease Patients and Elderly Individuals.
    J Alzheimers Dis. 2017 Dec 13. pii: JAD170433. doi: 10.3233/JAD-170433.
    PubMed     Text format     Abstract available


  339. LOVHEIM H, Olsson J, Weidung B, Johansson A, et al
    Interaction between Cytomegalovirus and Herpes Simplex Virus Type 1 Associated with the Risk of Alzheimer's Disease Development.
    J Alzheimers Dis. 2017 Dec 13. pii: JAD161305. doi: 10.3233/JAD-161305.
    PubMed     Text format     Abstract available


  340. DI MECO A, Li JG, Pratico D
    Dissecting the Role of 5-Lipoxygenase in the Homocysteine-Induced Alzheimer's Disease Pathology.
    J Alzheimers Dis. 2017 Dec 12. pii: JAD170700. doi: 10.3233/JAD-170700.
    PubMed     Text format     Abstract available


  341. WISCHIK CM, Schelter BO, Wischik DJ, Storey JMD, et al
    Modeling Prion-Like Processing of Tau Protein in Alzheimer's Disease for Pharmaceutical Development.
    J Alzheimers Dis. 2017 Dec 8. pii: JAD170727. doi: 10.3233/JAD-170727.
    PubMed     Text format     Abstract available


  342. FERRARI C, Lombardi G, Polito C, Lucidi G, et al
    Alzheimer's Disease Progression: Factors Influencing Cognitive Decline.
    J Alzheimers Dis. 2017 Dec 8. pii: JAD170665. doi: 10.3233/JAD-170665.
    PubMed     Text format     Abstract available


  343. EL HAJ M, Coello Y, Kapogiannis D, Gallouj K, et al
    Negative Prospective Memory in Alzheimer's Disease: "Do Not Perform That Action".
    J Alzheimers Dis. 2017 Dec 6. pii: JAD170807. doi: 10.3233/JAD-170807.
    PubMed     Text format     Abstract available


  344. HARRIS R, Miners JS, Allen S, Love S, et al
    VEGFR1 and VEGFR2 in Alzheimer's Disease.
    J Alzheimers Dis. 2017 Dec 6. pii: JAD170745. doi: 10.3233/JAD-170745.
    PubMed     Text format     Abstract available


  345. SINAI A, Mokrysz C, Bernal J, Bohnen I, et al
    Predictors of Age of Diagnosis and Survival of Alzheimer's Disease in Down Syndrome.
    J Alzheimers Dis. 2017 Dec 6. pii: JAD170624. doi: 10.3233/JAD-170624.
    PubMed     Text format     Abstract available


  346. KEHOE PG, Blair PS, Howden B, Thomas DL, et al
    The Rationale and Design of the Reducing Pathology in Alzheimer's Disease through Angiotensin TaRgeting (RADAR) Trial.
    J Alzheimers Dis. 2017 Dec 6. pii: JAD170101. doi: 10.3233/JAD-170101.
    PubMed     Text format     Abstract available


  347. TELL-MARTI G, Puig-Butille JA, Potrony M, Plana E, et al
    A Common Variant in the MC1R Gene (p.V92M) is associated with Alzheimer's Disease Risk.
    J Alzheimers Dis. 2017 Dec 3. doi: 10.3233/JAD-161113.
    PubMed     Text format     Abstract available


  348. TONNIES E, Trushina E
    Oxidative Stress, Synaptic Dysfunction, and Alzheimer's Disease.
    J Alzheimers Dis. 2017 Dec 3. doi: 10.3233/JAD-161088.
    PubMed     Text format     Abstract available


  349. SATHYA M, Moorthi P, Premkumar P, Kandasamy M, et al
    Resveratrol Intervenes in the Cholesterol- and Isoprenoid-Mediated Amyloidogenic Processing of AbetaPP in Familial Alzheimer's Disease.
    J Alzheimers Dis. 2017 Dec 3. doi: 10.3233/JAD-161034.
    PubMed     Text format     Abstract available


  350. WANG H, Hong X, Wang Y
    Mitochondrial Repair Effects of Oxygen Treatment on Alzheimer's Disease Model Mice Revealed by Quantitative Proteomics.
    J Alzheimers Dis. 2017 Dec 3. doi: 10.3233/JAD-161010.
    PubMed     Text format     Abstract available


  351. BASTIAN FO
    Combined Creutzfeldt-Jakob-Jacob/ Alzheimer's Disease Cases are Important in Search for Microbes in Alzheimer's Disease.
    J Alzheimers Dis. 2017 Dec 3. doi: 10.3233/JAD-160999.
    PubMed     Text format     Abstract available


  352. DASHINIMAEV EB, Artyuhov AS, Bolshakov AP, Vorotelyak EA, et al
    Neurons Derived from Induced Pluripotent Stem Cells of Patients with Down Syndrome Reproduce Early Stages of Alzheimer's Disease Type Pathology in vitro.
    J Alzheimers Dis. 2017 Dec 3. doi: 10.3233/JAD-160945.
    PubMed     Text format     Abstract available


  353. VAN WAALWIJK VAN DOORN LJ, Gispert JD, Kuiperij HB, Claassen JA, et al
    Improved Cerebrospinal Fluid-Based Discrimination between Alzheimer's Disease Patients and Controls after Correction for Ventricular Volumes.
    J Alzheimers Dis. 2017 Dec 3. doi: 10.3233/JAD-160668.
    PubMed     Text format     Abstract available


  354. SHEA TB
    While I Still Remember: 30 Years of Alzheimer's Disease Research.
    J Alzheimers Dis. 2017 Dec 2. pii: JAD170724. doi: 10.3233/JAD-170724.
    PubMed     Text format     Abstract available


  355. TSOU HH, Hsu WC, Fuh JL, Chen SP, et al
    Alterations in Acrolein Metabolism Contribute to Alzheimer's Disease.
    J Alzheimers Dis. 2017 Dec 1. pii: JAD170736. doi: 10.3233/JAD-170736.
    PubMed     Text format     Abstract available


  356. SLACHEVSKY A, Barraza P, Hornberger M, Munoz-Neira C, et al
    Neuroanatomical Comparison of the "Word" and "Picture" Versions of the Free and Cued Selective Reminding Test in Alzheimer's Disease.
    J Alzheimers Dis. 2017 Dec 1. pii: JAD160973. doi: 10.3233/JAD-160973.
    PubMed     Text format     Abstract available


    November 2017
  357. THANGAVEL R, Bhagavan SM, Ramaswamy SB, Surpur S, et al
    Co-Expression of Glia Maturation Factor and Apolipoprotein E4 in Alzheimer's Disease Brain.
    J Alzheimers Dis. 2017 Nov 20. pii: JAD170777. doi: 10.3233/JAD-170777.
    PubMed     Text format     Abstract available


  358. DI FEDE G, Giaccone G, Salmona M, Tagliavini F, et al
    Translational Research in Alzheimer's and Prion Diseases.
    J Alzheimers Dis. 2017 Nov 20. pii: JAD170770. doi: 10.3233/JAD-170770.
    PubMed     Text format     Abstract available


  359. PEREIRA CD, Martins F, Wiltfang J, da Cruz E Silva OAB, et al
    ABC Transporters Are Key Players in Alzheimer's Disease.
    J Alzheimers Dis. 2017 Nov 20. pii: JAD170639. doi: 10.3233/JAD-170639.
    PubMed     Text format     Abstract available


  360. ROE CM, Babulal GM, Mishra S, Gordon BA, et al
    Tau and Amyloid Positron Emission Tomography Imaging Predict Driving Performance Among Older Adults with and without Preclinical Alzheimer's Disease.
    J Alzheimers Dis. 2017 Nov 20. pii: JAD170521. doi: 10.3233/JAD-170521.
    PubMed     Text format     Abstract available


  361. KIMURA A, Yoshikura N, Hayashi Y, Inuzuka T, et al
    Cerebrospinal Fluid C-C Motif Chemokine Ligand 2 Correlates with Brain Atrophy and Cognitive Impairment in Alzheimer's Disease.
    J Alzheimers Dis. 2017 Nov 20. pii: JAD170519. doi: 10.3233/JAD-170519.
    PubMed     Text format     Abstract available


  362. DOECKE JD, Rembach A, Villemagne VL, Varghese S, et al
    Concordance Between Cerebrospinal Fluid Biomarkers with Alzheimer's Disease Pathology Between Three Independent Assay Platforms.
    J Alzheimers Dis. 2017 Nov 20. pii: JAD170128. doi: 10.3233/JAD-170128.
    PubMed     Text format     Abstract available


  363. CUBERAS-BORROS G, Roca I, Boada M, Tarraga L, et al
    Longitudinal Neuroimaging Analysis in Mild-Moderate Alzheimer's Disease Patients Treated with Plasma Exchange with 5% Human Albumin.
    J Alzheimers Dis. 2017 Nov 17. doi: 10.3233/JAD-170693.
    PubMed     Text format     Abstract available


  364. WILCOCK GK, Gauthier S, Frisoni GB, Jia J, et al
    Potential of Low Dose Leuco-Methylthioninium Bis(Hydromethanesulphonate) (LMTM) Monotherapy for Treatment of Mild Alzheimer's Disease: Cohort Analysis as Modified Primary Outcome in a Phase III Clinical Trial.
    J Alzheimers Dis. 2017 Nov 17. doi: 10.3233/JAD-170560.
    PubMed     Text format     Abstract available


  365. FREDERIKSEN KS, Gjerum L, Waldemar G, Hasselbalch SG, et al
    Effects of Physical Exercise on Alzheimer's Disease Biomarkers: A Systematic Review of Intervention Studies.
    J Alzheimers Dis. 2017 Nov 16. doi: 10.3233/JAD-170567.
    PubMed     Text format     Abstract available


  366. SEDDIGHI S, Varma VR, An Y, Varma S, et al
    SPARCL1 Accelerates Symptom Onset in Alzheimer's Disease and Influences Brain Structure and Function During Aging.
    J Alzheimers Dis. 2017 Nov 16. doi: 10.3233/JAD-170557.
    PubMed     Text format     Abstract available


  367. GEIJSELAERS SLC, Aalten P, Ramakers IHGB, De Deyn PP, et al
    Association of Cerebrospinal Fluid (CSF) Insulin with Cognitive Performance and CSF Biomarkers of Alzheimer's Disease.
    J Alzheimers Dis. 2017 Nov 16. doi: 10.3233/JAD-170522.
    PubMed     Text format     Abstract available


  368. MUTHUKUMARAN K, Kanwar A, Vegh C, Marginean A, et al
    Ubisol-Q10 (a Nanomicellar Water- Soluble Formulation of CoQ10) Treatment Inhibits Alzheimer-Type Behavioral and Pathological Symptoms in a Double Transgenic Mouse (TgAPEswe, PSEN1dE9) Model of Alzheimer's Disease.
    J Alzheimers Dis. 2017 Nov 16. doi: 10.3233/JAD-170275.
    PubMed     Text format     Abstract available


  369. DOS SANTOS JPA, Vizuete A, Hansen F, Biasibetti R, et al
    Early and Persistent O-GlcNAc Protein Modification in the Streptozotocin Model of Alzheimer's Disease.
    J Alzheimers Dis. 2017 Nov 16. doi: 10.3233/JAD-170211.
    PubMed     Text format     Abstract available


  370. LANGE C, Suppa P, Pietrzyk U, Makowski MR, et al
    Prediction of Alzheimer's Dementia in Patients with Amnestic Mild Cognitive Impairment in Clinical Routine: Incremental Value of Biomarkers of Neurodegeneration and Brain Amyloidosis Added Stepwise to Cognitive Status.
    J Alzheimers Dis. 2017 Nov 14. doi: 10.3233/JAD-170705.
    PubMed     Text format     Abstract available


  371. HASEGAWA Y, Toyama K, Uekawa K, Ichijo H, et al
    Role of ASK1/p38 Cascade in a Mouse Model of Alzheimer's Disease and Brain Aging.
    J Alzheimers Dis. 2017 Nov 14. doi: 10.3233/JAD-170645.
    PubMed     Text format     Abstract available


  372. HUBER CM, Yee C, May T, Dhanala A, et al
    Cognitive Decline in Preclinical Alzheimer's Disease: Amyloid-Beta versus Tauopathy.
    J Alzheimers Dis. 2017 Nov 14. doi: 10.3233/JAD-170490.
    PubMed     Text format     Abstract available


  373. GELMAN S, Palma J, Tombaugh G, Ghavami A, et al
    Differences in Synaptic Dysfunction Between rTg4510 and APP/PS1 Mouse Models of Alzheimer's Disease.
    J Alzheimers Dis. 2017 Nov 14. doi: 10.3233/JAD-170457.
    PubMed     Text format     Abstract available


  374. FAXEN-IRVING G, Falahati F, Basun H, Eriksdotter M, et al
    Does Fatty Acid Composition in Subcutaneous Adipose Tissue Differ between Patients with Alzheimer's Disease and Cohabiting Proxies?
    J Alzheimers Dis. 2017 Nov 14. doi: 10.3233/JAD-170359.
    PubMed     Text format     Abstract available


  375. KIRSON NY, Andrews JS, Desai U, King SB, et al
    Patient Characteristics and Outcomes Associated with Receiving an Earlier Versus Later Diagnosis of Probable Alzheimer's Disease.
    J Alzheimers Dis. 2017 Nov 14. doi: 10.3233/JAD-170078.
    PubMed     Text format     Abstract available


  376. MATIAS-GUIU JA, Cabrera-Martin MN, Curiel RE, Valles-Salgado M, et al
    Comparison between FCSRT and LASSI-L to Detect Early Stage Alzheimer's Disease.
    J Alzheimers Dis. 2017 Nov 8. doi: 10.3233/JAD-170604.
    PubMed     Text format     Abstract available


  377. VILLAMIL-ORTIZ JG, Barrera-Ocampo A, Arias-Londono JD, Villegas A, et al
    Differential Pattern of Phospholipid Profile in the Temporal Cortex from E280A-Familiar and Sporadic Alzheimer's Disease Brains.
    J Alzheimers Dis. 2017 Nov 8. doi: 10.3233/JAD-170554.
    PubMed     Text format     Abstract available


  378. GLEASON CE, Norton D, Anderson ED, Wahoske M, et al
    Cognitive Variability Predicts Incident Alzheimer's Disease and Mild Cognitive Impairment Comparable to a Cerebrospinal Fluid Biomarker.
    J Alzheimers Dis. 2017 Nov 8. doi: 10.3233/JAD-170498.
    PubMed     Text format     Abstract available


  379. MEDORO A, Bartollino S, Mignogna D, Passarella D, et al
    Complexity and Selectivity of gamma-Secretase Cleavage on Multiple Substrates: Consequences in Alzheimer's Disease and Cancer.
    J Alzheimers Dis. 2017 Nov 1. doi: 10.3233/JAD-170628.
    PubMed     Text format     Abstract available


  380. NACMIAS B, Bagnoli S, Piaceri I, Sorbi S, et al
    Genetic Heterogeneity of Alzheimer's Disease: Embracing Research Partnerships.
    J Alzheimers Dis. 2017 Nov 1. doi: 10.3233/JAD-170570.
    PubMed     Text format     Abstract available


    October 2017
  381. FAJARDO VA, Fajardo VA, LeBlanc PJ, MacPherson REK, et al
    Examining the Relationship between Trace Lithium in Drinking Water and the Rising Rates of Age-Adjusted Alzheimer's Disease Mortality in Texas.
    J Alzheimers Dis. 2017 Oct 30. doi: 10.3233/JAD-170744.
    PubMed     Text format     Abstract available


  382. MCGEER PL, Guo JP, Lee M, Kennedy K, et al
    Alzheimer's Disease Can Be Spared by Nonsteroidal Anti-Inflammatory Drugs.
    J Alzheimers Dis. 2017 Oct 30. doi: 10.3233/JAD-170706.
    PubMed     Text format     Abstract available


  383. TAMAGNO E, Guglielmotto M, Monteleone D, Manassero G, et al
    The Unexpected Role of Abeta1-42 Monomers in the Pathogenesis of Alzheimer's Disease.
    J Alzheimers Dis. 2017 Oct 30. doi: 10.3233/JAD-170581.
    PubMed     Text format     Abstract available


  384. BLACK CM, Fillit H, Xie L, Hu X, et al
    Economic Burden, Mortality, and Institutionalization in Patients Newly Diagnosed with Alzheimer's Disease.
    J Alzheimers Dis. 2017 Oct 30. doi: 10.3233/JAD-170518.
    PubMed     Text format     Abstract available


  385. DEVANAND DP, Lentz C, Chunga RE, Ciarleglio A, et al
    Change in Odor Identification Impairment is Associated with Improvement with Cholinesterase Inhibitor Treatment in Mild Cognitive Impairment.
    J Alzheimers Dis. 2017 Oct 21. doi: 10.3233/JAD-170497.
    PubMed     Text format     Abstract available


  386. HANDELS RLH, Wimo A, Dodel R, Kramberger MG, et al
    Cost-Utility of Using Alzheimer's Disease Biomarkers in Cerebrospinal Fluid to Predict Progression from Mild Cognitive Impairment to Dementia.
    J Alzheimers Dis. 2017 Oct 21. doi: 10.3233/JAD-170324.
    PubMed     Text format     Abstract available


  387. VAN DUIJN S, Bulk M, van Duinen SG, Nabuurs RJA, et al
    Cortical Iron Reflects Severity of Alzheimer's Disease.
    J Alzheimers Dis. 2017 Oct 21. doi: 10.3233/JAD-161143.
    PubMed     Text format     Abstract available


  388. SEJUNAITE K, Lanza C, Riepe MW
    Everyday Memory in Patients with Alzheimer's Disease: Fragmentary and Distorted.
    J Alzheimers Dis. 2017 Oct 16. doi: 10.3233/JAD-170493.
    PubMed     Text format     Abstract available


  389. HARES K, Miners JS, Cook AJ, Rice C, et al
    Overexpression of Kinesin Superfamily Motor Proteins in Alzheimer's Disease.
    J Alzheimers Dis. 2017 Oct 16. doi: 10.3233/JAD-170094.
    PubMed     Text format     Abstract available


  390. DUMURGIER J, Hanseeuw BJ, Hatling FB, Judge KA, et al
    Alzheimer's Disease Biomarkers and Future Decline in Cognitive Normal Older Adults.
    J Alzheimers Dis. 2017 Oct 12. doi: 10.3233/JAD-170511.
    PubMed     Text format     Abstract available


  391. GUO R, Fan G, Zhang J, Wu C, et al
    A 9-microRNA Signature in Serum Serves as a Noninvasive Biomarker in Early Diagnosis of Alzheimer's Disease.
    J Alzheimers Dis. 2017 Oct 12. doi: 10.3233/JAD-170343.
    PubMed     Text format     Abstract available


  392. SUNDARAM JR, Poore CP, Sulaimee NHB, Pareek T, et al
    Curcumin Ameliorates Neuroinflammation, Neurodegeneration, and Memory Deficits in p25 Transgenic Mouse Model that Bears Hallmarks of Alzheimer's Disease.
    J Alzheimers Dis. 2017 Oct 12. doi: 10.3233/JAD-170093.
    PubMed     Text format     Abstract available


  393. PATERSON EN, Williams MA, Passmore P, Silvestri G, et al
    Estimated Glomerular Filtration Rate is not Associated with Alzheimer's Disease in a Northern Ireland Cohort.
    J Alzheimers Dis. 2017 Oct 11. doi: 10.3233/JAD-170480.
    PubMed     Text format     Abstract available


  394. JOSHI A, Jimenez E, Mendez MF
    Initial Heart Rate Reactivity to Socioemotional Pictures in Early-Onset Alzheimer's Disease.
    J Alzheimers Dis. 2017 Oct 11. doi: 10.3233/JAD-170319.
    PubMed     Text format     Abstract available


  395. REIJS BLR, Vos SJB, Soininen H, Lotjonen J, et al
    Association Between Later Life Lifestyle Factors and Alzheimer's Disease Biomarkers in Non-Demented Individuals: A Longitudinal Descriptive Cohort Study.
    J Alzheimers Dis. 2017 Oct 11. doi: 10.3233/JAD-170039.
    PubMed     Text format     Abstract available


  396. MANZINE PR, Pelucchi S, Horst MA, Vale FAC, et al
    microRNA 221 Targets ADAM10 mRNA and is Downregulated in Alzheimer's Disease.
    J Alzheimers Dis. 2017 Oct 7. doi: 10.3233/JAD-170592.
    PubMed     Text format     Abstract available


  397. SWERDLOW RH
    Mitochondria and Mitochondrial Cascades in Alzheimer's Disease.
    J Alzheimers Dis. 2017 Oct 7. doi: 10.3233/JAD-170585.
    PubMed     Text format     Abstract available


  398. BRUNO D
    The Emergence of a New Conceptual Framework for Alzheimer's Disease.
    J Alzheimers Dis. 2017 Oct 7. doi: 10.3233/JAD-170536.
    PubMed     Text format     Abstract available


  399. ZHANG L, Wang Y, Xiayu X, Shi C, et al
    Altered Gut Microbiota in a Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2017 Oct 7. doi: 10.3233/JAD-170020.
    PubMed     Text format     Abstract available


  400. SHENG M, Lu H, Liu P, Li Y, et al
    Sildenafil Improves Vascular and Metabolic Function in Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2017 Oct 7. doi: 10.3233/JAD-161006.
    PubMed     Text format     Abstract available


  401. TUWAIG M, Savard M, Jutras B, Poirier J, et al
    Deficit in Central Auditory Processing as a Biomarker of Pre-Clinical Alzheimer's Disease.
    J Alzheimers Dis. 2017 Oct 3. doi: 10.3233/JAD-170545.
    PubMed     Text format     Abstract available


  402. KIRSEBOM BE, Espenes R, Waterloo K, Hessen E, et al
    Screening for Alzheimer's Disease: Cognitive Impairment in Self-Referred and Memory Clinic-Referred Patients.
    J Alzheimers Dis. 2017 Oct 3. doi: 10.3233/JAD-170385.
    PubMed     Text format     Abstract available


    September 2017
  403. COWAN RL, Beach PA, Atalla SW, Dietrich MS, et al
    Sex Differences in the Psychophysical Response to Contact Heat in Moderate Cognitive Impairment Alzheimer's Disease: A Cross-Sectional Brief Report.
    J Alzheimers Dis. 2017 Sep 29. doi: 10.3233/JAD-170532.
    PubMed     Text format     Abstract available


  404. WARAGAI M, Moriya M, Nojo T
    Decreased N-Acetyl Aspartate/Myo-Inositol Ratio in the Posterior Cingulate Cortex Shown by Magnetic Resonance Spectroscopy May Be One of the Risk Markers of Preclinical Alzheimer's Disease: A 7-Year Follow-Up Study.
    J Alzheimers Dis. 2017 Sep 29. doi: 10.3233/JAD-170450.
    PubMed     Text format     Abstract available


  405. MCLIMANS KE, Webb JL, Anantharam V, Kanthasamy A, et al
    Peripheral versus Central Index of Metabolic Dysfunction and Associations with Clinical and Pathological Outcomes in Alzheimer's Disease.
    J Alzheimers Dis. 2017 Sep 29. doi: 10.3233/JAD-170263.
    PubMed     Text format     Abstract available


  406. DIFRANCESCO JC, Tremolizzo L, Polonia V, Giussani G, et al
    Adult-Onset Epilepsy in Presymptomatic Alzheimer's Disease: A Retrospective Study.
    J Alzheimers Dis. 2017 Sep 28. doi: 10.3233/JAD-170392.
    PubMed     Text format     Abstract available


  407. BLONZ ER
    Alzheimer's Disease as the Product of a Progressive Energy Deficiency Syndrome in the Central Nervous System: The Neuroenergetic Hypothesis.
    J Alzheimers Dis. 2017 Sep 19. doi: 10.3233/JAD-170549.
    PubMed     Text format     Abstract available


  408. MARTINEZ MARTINEZ P, Mielke M
    Sphingolipids in Alzheimer's Disease and Related Disorders.
    J Alzheimers Dis. 2017 Sep 11. doi: 10.3233/JAD-170735.
    PubMed     Text format    


  409. KISHI T, Matsunaga S, Oya K, Nomura I, et al
    Memantine for Alzheimer's Disease: An Updated Systematic Review and Meta-analysis.
    J Alzheimers Dis. 2017 Sep 11. doi: 10.3233/JAD-170424.
    PubMed     Text format     Abstract available


  410. INUI Y, Ito K, Kato T
    Longer-Term Investigation of the Value of 18F-FDG-PET and Magnetic Resonance Imaging for Predicting the Conversion of Mild Cognitive Impairment to Alzheimer's Disease: A Multicenter Study.
    J Alzheimers Dis. 2017 Sep 11. doi: 10.3233/JAD-170395.
    PubMed     Text format     Abstract available


  411. KARKI R, Tom Kodamullil A, Hofmann-Apitius M
    Comorbidity Analysis between Alzheimer's Disease and Type 2 Diabetes Mellitus (T2DM) Based on Shared Pathways and the Role of T2DM Drugs.
    J Alzheimers Dis. 2017 Sep 8. doi: 10.3233/JAD-170440.
    PubMed     Text format     Abstract available


  412. PONGAN E, Tillmann B, Leveque Y, Trombert B, et al
    Can Musical or Painting Interventions Improve Chronic Pain, Mood, Quality of Life, and Cognition in Patients with Mild Alzheimer's Disease? Evidence from a Randomized Controlled Trial.
    J Alzheimers Dis. 2017 Sep 8. doi: 10.3233/JAD-170410.
    PubMed     Text format     Abstract available


  413. KUTTNER-HIRSHLER Y, Venkatasubramanian PN, Apolinario J, Bonds J, et al
    Brain Biomarkers in Familial Alzheimer's Disease Mouse Models.
    J Alzheimers Dis. 2017 Sep 8. doi: 10.3233/JAD-170269.
    PubMed     Text format     Abstract available


  414. ZHANG L, Sun C, Jin Y, Gao K, et al
    Dickkopf 3 (Dkk3) Improves Amyloid-beta Pathology, Cognitive Dysfunction, and Cerebral Glucose Metabolism in a Transgenic Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2017 Sep 8. doi: 10.3233/JAD-161254.
    PubMed     Text format     Abstract available


  415. WEISSBERGER GH, Melrose RJ, Fanale CM, Veliz JV, et al
    Cortical Metabolic and Cognitive Correlates of Disorientation in Alzheimer's Disease.
    J Alzheimers Dis. 2017 Sep 1. doi: 10.3233/JAD-170420.
    PubMed     Text format     Abstract available


  416. AMORIM JA, Canas PM, Tome AR, Rolo AP, et al
    Mitochondria in Excitatory and Inhibitory Synapses have Similar Susceptibility to Amyloid-beta Peptides Modeling Alzheimer's Disease.
    J Alzheimers Dis. 2017 Sep 1. doi: 10.3233/JAD-170356.
    PubMed     Text format     Abstract available


  417. NIEMANTSVERDRIET E, Ottoy J, Somers C, De Roeck E, et al
    The Cerebrospinal Fluid Abeta1-42/Abeta1-40 Ratio Improves Concordance with Amyloid-PET for Diagnosing Alzheimer's Disease in a Clinical Setting.
    J Alzheimers Dis. 2017 Sep 1. doi: 10.3233/JAD-170327.
    PubMed     Text format     Abstract available


  418. POULIN SP, Bergeron D, Dickerson BC
    Risk Factors, Neuroanatomical Correlates, and Outcome of Neuropsychiatric Symptoms of Alzheimer's Disease.
    J Alzheimers Dis. 2017 Sep 1. doi: 10.3233/JAD-160767.
    PubMed     Text format     Abstract available


    August 2017
  419. LEVY NOGUEIRA M, Samri D, Epelbaum S, Lista S, et al
    Alzheimer's Disease Diagnosis Relies on a Twofold Clinical-Biological Algorithm: Three Memory Clinic Case Reports.
    J Alzheimers Dis. 2017 Aug 30. doi: 10.3233/JAD-170574.
    PubMed     Text format     Abstract available


  420. LARSSON SC, Traylor M, Burgess S, Markus HS, et al
    Genetically-Predicted Adult Height an Alzheimer's Disease.
    J Alzheimers Dis. 2017 Aug 30. doi: 10.3233/JAD-170528.
    PubMed     Text format     Abstract available


  421. GIIL LM, Midttun O, Refsum H, Ulvik A, et al
    Kynurenine Pathway Metabolites in Alzheimer's Disease.
    J Alzheimers Dis. 2017 Aug 30. doi: 10.3233/JAD-170485.
    PubMed     Text format     Abstract available


  422. PORTBURY SD, Hare DJ, Sgambelloni C, Perronnes K, et al
    Trehalose Improves Cognition in the Transgenic Tg2576 Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2017 Aug 30. doi: 10.3233/JAD-170322.
    PubMed     Text format     Abstract available


  423. WILLEN K, Sroka A, Takahashi RH, Gouras GK, et al
    Heterogeneous Association of Alzheimer's Disease-Linked Amyloid-beta and Amyloid-beta Protein Precursor with Synapses.
    J Alzheimers Dis. 2017 Aug 30. doi: 10.3233/JAD-170262.
    PubMed     Text format     Abstract available


  424. MORALES I, Cerda-Troncoso C, Andrade V, Maccioni RB, et al
    The Natural Product Curcumin as a Potential Coadjuvant in Alzheimer's Treatment.
    J Alzheimers Dis. 2017 Aug 21. doi: 10.3233/JAD-170354.
    PubMed     Text format     Abstract available


  425. BASSELERIE H, Bracoud L, Zeestraten E, Bouguen E, et al
    Incident Cerebral Microbleeds on Longitudinal 3T MRI with Susceptibility Weight-Imaging Help to Identify Patients with Mild Cognitive Impairment Progressing to Alzheimer's Disease.
    J Alzheimers Dis. 2017 Aug 17. doi: 10.3233/JAD-170470.
    PubMed     Text format     Abstract available


  426. PAOURI E, Tzara O, Zenelak S, Georgopoulos S, et al
    Genetic Deletion of Tumor Necrosis Factor-alpha Attenuates Amyloid-beta Production and Decreases Amyloid Plaque Formation and Glial Response in the 5XFAD Model of Alzheimer's Disease.
    J Alzheimers Dis. 2017 Aug 17. doi: 10.3233/JAD-170065.
    PubMed     Text format     Abstract available


  427. BEAGLE AJ, Darwish SM, Ranasinghe KG, La AL, et al
    Relative Incidence of Seizures and Myoclonus in Alzheimer's Disease, Dementia with Lewy Bodies, and Frontotemporal Dementia.
    J Alzheimers Dis. 2017 Aug 17. doi: 10.3233/JAD-170031.
    PubMed     Text format     Abstract available


  428. GERSTENECKER A, Hoagey DA, Marson DC, Kennedy KM, et al
    White Matter Degradation is Associated with Reduced Financial Capacity in Mild Cognitive Impairment and Alzheimer's Disease.
    J Alzheimers Dis. 2017 Aug 16. doi: 10.3233/JAD-170341.
    PubMed     Text format     Abstract available


  429. OIKONOMIDI A, Tautvydaite D, Gholamrezaee MM, Henry H, et al
    Macrophage Migration Inhibitory Factor is Associated with Biomarkers of Alzheimer's Disease Pathology and Predicts Cognitive Decline in Mild Cognitive Impairment and Mild Dementia.
    J Alzheimers Dis. 2017 Aug 16. doi: 10.3233/JAD-170335.
    PubMed     Text format     Abstract available


  430. SUGIMOTO T, Nakamura A, Kato T, Iwata K, et al
    Decreased Glucose Metabolism in Medial Prefrontal Areas is Associated with Nutritional Status in Patients with Prodromal and Early Alzheimer's Disease.
    J Alzheimers Dis. 2017 Aug 16. doi: 10.3233/JAD-170257.
    PubMed     Text format     Abstract available


  431. FLADBY T, Palhaugen L, Selnes P, Waterloo K, et al
    Detecting At-Risk Alzheimer's Disease Cases.
    J Alzheimers Dis. 2017 Aug 16. doi: 10.3233/JAD-170231.
    PubMed     Text format     Abstract available


  432. SANTANGELO R, Cecchetti G, Bernasconi MP, Cardamone R, et al
    Cerebrospinal Fluid Amyloid-beta 42, Total Tau, and Phosphorylated Tau are Low in Patients with Normal Pressure Hydrocephalus: Analogies and Differences with Alzheimer's Disease.
    J Alzheimers Dis. 2017 Aug 16. doi: 10.3233/JAD-170186.
    PubMed     Text format     Abstract available


  433. CHUNG JK, Plitman E, Nakajima S, Caravaggio F, et al
    The Effects of Cortical Hypometabolism and Hippocampal Atrophy on Clinical Trajectories in Mild Cognitive Impairment with Suspected Non-Alzheimer's Pathology: A Brief Report.
    J Alzheimers Dis. 2017 Aug 16. doi: 10.3233/JAD-170098.
    PubMed     Text format     Abstract available


  434. NAGATA T, Nakajima S, Shinagawa S, Plitman E, et al
    Baseline Predictors of Antipsychotic Treatment Continuation and Response at Week 8 in Patients with Alzheimer's Disease with Psychosis or Aggressive Symptoms: An Analysis of the CATIE-AD Study.
    J Alzheimers Dis. 2017 Aug 9. doi: 10.3233/JAD-170412.
    PubMed     Text format     Abstract available


  435. THIBEAU S, McFall GP, Camicioli R, Dixon RA, et al
    Alzheimer's Disease Biomarkers Interactively Influence Physical Activity, Mobility, and Cognition Associations in a Non-Demented Aging Population.
    J Alzheimers Dis. 2017 Aug 8. doi: 10.3233/JAD-170130.
    PubMed     Text format     Abstract available


  436. KOYCHEV I, Gunn RN, Firouzian A, Lawson J, et al
    PET Tau and Amyloid-beta Burden in Mild Alzheimer's Disease: Divergent Relationship with Age, Cognition, and Cerebrospinal Fluid Biomarkers.
    J Alzheimers Dis. 2017 Aug 8. doi: 10.3233/JAD-170129.
    PubMed     Text format     Abstract available


  437. KAWALIA SB, Raschka T, Naz M, de Matos Simoes R, et al
    Analytical Strategy to Prioritize Alzheimer's Disease Candidate Genes in Gene Regulatory Networks Using Public Expression Data.
    J Alzheimers Dis. 2017 Aug 8. doi: 10.3233/JAD-170011.
    PubMed     Text format     Abstract available


  438. BEHESHTI I, Maikusa N, Daneshmand M, Matsuda H, et al
    Classification of Alzheimer's Disease and Prediction of Mild Cognitive Impairment Conversion Using Histogram-Based Analysis of Patient-Specific Anatomical Brain Connectivity Networks.
    J Alzheimers Dis. 2017 Aug 8. doi: 10.3233/JAD-161080.
    PubMed     Text format     Abstract available


    July 2017
  439. ADAMS SL, Benayoun L, Tilton K, Chavez OR, et al
    Methionine Sulfoxide Reductase-B3 (MsrB3) Protein Associates with Synaptic Vesicles and its Expression Changes in the Hippocampi of Alzheimer's Disease Patients.
    J Alzheimers Dis. 2017 Jul 29. doi: 10.3233/JAD-170459.
    PubMed     Text format     Abstract available


  440. ZHANG N, Zhang L, Li Y, Gordon ML, et al
    Urine AD7c-NTP Predicts Amyloid Deposition and Symptom of Agitation in Patients with Alzheimer's Disease and Mild Cognitive Impairment.
    J Alzheimers Dis. 2017 Jul 29. doi: 10.3233/JAD-170383.
    PubMed     Text format     Abstract available


  441. LE PAGE A, Lamoureux J, Bourgade K, Frost EH, et al
    Polymorphonuclear Neutrophil Functions are Differentially Altered in Amnestic Mild Cognitive Impairment and Mild Alzheimer's Disease Patients.
    J Alzheimers Dis. 2017 Jul 29. doi: 10.3233/JAD-170124.
    PubMed     Text format     Abstract available


  442. CAVEDO E, Suppa P, Lange C, Opfer R, et al
    Fully Automatic MRI-Based Hippocampus Volumetry Using FSL-FIRST: Intra-Scanner Test-Retest Stability, Inter-Field Strength Variability, and Performance as Enrichment Biomarker for Clinical Trials Using Prodromal Target Populations at Risk for Alzheime
    J Alzheimers Dis. 2017 Jul 29. doi: 10.3233/JAD-161108.
    PubMed     Text format     Abstract available


  443. EVGEN'EV MB, Krasnov GS, Nesterova IV, Garbuz DG, et al
    Molecular Mechanisms Underlying Neuroprotective Effect of Intranasal Administration of Human Hsp70 in Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2017 Jul 25. doi: 10.3233/JAD-170398.
    PubMed     Text format     Abstract available


  444. RADAKOVIC R, Starr JM, Abrahams S
    A Novel Assessment and Profiling of Multidimensional Apathy in Alzheimer's Disease.
    J Alzheimers Dis. 2017 Jul 25. doi: 10.3233/JAD-170292.
    PubMed     Text format     Abstract available


  445. LAWRENCE E, Vegvari C, Ower A, Hadjichrysanthou C, et al
    A Systematic Review of Longitudinal Studies Which Measure Alzheimer's Disease Biomarkers.
    J Alzheimers Dis. 2017 Jul 25. doi: 10.3233/JAD-170261.
    PubMed     Text format     Abstract available


  446. HAJIPOUR MJ, Ghasemi F, Aghaverdi H, Raoufi M, et al
    Sensing of Alzheimer's Disease and Multiple Sclerosis Using Nano-Bio Interfaces.
    J Alzheimers Dis. 2017 Jul 25. doi: 10.3233/JAD-160206.
    PubMed     Text format     Abstract available


  447. DEFRANCESCO M, Marksteiner J, Kemmler G, Fleischhacker WW, et al
    Severity of Depression Impacts Imminent Conversion from Mild Cognitive Impairment to Alzheimer's Disease.
    J Alzheimers Dis. 2017 Jul 19. doi: 10.3233/JAD-161135.
    PubMed     Text format     Abstract available


  448. BILGEL M, Koscik RL, An Y, Prince JL, et al
    Temporal Order of Alzheimer's Disease-Related Cognitive Marker Changes in BLSA and WRAP Longitudinal Studies.
    J Alzheimers Dis. 2017 Jul 18. doi: 10.3233/JAD-170448.
    PubMed     Text format     Abstract available


  449. SHI Y, Gu L, Alsharif AA, Zhang Z, et al
    The Distinction of Amyloid-beta Protein Precursor (AbetaPP) Ratio in Platelet Between Alzheimer's Disease Patients and Controls: A Systematic Review and Meta-Analysis.
    J Alzheimers Dis. 2017 Jul 18. doi: 10.3233/JAD-170253.
    PubMed     Text format     Abstract available


  450. DE BELDER M, Santens P, Sieben A, Fias W, et al
    Impaired Processing of Serial Order Determines Working Memory Impairments in Alzheimer's Disease.
    J Alzheimers Dis. 2017 Jul 17. doi: 10.3233/JAD-170193.
    PubMed     Text format     Abstract available


  451. HONG H, Li Y, Su B
    Identification of Circulating miR-125b as a Potential Biomarker of Alzheimer's Disease in APP/PS1 Transgenic Mouse.
    J Alzheimers Dis. 2017 Jul 17. doi: 10.3233/JAD-170156.
    PubMed     Text format     Abstract available


  452. ZHANG Y, Wang S, Sui Y, Yang M, et al
    Multivariate Approach for Alzheimer's Disease Detection Using Stationary Wavelet Entropy and Predator-Prey Particle Swarm Optimization.
    J Alzheimers Dis. 2017 Jul 17. doi: 10.3233/JAD-170069.
    PubMed     Text format     Abstract available


  453. SOLFRIZZI V, Custodero C, Lozupone M, Imbimbo BP, et al
    Relationships of Dietary Patterns, Foods, and Micro- and Macronutrients with Alzheimer's Disease and Late-Life Cognitive Disorders: A Systematic Review.
    J Alzheimers Dis. 2017 Jul 5. doi: 10.3233/JAD-170248.
    PubMed     Text format     Abstract available


  454. JOHANSSON P, Almqvist EG, Bjerke M, Wallin A, et al
    Reduced Cerebrospinal Fluid Concentration of Apolipoprotein A-I in Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2017 Jul 5. doi: 10.3233/JAD-170226.
    PubMed     Text format     Abstract available


  455. BUSSE C, Anselmi P, Pompanin S, Zorzi G, et al
    Specific Verbal Memory Measures May Distinguish Alzheimer's Disease from Dementia with Lewy Bodies.
    J Alzheimers Dis. 2017 Jul 5. doi: 10.3233/JAD-170154.
    PubMed     Text format     Abstract available


  456. ESQUERDA-CANALS G, Marti-Clua J, Roda AR, Villegas S, et al
    An Intracellular Amyloid-beta/AbetaPP Epitope Correlates with Neurodegeneration in those Neuronal Populations Early Involved in Alzheimer's Disease.
    J Alzheimers Dis. 2017 Jul 4. doi: 10.3233/JAD-170218.
    PubMed     Text format     Abstract available


  457. SANTOS CY, Machan JT, Wu WC, Snyder PJ, et al
    Autonomic Cardiac Function in Preclinical Alzheimer's Disease.
    J Alzheimers Dis. 2017 Jul 4. doi: 10.3233/JAD-170217.
    PubMed     Text format     Abstract available


  458. GIIL LM, Vedeler CA, Kristoffersen EK, Nordrehaug JE, et al
    Antibodies to Signaling Molecules and Receptors in Alzheimer's Disease are Associated with Psychomotor Slowing, Depression, and Poor Visuospatial Function.
    J Alzheimers Dis. 2017 Jul 1. doi: 10.3233/JAD-170245.
    PubMed     Text format     Abstract available


  459. MUSZYNSKI P, Kulczynska-Przybik A, Borawska R, Litman-Zawadzka A, et al
    The Relationship between Markers of Inflammation and Degeneration in the Central Nervous System and the Blood-Brain Barrier Impairment in Alzheimer's Disease.
    J Alzheimers Dis. 2017 Jul 1. doi: 10.3233/JAD-170220.
    PubMed     Text format     Abstract available


  460. DYRBA M, Grothe MJ, Mohammadi A, Binder H, et al
    Comparison of Different Hypotheses Regarding the Spread of Alzheimer's Disease Using Markov Random Fields and Multimodal Imaging.
    J Alzheimers Dis. 2017 Jul 1. doi: 10.3233/JAD-161197.
    PubMed     Text format     Abstract available


  461. TU S, Spiers HJ, Hodges JR, Piguet O, et al
    Egocentric versus Allocentric Spatial Memory in Behavioral Variant Frontotemporal Dementia and Alzheimer's Disease.
    J Alzheimers Dis. 2017 Jul 1. doi: 10.3233/JAD-160592.
    PubMed     Text format     Abstract available


    June 2017
  462. VALERO J, Bernardino L, Cardoso F, Silva AP, et al
    Impact of Neuroinflammation on Hippocampal Neurogenesis: Relevance to Aging and Alzheimer's Disease.
    J Alzheimers Dis. 2017 Jun 28. doi: 10.3233/JAD-170239.
    PubMed     Text format     Abstract available


  463. SERRANO-POZO A, Aldridge GM, Zhang Q
    Four Decades of Research in Alzheimer's Disease (1975-2014): A Bibliometric and Scientometric Analysis.
    J Alzheimers Dis. 2017 Jun 27. doi: 10.3233/JAD-170184.
    PubMed     Text format     Abstract available


  464. CACCIAMANI F, Tandetnik C, Gagliardi G, Bertin H, et al
    Low Cognitive Awareness, but Not Complaint, is a Good Marker of Preclinical Alzheimer's Disease.
    J Alzheimers Dis. 2017 Jun 26. doi: 10.3233/JAD-170399.
    PubMed     Text format     Abstract available


  465. ZAFAR S, Shafiq M, Younas N, Schmitz M, et al
    Prion Protein Interactome: Identifying Novel Targets in Slowly and Rapidly Progressive Forms of Alzheimer's Disease.
    J Alzheimers Dis. 2017 Jun 26. doi: 10.3233/JAD-170237.
    PubMed     Text format     Abstract available


  466. MICHALSKI D, Hofmann S, Pitsch R, Grosche J, et al
    Neurovascular Specifications in the Alzheimer-Like Brain of Mice Affected by Focal Cerebral Ischemia: Implications for Future Therapies.
    J Alzheimers Dis. 2017 Jun 26. doi: 10.3233/JAD-170185.
    PubMed     Text format     Abstract available


  467. VASAVADA MM, Martinez B, Wang J, Eslinger PJ, et al
    Central Olfactory Dysfunction in Alzheimer's Disease and Mild Cognitive Impairment: A Functional MRI Study.
    J Alzheimers Dis. 2017 Jun 24. doi: 10.3233/JAD-170310.
    PubMed     Text format     Abstract available


  468. IACCARINO L, Chiotis K, Alongi P, Almkvist O, et al
    A Cross-Validation of FDG- and Amyloid-PET Biomarkers in Mild Cognitive Impairment for the Risk Prediction to Dementia due to Alzheimer's Disease in a Clinical Setting.
    J Alzheimers Dis. 2017 Jun 24. doi: 10.3233/JAD-170158.
    PubMed     Text format     Abstract available


  469. BAGATTINI C, Mazza V, Panizza L, Ferrari C, et al
    Neural Dynamics of Multiple Object Processing in Mild Cognitive Impairment and Alzheimer's Disease: Future Early Diagnostic Biomarkers?
    J Alzheimers Dis. 2017 Jun 24. doi: 10.3233/JAD-161274.
    PubMed     Text format     Abstract available


  470. BELLANTI F, Iannelli G, Blonda M, Tamborra R, et al
    Alterations of Clock Gene RNA Expression in Brain Regions of a Triple Transgenic Model of Alzheimer's Disease.
    J Alzheimers Dis. 2017 Jun 24. doi: 10.3233/JAD-160942.
    PubMed     Text format     Abstract available


  471. VASQUEZ JB, Simpson JF, Harpole R, Estus S, et al
    Alzheimer's Disease Genetics and ABCA7 Splicing.
    J Alzheimers Dis. 2017 Jun 22. doi: 10.3233/JAD-170872.
    PubMed     Text format     Abstract available


  472. STOCCORO A, Siciliano G, Migliore L, Coppede F, et al
    Decreased Methylation of the Mitochondrial D-Loop Region in Late-Onset Alzheimer's Disease.
    J Alzheimers Dis. 2017 Jun 22. doi: 10.3233/JAD-170139.
    PubMed     Text format     Abstract available


  473. PADALA KP, Padala PR, Lensing SY, Dennis RA, et al
    Home-Based Exercise Program Improves Balance and Fear of Falling in Community-Dwelling Older Adults with Mild Alzheimer's Disease: A Pilot Study.
    J Alzheimers Dis. 2017 Jun 22. doi: 10.3233/JAD-170120.
    PubMed     Text format     Abstract available


  474. ASIH PR, Tegg ML, Sohrabi H, Carruthers M, et al
    Multiple Mechanisms Linking Type 2 Diabetes and Alzheimer's Disease: Testosterone as a Modifier.
    J Alzheimers Dis. 2017 Jun 22. doi: 10.3233/JAD-161259.
    PubMed     Text format     Abstract available


  475. TRIPODIS Y, Alosco ML, Zirogiannis N, Gavett BE, et al
    The Effect of Traumatic Brain Injury History with Loss of Consciousness on Rate of Cognitive Decline Among Older Adults with Normal Cognition and Alzheimer's Disease Dementia.
    J Alzheimers Dis. 2017 Jun 22. doi: 10.3233/JAD-160585.
    PubMed     Text format     Abstract available


  476. LEHRER S, Rheinstein PH, Rosenzweig KE
    Association of Radon Background and Total Background Ionizing Radiation with Alzheimer's Disease Deaths in U.S. States.
    J Alzheimers Dis. 2017 Jun 22. doi: 10.3233/JAD-170308.
    PubMed     Text format     Abstract available


  477. XIE F, Peng F
    Radiopharmaceuticals for Assessment of Altered Metabolism and Biometal Fluxes in Brain Aging and Alzheimer's Disease with Positron Emission Tomography.
    J Alzheimers Dis. 2017 Jun 22. doi: 10.3233/JAD-170280.
    PubMed     Text format     Abstract available


  478. BABILONI C, Del Percio C, Lizio R, Noce G, et al
    Abnormalities of Cortical Neural Synchronization Mechanisms in Subjects with Mild Cognitive Impairment due to Alzheimer's and Parkinson's Diseases: An EEG Study.
    J Alzheimers Dis. 2017 Jun 10. doi: 10.3233/JAD-160883.
    PubMed     Text format     Abstract available


  479. CANSEV M, Turkyilmaz M, Sijben JWC, Sevinc C, et al
    Synaptic Membrane Synthesis in Rats Depends on Dietary Sufficiency of Vitamin C, Vitamin E, and Selenium: Relevance for Alzheimer's Disease.
    J Alzheimers Dis. 2017 Jun 9. doi: 10.3233/JAD-170081.
    PubMed     Text format     Abstract available


  480. ANAND S, Barnes JM, Young SA, Garcia DM, et al
    Discovery and Confirmation of Diagnostic Serum Lipid Biomarkers for Alzheimer's Disease Using Direct Infusion Mass Spectrometry.
    J Alzheimers Dis. 2017 Jun 9. doi: 10.3233/JAD-170035.
    PubMed     Text format     Abstract available


  481. ADEGOKE OO, Qiao F, Liu Y, Longley K, et al
    Overexpression of Ubiquilin-1 Alleviates Alzheimer's Disease-Caused Cognitive and Motor Deficits and Reduces Amyloid-beta Accumulation in Mice.
    J Alzheimers Dis. 2017 Jun 8. doi: 10.3233/JAD-170173.
    PubMed     Text format     Abstract available


  482. WILKINS HM, Mahnken JD, Welch P, Bothwell R, et al
    A Mitochondrial Biomarker-Based Study of S-Equol in Alzheimer's Disease Subjects: Results of a Single-Arm, Pilot Trial.
    J Alzheimers Dis. 2017 Jun 7. doi: 10.3233/JAD-170077.
    PubMed     Text format     Abstract available


  483. NAGAI M, Dote K, Kato M, Sasaki S, et al
    Visit-to-Visit Blood Pressure Variability and Alzheimer's Disease: Links and Risks.
    J Alzheimers Dis. 2017 Jun 7. doi: 10.3233/JAD-161172.
    PubMed     Text format     Abstract available


  484. YU Q, Du F, Douglas JT, Yu H, et al
    Mitochondrial Dysfunction Triggers Synaptic Deficits via Activation of p38 MAP Kinase Signaling in Differentiated Alzheimer's Disease Trans-Mitochondrial Cybrid Cells.
    J Alzheimers Dis. 2017 Jun 6. doi: 10.3233/JAD-170283.
    PubMed     Text format     Abstract available


  485. GONZALEZ-MACIEL A, Reynoso-Robles R, Torres-Jardon R, Mukherjee PS, et al
    Combustion-Derived Nanoparticles in Key Brain Target Cells and Organelles in Young Urbanites: Culprit Hidden in Plain Sight in Alzheimer's Disease Development.
    J Alzheimers Dis. 2017 Jun 3. doi: 10.3233/JAD-170012.
    PubMed     Text format     Abstract available


  486. DILLEN KNH, Jacobs HIL, Kukolja J, Richter N, et al
    Functional Disintegration of the Default Mode Network in Prodromal Alzheimer's Disease.
    J Alzheimers Dis. 2017 Jun 3. doi: 10.3233/JAD-161120.
    PubMed     Text format     Abstract available


  487. ANDREADOU E, Pantazaki AA, Daniilidou M, Tsolaki M, et al
    Rhamnolipids, Microbial Virulence Factors, in Alzheimer's Disease.
    J Alzheimers Dis. 2017 Jun 3. doi: 10.3233/JAD-161020.
    PubMed     Text format     Abstract available


    May 2017
  488. FERGUSON SA, Panos JJ, Sloper D, Varma V, et al
    Neurodegenerative Markers are Increased in Postmortem BA21 Tissue from African Americans with Alzheimer's Disease.
    J Alzheimers Dis. 2017 May 30. doi: 10.3233/JAD-170204.
    PubMed     Text format     Abstract available


  489. LUPTON MK, Benyamin B, Proitsi P, Nyholt DR, et al
    No Genetic Overlap Between Circulating Iron Levels and Alzheimer's Disease.
    J Alzheimers Dis. 2017 May 30. doi: 10.3233/JAD-170027.
    PubMed     Text format     Abstract available


  490. LIN FV, Wang X, Wu R, Rebok GW, et al
    Identification of Successful Cognitive Aging in the Alzheimer's Disease Neuroimaging Initiative Study.
    J Alzheimers Dis. 2017 May 30. doi: 10.3233/JAD-161278.
    PubMed     Text format     Abstract available


  491. BINOSHA FWMAD, Somaratne G, Williams S, Goozee KG, et al
    Diabetes and Alzheimer's Disease: Can Tea Phytochemicals Play a Role in Prevention?
    J Alzheimers Dis. 2017 May 30. doi: 10.3233/JAD-161200.
    PubMed     Text format     Abstract available


  492. SHAW ME, Abhayaratna WP, Anstey KJ, Cherbuin N, et al
    Increasing Body Mass Index at Midlife is Associated with Increased Cortical Thinning in Alzheimer's Disease-Vulnerable Regions.
    J Alzheimers Dis. 2017 May 26. doi: 10.3233/JAD-170055.
    PubMed     Text format     Abstract available


  493. NAVE S, Doody RS, Boada M, Grimmer T, et al
    Sembragiline in Moderate Alzheimer's Disease: Results of a Randomized, Double-Blind, Placebo-Controlled Phase II Trial (MAyflOwer RoAD).
    J Alzheimers Dis. 2017 May 26. doi: 10.3233/JAD-161309.
    PubMed     Text format     Abstract available


  494. OCHOA JF, Alonso JF, Duque JE, Tobon CA, et al
    Precuneus Failures in Subjects of the PSEN1 E280A Family at Risk of Developing Alzheimer's Disease Detected Using Quantitative Electroencephalography.
    J Alzheimers Dis. 2017 May 26. doi: 10.3233/JAD-161291.
    PubMed     Text format     Abstract available


  495. MACEDO AC, Balouch S, Tabet N
    Is Sleep Disruption a Risk Factor for Alzheimer's Disease?
    J Alzheimers Dis. 2017 May 26. doi: 10.3233/JAD-161287.
    PubMed     Text format     Abstract available


  496. MORRIS K J, Uy RAZ, Vidoni ED, Wilkins HM, et al
    Effect of APOE epsilon4 Genotype on Metabolic Biomarkers in Aging and Alzheimer's Disease.
    J Alzheimers Dis. 2017 May 25. doi: 10.3233/JAD-170148.
    PubMed     Text format     Abstract available


  497. CERMAKOVA P, Nelson M, Secnik J, Garcia-Ptacek S, et al
    Living Alone with Alzheimer's Disease: Data from SveDem, the Swedish Dementia Registry.
    J Alzheimers Dis. 2017 May 25. doi: 10.3233/JAD-170102.
    PubMed     Text format     Abstract available


  498. TRIPATHI AK, Karmakar S, Asthana A, Ashok A, et al
    Transport of Non-Transferrin Bound Iron to the Brain: Implications for Alzheimer's Disease.
    J Alzheimers Dis. 2017 May 25. doi: 10.3233/JAD-170097.
    PubMed     Text format     Abstract available


  499. PINNER E, Gruper Y, Ben Zimra M, Kristt D, et al
    CD44 Splice Variants as Potential Players in Alzheimer's Disease Pathology.
    J Alzheimers Dis. 2017 May 25. doi: 10.3233/JAD-161245.
    PubMed     Text format     Abstract available


  500. LIU CY, Ohki Y, Tomita T, Osawa S, et al
    Two Novel Mutations in the First Transmembrane Domain of Presenilin1 Cause Young-Onset Alzheimer's Disease.
    J Alzheimers Dis. 2017 May 25. doi: 10.3233/JAD-161203.
    PubMed     Text format     Abstract available


  501. DETERS KD, Risacher SL, Kim S, Nho K, et al
    Plasma Tau Association with Brain Atrophy in Mild Cognitive Impairment and Alzheimer's Disease.
    J Alzheimers Dis. 2017 May 25. doi: 10.3233/JAD-161114.
    PubMed     Text format     Abstract available


  502. NAKAMURA N, Ohyagi Y, Imamura T, Yanagihara YT, et al
    Apomorphine Therapy for Neuronal Insulin Resistance in a Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2017 May 25. doi: 10.3233/JAD-160344.
    PubMed     Text format     Abstract available


  503. SIEDLAK SL, Jiang Y, Huntley ML, Wang L, et al
    TMEM230 Accumulation in Granulovacuolar Degeneration Bodies and Dystrophic Neurites of Alzheimer's Disease.
    J Alzheimers Dis. 2017 May 17. doi: 10.3233/JAD-170190.
    PubMed     Text format     Abstract available


  504. TANG M, Taghibiglou C
    The Mechanisms of Action of Curcumin in Alzheimer's Disease.
    J Alzheimers Dis. 2017 May 17. doi: 10.3233/JAD-170188.
    PubMed     Text format     Abstract available


  505. OLIVEIRA J, Costa M, de Almeida MSC, da Cruz E Silva OAB, et al
    Protein Phosphorylation is a Key Mechanism in Alzheimer's Disease.
    J Alzheimers Dis. 2017 May 17. doi: 10.3233/JAD-170176.
    PubMed     Text format     Abstract available


  506. LIU G, Sun JY, Xu M, Yang XY, et al
    SORL1 Variants Show Different Association with Early-Onset and Late-Onset Alzheimer's Disease Risk.
    J Alzheimers Dis. 2017 May 17. doi: 10.3233/JAD-170005.
    PubMed     Text format     Abstract available


  507. CALDERON-GARCIDUENAS L, de la Monte SM
    Apolipoprotein E4, Gender, Body Mass Index, Inflammation, Insulin Resistance, and Air Pollution Interactions: Recipe for Alzheimer's Disease Development in Mexico City Young Females.
    J Alzheimers Dis. 2017 May 17. doi: 10.3233/JAD-161299.
    PubMed     Text format     Abstract available


  508. VEGA IE, Cabrera LY, Wygant CM, Velez-Ortiz D, et al
    Alzheimer's Disease in the Latino Community: Intersection of Genetics and Social Determinants of Health.
    J Alzheimers Dis. 2017 May 17. doi: 10.3233/JAD-161261.
    PubMed     Text format     Abstract available


  509. DOUGHERTY RJ, Schultz SA, Kirby TK, Boots EA, et al
    Moderate Physical Activity is Associated with Cerebral Glucose Metabolism in Adults at Risk for Alzheimer's Disease.
    J Alzheimers Dis. 2017 May 17. doi: 10.3233/JAD-161067.
    PubMed     Text format     Abstract available


  510. MUSAEUS CS, Shafi MM, Santarnecchi E, Herman ST, et al
    Levetiracetam Alters Oscillatory Connectivity in Alzheimer's Disease.
    J Alzheimers Dis. 2017 May 17. doi: 10.3233/JAD-160742.
    PubMed     Text format     Abstract available


  511. SALA I, Illan-Gala I, Alcolea D, Sanchez-Saudinos MB, et al
    Diagnostic and Prognostic Value of the Combination of Two Measures of Verbal Memory in Mild Cognitive Impairment due to Alzheimer's Disease.
    J Alzheimers Dis. 2017 May 13. doi: 10.3233/JAD-170073.
    PubMed     Text format     Abstract available


  512. SUN H
    Associations of Spatial Disparities of Alzheimer's Disease Mortality Rates and Soil Selenium, Sulfur Concentrations, and Risk Factors in the United States.
    J Alzheimers Dis. 2017 May 13. doi: 10.3233/JAD-170059.
    PubMed     Text format     Abstract available


  513. BEN JEMAA S, Attia Romdhane N, Bahri-Mrabet A, Jendli A, et al
    An Arabic Version of the Cognitive Subscale of the Alzheimer's Disease Assessment Scale (ADAS-Cog): Reliability, Validity, and Normative Data.
    J Alzheimers Dis. 2017 May 11. doi: 10.3233/JAD-170222.
    PubMed     Text format     Abstract available


  514. JIN WS, Bu XL, Wang YR, Li L, et al
    Reduced Cardiovascular Functions in Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2017 May 11. doi: 10.3233/JAD-170088.
    PubMed     Text format     Abstract available


  515. ZHU JB, Tan CC, Tan L, Yu JT, et al
    State of Play in Alzheimer's Disease Genetics.
    J Alzheimers Dis. 2017 May 11. doi: 10.3233/JAD-170062.
    PubMed     Text format     Abstract available


  516. CHUNG JK, Plitman E, Nakajima S, Caravaggio F, et al
    Hippocampal and Clinical Trajectories of Mild Cognitive Impairment with Suspected Non-Alzheimer's Disease Pathology.
    J Alzheimers Dis. 2017 May 8. doi: 10.3233/JAD-170201.
    PubMed     Text format     Abstract available


  517. SNOW WM, Dale R, O'Brien-Moran Z, Buist R, et al
    In Vivo Detection of Gray Matter Neuropathology in the 3xTg Mouse Model of Alzheimer's Disease with Diffusion Tensor Imaging.
    J Alzheimers Dis. 2017 May 8. doi: 10.3233/JAD-170136.
    PubMed     Text format     Abstract available


  518. EDSBAGGE M, Andreasson U, Ambarki K, Wikkelso C, et al
    Alzheimer's Disease-Associated Cerebrospinal Fluid (CSF) Biomarkers do not Correlate with CSF Volumes or CSF Production Rate.
    J Alzheimers Dis. 2017 May 8. doi: 10.3233/JAD-161257.
    PubMed     Text format     Abstract available


  519. ORGETA V, Tabet N, Nilforooshan R, Howard R, et al
    Efficacy of Antidepressants for Depression in Alzheimer's Disease: Systematic Review and Meta-Analysis.
    J Alzheimers Dis. 2017 May 8. doi: 10.3233/JAD-161247.
    PubMed     Text format     Abstract available


  520. TORT-MERINO A, Valech N, Penaloza C, Gronholm-Nyman P, et al
    Early Detection of Learning Difficulties when Confronted with Novel Information in Preclinical Alzheimer's Disease Stage 1.
    J Alzheimers Dis. 2017 May 8. doi: 10.3233/JAD-161173.
    PubMed     Text format     Abstract available


  521. MANOCHA GD, Ghatak A, Puig KL, Kraner SD, et al
    NFATc2 Modulates Microglial Activation in the AbetaPP/PS1 Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2017 May 8. doi: 10.3233/JAD-151203.
    PubMed     Text format     Abstract available


  522. NELSON TJ, Sun MK, Lim C, Sen A, et al
    Bryostatin Effects on Cognitive Function and PKCvarepsilon in Alzheimer's Disease Phase IIa and Expanded Access Trials.
    J Alzheimers Dis. 2017 May 2. doi: 10.3233/JAD-170161.
    PubMed     Text format     Abstract available


  523. PASQUINI L, Benson G, Grothe MJ, Utz L, et al
    Individual Correspondence of Amyloid-beta and Intrinsic Connectivity in the Posterior Default Mode Network Across Stages of Alzheimer's Disease.
    J Alzheimers Dis. 2017 May 2. doi: 10.3233/JAD-170096.
    PubMed     Text format     Abstract available


  524. YOSHINO Y, Yamazaki K, Ozaki Y, Sao T, et al
    INPP5D mRNA Expression and Cognitive Decline in Japanese Alzheimer's Disease Subjects.
    J Alzheimers Dis. 2017 May 2. doi: 10.3233/JAD-161211.
    PubMed     Text format     Abstract available


    April 2017
  525. MACDONALD IR, Maxwell SP, Reid GA, Cash MK, et al
    Quantification of Butyrylcholinesterase Activity as a Sensitive and Specific Biomarker of Alzheimer's Disease.
    J Alzheimers Dis. 2017 Apr 28. doi: 10.3233/JAD-170164.
    PubMed     Text format     Abstract available


  526. LACOSTA AM, Insua D, Badi H, Pesini P, et al
    Neurofibrillary Tangles of Abetax-40 in Alzheimer's Disease Brains.
    J Alzheimers Dis. 2017 Apr 28. doi: 10.3233/JAD-170163.
    PubMed     Text format     Abstract available


  527. BABULAL GM, Stout SH, Head D, Holtzman DM, et al
    Neuropsychiatric Symptoms and Alzheimer's Disease Biomarkers Predict Driving Decline: Brief Report.
    J Alzheimers Dis. 2017 Apr 28. doi: 10.3233/JAD-170067.
    PubMed     Text format     Abstract available


  528. KOLAROVA M, Sengupta U, Bartos A, Ricny J, et al
    Tau Oligomers in Sera of Patients with Alzheimer's Disease and Aged Controls.
    J Alzheimers Dis. 2017 Apr 28. doi: 10.3233/JAD-170048.
    PubMed     Text format     Abstract available


  529. SUN J, Zhou H, Bai F, Zhang Z, et al
    Remyelination: A Potential Therapeutic Strategy for Alzheimer's Disease?
    J Alzheimers Dis. 2017 Apr 28. doi: 10.3233/JAD-170036.
    PubMed     Text format     Abstract available


  530. SEGAL-GAVISH H, Danino O, Barhum Y, Ben-Zur T, et al
    A Multifunctional Biocompatible Drug Candidate is Highly Effective in Delaying Pathological Signs of Alzheimer's Disease in 5XFAD Mice.
    J Alzheimers Dis. 2017 Apr 28. doi: 10.3233/JAD-161236.
    PubMed     Text format     Abstract available


  531. MALEK-AHMADI M, Lu S, Chan Y, Perez SE, et al
    Cognitive Domain Dispersion Association with Alzheimer's Disease Pathology.
    J Alzheimers Dis. 2017 Apr 28. doi: 10.3233/JAD-161233.
    PubMed     Text format     Abstract available


  532. SADIQ D, Whitfield T, Lee L, Stevens T, et al
    Prodromal Dementia with Lewy Bodies and Prodromal Alzheimer's Disease: A Comparison of the Cognitive and Clinical Profiles.
    J Alzheimers Dis. 2017 Apr 28. doi: 10.3233/JAD-161089.
    PubMed     Text format     Abstract available


  533. SEPEHRY AA, Lee PE, Hsiung GR, Beattie BL, et al
    The 2002 NIMH Provisional Diagnostic Criteria for Depression of Alzheimer's Disease (PDC-dAD): Gauging their Validity over a Decade Later.
    J Alzheimers Dis. 2017 Apr 28. doi: 10.3233/JAD-161061.
    PubMed     Text format     Abstract available


  534. SUHONEN NM, Haanpaa RM, Korhonen V, Jokelainen J, et al
    Neuropsychological Profile in the C9ORF72 Associated Behavioral Variant Frontotemporal Dementia.
    J Alzheimers Dis. 2017 Apr 28. doi: 10.3233/JAD-161142.
    PubMed     Text format     Abstract available


  535. YAMAZAKI C, Tamaoki T, Nunomura A, Tamai K, et al
    Plasma Amyloid-beta and Alzheimer's Disease-Related Changes in Late-Life Depression.
    J Alzheimers Dis. 2017 Apr 25. doi: 10.3233/JAD-170111.
    PubMed     Text format     Abstract available


  536. LAKEY-BEITIA J, Gonzalez Y, Doens D, Stephens DE, et al
    Assessment of Novel Curcumin Derivatives as Potent Inhibitors of Inflammation and Amyloid-beta Aggregation in Alzheimer's Disease.
    J Alzheimers Dis. 2017 Apr 25. doi: 10.3233/JAD-170071.
    PubMed     Text format     Abstract available


  537. HARDING A, Robinson S, Crean SJ, Singhrao SK, et al
    Can Better Management of Periodontal Disease Delay the Onset and Progression of Alzheimer's Disease?
    J Alzheimers Dis. 2017 Apr 25. doi: 10.3233/JAD-170046.
    PubMed     Text format     Abstract available


  538. TAN YJ, Ng ASL, Vipin A, Lim JKW, et al
    Higher Peripheral TREM2 mRNA Levels Relate to Cognitive Deficits and Hippocampal Atrophy in Alzheimer's Disease and Amnestic Mild Cognitive Impairment.
    J Alzheimers Dis. 2017 Apr 25. doi: 10.3233/JAD-161277.
    PubMed     Text format     Abstract available


  539. YILMAZ A, Geddes T, Han B, Bahado-Singh RO, et al
    Diagnostic Biomarkers of Alzheimer's Disease as Identified in Saliva using 1H NMR-Based Metabolomics.
    J Alzheimers Dis. 2017 Apr 25. doi: 10.3233/JAD-161226.
    PubMed     Text format     Abstract available


  540. LI K, Chan W, Doody RS, Quinn J, et al
    Prediction of Conversion to Alzheimer's Disease with Longitudinal Measures and Time-To-Event Data.
    J Alzheimers Dis. 2017 Apr 18. doi: 10.3233/JAD-161201.
    PubMed     Text format     Abstract available


  541. PAOLACCI L, Giannandrea D, Mecocci P, Parnetti L, et al
    Biomarkers for Early Diagnosis of Alzheimer's Disease in the Oldest Old: Yes or No?
    J Alzheimers Dis. 2017 Apr 15. doi: 10.3233/JAD-161127.
    PubMed     Text format     Abstract available


  542. VIANA JNM, Bittlinger M, Gilbert F
    Ethical Considerations for Deep Brain Stimulation Trials in Patients with Early-Onset Alzheimer's Disease.
    J Alzheimers Dis. 2017 Apr 15. doi: 10.3233/JAD-161073.
    PubMed     Text format     Abstract available


  543. REDDY PH
    A Critical Assessment of Research on Neurotransmitters in Alzheimer's Disease.
    J Alzheimers Dis. 2017 Apr 10. doi: 10.3233/JAD-170256.
    PubMed     Text format     Abstract available


  544. YUAN XZ, Sun S, Tan CC, Yu JT, et al
    The Role of ADAM10 in Alzheimer's Disease.
    J Alzheimers Dis. 2017 Apr 10. doi: 10.3233/JAD-170061.
    PubMed     Text format     Abstract available


  545. REDDY PH, Manczak M, Yin X
    Mitochondria-Division Inhibitor 1 Protects Against Amyloid-beta induced Mitochondrial Fragmentation and Synaptic Damage in Alzheimer's Disease.
    J Alzheimers Dis. 2017 Apr 10. doi: 10.3233/JAD-170051.
    PubMed     Text format     Abstract available


  546. ALONSO R, Pisa D, Aguado B, Carrasco L, et al
    Identification of Fungal Species in Brain Tissue from Alzheimer's Disease by Next-Generation Sequencing.
    J Alzheimers Dis. 2017 Apr 3. doi: 10.3233/JAD-170058.
    PubMed     Text format     Abstract available


  547. XIE B, Liu Z, Liu W, Jiang L, et al
    DNA Methylation and Tag SNPs of the BDNF Gene in Conversion of Amnestic Mild Cognitive Impairment into Alzheimer's Disease: A Cross-Sectional Cohort Study.
    J Alzheimers Dis. 2017 Apr 3. doi: 10.3233/JAD-170007.
    PubMed     Text format     Abstract available


  548. GARCIA B, Martin C, Olivia GS, Muniz-Alonso B, et al
    Upregulated Expression of Heparanase and Heparanase 2 in the Brains of Alzheimer's Disease.
    J Alzheimers Dis. 2017 Apr 3. doi: 10.3233/JAD-161298.
    PubMed     Text format     Abstract available


  549. KEHOE PG, Hibbs E, Palmer LE, Miners JS, et al
    Angiotensin-III is Increased in Alzheimer's Disease in Association with Amyloid-beta and Tau Pathology.
    J Alzheimers Dis. 2017 Apr 3. doi: 10.3233/JAD-161265.
    PubMed     Text format     Abstract available


  550. GARCIA A, Mathur S, Kalaw MC, McAvoy E, et al
    Quantitative 3D Telomeric Imaging of Buccal Cells Reveals Alzheimer's Disease-Specific Signatures.
    J Alzheimers Dis. 2017 Apr 3. doi: 10.3233/JAD-161169.
    PubMed     Text format     Abstract available


  551. NGUYEN MF, Bonnefoy M, Adrait A, Gueugnon M, et al
    Efficacy of Hearing Aids on the Cognitive Status of Patients with Alzheimer's Disease and Hearing Loss: A Multicenter Controlled Randomized Trial.
    J Alzheimers Dis. 2017 Apr 3. doi: 10.3233/JAD-160793.
    PubMed     Text format     Abstract available


    March 2017
  552. BOHLKEN J, Jacob L, Kostev K
    Association between Anti-Dementia Treatment Persistence and Daily Dosage of the First Prescription: A Retrospective Analysis in Neuropsychiatric Practices in Germany.
    J Alzheimers Dis. 2017 Mar 29. doi: 10.3233/JAD-170091.
    PubMed     Text format     Abstract available


  553. LOPEZ-FONT I, Boix CP, Zetterberg H, Blennow K, et al
    Alterations in the Balance of Amyloid-beta Protein Precursor Species in the Cerebrospinal Fluid of Alzheimer's Disease Patients.
    J Alzheimers Dis. 2017 Mar 29. doi: 10.3233/JAD-161275.
    PubMed     Text format     Abstract available


  554. CRAFT S, Claxton A, Baker LD, Hanson AJ, et al
    Effects of Regular and Long-Acting Insulin on Cognition and Alzheimer's Disease Biomarkers: A Pilot Clinical Trial.
    J Alzheimers Dis. 2017 Mar 29. doi: 10.3233/JAD-161256.
    PubMed     Text format     Abstract available


  555. ROBB C, Udeh-Momoh C, Wagenpfeil S, Schope J, et al
    Biomarkers and Functional Decline in Prodromal Alzheimer's Disease.
    J Alzheimers Dis. 2017 Mar 29. doi: 10.3233/JAD-161162.
    PubMed     Text format     Abstract available


  556. JIANG C, Li G, Huang P, Liu Z, et al
    The Gut Microbiota and Alzheimer's Disease.
    J Alzheimers Dis. 2017 Mar 29. doi: 10.3233/JAD-161141.
    PubMed     Text format     Abstract available


  557. JIANG S, Bhaskar K
    Dynamics of the Complement, Cytokine, and Chemokine Systems in the Regulation of Synaptic Function and Dysfunction Relevant to Alzheimer's Disease.
    J Alzheimers Dis. 2017 Mar 29. doi: 10.3233/JAD-161123.
    PubMed     Text format     Abstract available


  558. WILLIAMS SM, Schulz P, Rosenberry TL, Caselli RJ, et al
    Blood-Based Oligomeric and Other Protein Variant Biomarkers to Facilitate Pre-Symptomatic Diagnosis and Staging of Alzheimer's Disease.
    J Alzheimers Dis. 2017 Mar 29. doi: 10.3233/JAD-161116.
    PubMed     Text format     Abstract available


  559. OCHMANN S, Dyrba M, Grothe MJ, Kasper E, et al
    Does Functional Connectivity Provide a Marker for Cognitive Rehabilitation Effects in Alzheimer's Disease? An Interventional Study.
    J Alzheimers Dis. 2017 Mar 29. doi: 10.3233/JAD-160773.
    PubMed     Text format     Abstract available


  560. DOREY E, Bamji-Mirza M, Najem D, Li Y, et al
    Apolipoprotein E Isoforms Differentially Regulate Alzheimer's Disease and Amyloid-beta-Induced Inflammatory Response in vivo and in vitro.
    J Alzheimers Dis. 2017 Mar 29. doi: 10.3233/JAD-160133.
    PubMed     Text format     Abstract available


  561. LIU XJ, Wei J, Shang YH, Huang HC, et al
    Modulation of AbetaPP and GSK3beta by Endoplasmic Reticulum Stress and Involvement in Alzheimer's Disease.
    J Alzheimers Dis. 2017 Mar 20. doi: 10.3233/JAD-161111.
    PubMed     Text format     Abstract available


  562. BRUEGGEN K, Kasper E, Ochmann S, Pfaff H, et al
    Cognitive Rehabilitation in Alzheimer's Disease: A Controlled Intervention Trial.
    J Alzheimers Dis. 2017 Mar 18. doi: 10.3233/JAD-170771.
    PubMed     Text format     Abstract available


  563. HUANG CC, Isidoro C
    Raman Spectrometric Detection Methods for Early and Non-Invasive Diagnosis of Alzheimer's Disease.
    J Alzheimers Dis. 2017 Mar 18. doi: 10.3233/JAD-161238.
    PubMed     Text format     Abstract available


  564. REED C, Happich M, Argimon JM, Haro JM, et al
    What Drives Country Differences in Cost of Alzheimer's Disease? An Explanation from Resource Use in the GERAS Study.
    J Alzheimers Dis. 2017 Mar 18. doi: 10.3233/JAD-160449.
    PubMed     Text format     Abstract available


  565. BRUEGGEN K, Kasper E, Ochmann S, Pfaff H, et al
    Cognitive Rehabilitation in Alzheimer's Disease: A Controlled Intervention Trial.
    J Alzheimers Dis. 2017 Mar 18. doi: 10.3233/JAD-160771.
    PubMed     Text format     Abstract available


  566. ALOSCO ML, Duskin J, Besser LM, Martin B, et al
    Modeling the Relationships Among Late-Life Body Mass Index, Cerebrovascular Disease, and Alzheimer's Disease Neuropathology in an Autopsy Sample of 1,421 Subjects from the National Alzheimer's Coordinating Center Data Set.
    J Alzheimers Dis. 2017 Mar 13. doi: 10.3233/JAD-161205.
    PubMed     Text format     Abstract available


  567. PIEVANI M, Pini L, Ferrari C, Pizzini FB, et al
    Coordinate-Based Meta-Analysis of the Default Mode and Salience Network for Target Identification in Non-Invasive Brain Stimulation of Alzheimer's Disease and Behavior Variant Frontotemporal Dementia Networks.
    J Alzheimers Dis. 2017 Mar 13. doi: 10.3233/JAD-161105.
    PubMed     Text format     Abstract available


  568. ESQUERDA-CANALS G, Montoliu-Gaya L, Guell-Bosch J, Villegas S, et al
    Mouse Models of Alzheimer's Disease.
    J Alzheimers Dis. 2017 Mar 10. doi: 10.3233/JAD-170045.
    PubMed     Text format     Abstract available


  569. BAROCCO F, Spallazzi M, Concari L, Gardini S, et al
    The Progression of Alzheimer's Disease: Are Fast Decliners Really Fast? A Four-Year Follow-Up.
    J Alzheimers Dis. 2017 Mar 10. doi: 10.3233/JAD-161264.
    PubMed     Text format     Abstract available


  570. BEYDOUN MA, Gamaldo AA, Beydoun HA, Shaked D, et al
    Trends, Predictors, and Outcomes of Healthcare Resources Used in Patients Hospitalized with Alzheimer's Disease with at Least One Procedure: The Nationwide Inpatient Sample.
    J Alzheimers Dis. 2017 Mar 10. doi: 10.3233/JAD-161225.
    PubMed     Text format     Abstract available


  571. HATASHITA S, Wakebe D
    Amyloid-beta Deposition and Long-Term Progression in Mild Cognitive Impairment due to Alzheimer's Disease Defined with Amyloid PET Imaging.
    J Alzheimers Dis. 2017 Mar 10. doi: 10.3233/JAD-161074.
    PubMed     Text format     Abstract available


  572. GARCIA-CASAL JA, Goni-Imizcoz M, Perea-Bartolome MV, Soto-Perez F, et al
    The Efficacy of Emotion Recognition Rehabilitation for People with Alzheimer's Disease.
    J Alzheimers Dis. 2017 Mar 10. doi: 10.3233/JAD-160940.
    PubMed     Text format     Abstract available


  573. MASON EJ, Hussey EP, Molitor RJ, Ko PC, et al
    Family History of Alzheimer's Disease is Associated with Impaired Perceptual Discrimination of Novel Objects.
    J Alzheimers Dis. 2017 Mar 10. doi: 10.3233/JAD-160772.
    PubMed     Text format     Abstract available


  574. DALLAIRE-THEROUX C, Callahan BL, Potvin O, Saikali S, et al
    Radiological-Pathological Correlation in Alzheimer's Disease: Systematic Review of Antemortem Magnetic Resonance Imaging Findings.
    J Alzheimers Dis. 2017 Mar 6. doi: 10.3233/JAD-161028.
    PubMed     Text format     Abstract available


  575. BOUVY WH, Kuijf HJ, Zwanenburg JJ, Koek HL, et al
    Abnormalities of Cerebral Deep Medullary Veins on 7 Tesla MRI in Amnestic Mild Cognitive Impairment and Early Alzheimer's Disease: A Pilot Study.
    J Alzheimers Dis. 2017 Mar 6. doi: 10.3233/JAD-160952.
    PubMed     Text format     Abstract available


  576. ZHANG C, Zhang Y, Shen Y, Zhao G, et al
    Anesthesia/Surgery Induces Cognitive Impairment Only in Female Alzheimer's Disease Transgenic Mice.
    J Alzheimers Dis. 2017 Mar 2. doi: 10.3233/JAD-161268.
    PubMed     Text format     Abstract available


  577. DE MARCO M, Duzzi D, Meneghello F, Venneri A, et al
    Cognitive Efficiency in Alzheimer's Disease is Associated with Increased Occipital Connectivity.
    J Alzheimers Dis. 2017 Mar 2. doi: 10.3233/JAD-161164.
    PubMed     Text format     Abstract available


  578. RUB U, Stratmann K, Heinsen H, Seidel K, et al
    Alzheimer's Disease: Characterization of the Brain Sites of the Initial Tau Cytoskeletal Pathology Will Improve the Success of Novel Immunological Anti-Tau Treatment Approaches.
    J Alzheimers Dis. 2017 Mar 2. doi: 0.3233/JAD-161102.
    PubMed     Text format     Abstract available


  579. HANE FT, Robinson M, Lee BY, Bai O, et al
    Recent Progress in Alzheimer's Disease Research, Part 3: Diagnosis and Treatment.
    J Alzheimers Dis. 2017 Mar 2. doi: 10.3233/JAD-160907.
    PubMed     Text format     Abstract available


  580. ADRAIT A, Perrot X, Nguyen MF, Gueugnon M, et al
    Do Hearing Aids Influence Behavioral and Psychological Symptoms of Dementia and Quality of Life in Hearing Impaired Alzheimer's Disease Patients and Their Caregivers?
    J Alzheimers Dis. 2017 Mar 2. doi: 10.3233/JAD-160792.
    PubMed     Text format     Abstract available


  581. VAN DER VEN A, Pape J, Hermann D, Schloesser R, et al
    Methylene Blue (Tetramethylthionine Chloride) Influences the Mobility of Adult Neural Stem Cells: A Potentially Novel Therapeutic Mechanism of a Therapeutic Approach in the Treatment of Alzheimer's Disease.
    J Alzheimers Dis. 2017 Mar 2. doi: 10.3233/JAD-160755.
    PubMed     Text format     Abstract available


  582. KETTER N, Brashear HR, Bogert J, Di J, et al
    Central Review of Amyloid-Related Imaging Abnormalities in Two Phase III Clinical Trials of Bapineuzumab in Mild-To-Moderate Alzheimer's Disease Patients.
    J Alzheimers Dis. 2017 Mar 2. doi: 10.3233/JAD-160216.
    PubMed     Text format     Abstract available


    February 2017
  583. DONG J, Qin W, Wei C, Tang Y, et al
    A Novel PSEN1 K311R Mutation Discovered in Chinese Families with Late-Onset Alzheimer's Disease Affects Amyloid-beta Production and Tau Phosphorylation.
    J Alzheimers Dis. 2017 Feb 28. doi: 10.3233/JAD-161188.
    PubMed     Text format     Abstract available


  584. ANDREWS SJ, Das D, Anstey KJ, Easteal S, et al
    Late Onset Alzheimer's Disease Risk Variants in Cognitive Decline: The PATH Through Life Study.
    J Alzheimers Dis. 2017 Feb 28. doi: 10.3233/JAD-160774.
    PubMed     Text format     Abstract available


  585. BLONIECKI V, Aarsland D, Blennow K, Cummings J, et al
    Effects of Risperidone and Galantamine Treatment on Alzheimer's Disease Biomarker Levels in Cerebrospinal Fluid.
    J Alzheimers Dis. 2017 Feb 28. doi: 10.3233/JAD-160758.
    PubMed     Text format     Abstract available


  586. OBERACHER H, Arnhard K, Linhart C, Diwo A, et al
    Targeted Metabolomic Analysis of Soluble Lysates from Platelets of Patients with Mild Cognitive Impairment and Alzheimer's Disease Compared to Healthy Controls: Is PC aeC40:4 a Promising Diagnostic Tool?
    J Alzheimers Dis. 2017 Feb 28. doi: 10.3233/JAD-160172.
    PubMed     Text format     Abstract available


  587. RIANCHO J, Vazquez-Higuera JL, Pozueta A, Lage C, et al
    MicroRNA Profile in Patients with Alzheimer's Disease: Analysis of miR-9-5p and miR-598 in Raw and Exosome Enriched Cerebrospinal Fluid Samples.
    J Alzheimers Dis. 2017 Feb 25. doi: 10.3233/JAD-161179.
    PubMed     Text format     Abstract available


  588. PREMA A, Justin Thenmozhi A, Manivasagam T, Mohamed Essa M, et al
    Fenugreek Seed Powder Attenuated Aluminum Chloride-Induced Tau Pathology, Oxidative Stress, and Inflammation in a Rat Model of Alzheimer's Disease.
    J Alzheimers Dis. 2017 Feb 25. doi: 10.3233/JAD-161103.
    PubMed     Text format     Abstract available


  589. TOEPPER M
    Dissociating Normal Aging from Alzheimer's Disease: A View from Cognitive Neuroscience.
    J Alzheimers Dis. 2017 Feb 25. doi: 10.3233/JAD-161099.
    PubMed     Text format     Abstract available


  590. DELGADO-GONZALEZ JC, Florensa-Vila J, Mansilla-Legorburo F, Insausti R, et al
    Magnetic Resonance Imaging and Anatomical Correlation of Human Temporal Lobe Landmarks, in 3D Euclidean Space: A Study of Control and Alzheimer's Disease Subjects.
    J Alzheimers Dis. 2017 Feb 25. doi: 10.3233/JAD-160944.
    PubMed     Text format     Abstract available


  591. ROBINSON M, Lee BY, Hane FT
    Recent Progress in Alzheimer's Disease Research, Part 2: Genetics and Epidemiology.
    J Alzheimers Dis. 2017 Feb 16. doi: 10.3233/JAD-161149.
    PubMed     Text format     Abstract available


  592. GONZALES EB, Sumien N
    Acidity and Acid-Sensing Ion Channels in the Normal and Alzheimer's Disease Brain.
    J Alzheimers Dis. 2017 Feb 15. doi: 10.3233/JAD-161131.
    PubMed     Text format     Abstract available


  593. KANDIMALLA R, Reddy PH
    Therapeutics of Neurotransmitters in Alzheimer's Disease.
    J Alzheimers Dis. 2017 Feb 15. doi: 10.3233/JAD-161118.
    PubMed     Text format     Abstract available


  594. EL HAJ M, Gallouj K, Antoine P
    Google Calendar Enhances Prospective Memory in Alzheimer's Disease: A Case Report.
    J Alzheimers Dis. 2017 Feb 10. doi: 10.3233/JAD-161283.
    PubMed     Text format     Abstract available


  595. YAMAZAKI K, Yoshino Y, Mori T, Yoshida T, et al
    Gene Expression and Methylation Analysis of ABCA7 in Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2017 Feb 10. doi: 10.3233/JAD-161195.
    PubMed     Text format     Abstract available


  596. WANG J, Liu Y, Cheng X, Zhang X, et al
    The Effects of LW-AFC on the Hippocampus Transcriptome in Senescence-Accelerated Mouse Prone 8 Strain, a Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2017 Feb 10. doi: 10.3233/JAD-161079.
    PubMed     Text format     Abstract available


  597. MARIONI RE, Campbell A, Hagenaars SP, Nagy R, et al
    Genetic Stratification to Identify Risk Groups for Alzheimer's Disease.
    J Alzheimers Dis. 2017 Feb 10. doi: 10.3233/JAD-161070.
    PubMed     Text format     Abstract available


  598. LINDEMER ER, Greve DN, Fischl B, Augustinack JC, et al
    Differential Regional Distribution of Juxtacortical White Matter Signal Abnormalities in Aging and Alzheimer's Disease.
    J Alzheimers Dis. 2017 Feb 10. doi: 10.3233/JAD-161057.
    PubMed     Text format     Abstract available


  599. YANG J, Zhang R, Shi C, Mao C, et al
    AQP4 Association with Amyloid Deposition and Astrocyte Pathology in the Tg-ArcSwe Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2017 Feb 10. doi: 10.3233/JAD-160957.
    PubMed     Text format     Abstract available


  600. NAKAYAMA S, Suda A, Nakanishi H, Motoi Y, et al
    Galantamine Response Associates with Agitation and the Prefrontal Cortex in Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2017 Feb 10. doi: 10.3233/JAD-160902.
    PubMed     Text format     Abstract available


  601. HANE FT, Lee BY, Leonenko Z
    Recent Progress in Alzheimer's Disease Research, Part 1: Pathology.
    J Alzheimers Dis. 2017 Feb 10. doi: 10.3233/JAD-160882.
    PubMed     Text format     Abstract available


  602. CARDOSO BR, Hare DJ, Bush AI, Li QX, et al
    Selenium Levels in Serum, Red Blood Cells, and Cerebrospinal Fluid of Alzheimer's Disease Patients: A Report from the Australian Imaging, Biomarker & Lifestyle Flagship Study of Ageing (AIBL).
    J Alzheimers Dis. 2017 Feb 10. doi: 10.3233/JAD-160622.
    PubMed     Text format     Abstract available


  603. MONROE TB, Beach PA, Bruehl SP, Dietrich MS, et al
    The Impact of Alzheimer's Disease on the Resting State Functional Connectivity of Brain Regions Modulating Pain: A Cross Sectional Study.
    J Alzheimers Dis. 2017 Feb 7. doi: 10.3233/JAD-161187.
    PubMed     Text format     Abstract available


  604. BALIETTI M, Giuli C, Fattoretti P, Fabbietti P, et al
    Effect of a Comprehensive Intervention on Plasma BDNF in Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2017 Feb 7. doi: 10.3233/JAD-161168.
    PubMed     Text format     Abstract available


  605. IENCA M, Fabrice J, Elger B, Caon M, et al
    Intelligent Assistive Technology for Alzheimer's Disease and Other Dementias: A Systematic Review.
    J Alzheimers Dis. 2017 Feb 7. doi: 10.3233/JAD-161037.
    PubMed     Text format     Abstract available


  606. WANG Q, Li WX, Dai SX, Guo YC, et al
    Meta-Analysis of Parkinson's Disease and Alzheimer's Disease Revealed Commonly Impaired Pathways and Dysregulation of NRF2-Dependent Genes.
    J Alzheimers Dis. 2017 Feb 7. doi: 10.3233/JAD-161032.
    PubMed     Text format     Abstract available


  607. BAAZAOUI N, Flory M, Iqbal K
    Synaptic Compensation as a Probable Cause of Prolonged Mild Cognitive Impairment in Alzheimer's Disease: Implications from a Transgenic Mouse Model of the Disease.
    J Alzheimers Dis. 2017 Feb 7. doi: 10.3233/JAD-160845.
    PubMed     Text format     Abstract available


  608. KALLIO EL, Ohman H, Kautiainen H, Hietanen M, et al
    Cognitive Training Interventions for Patients with Alzheimer's Disease: A Systematic Review.
    J Alzheimers Dis. 2017 Feb 7. doi: 10.3233/JAD-160810.
    PubMed     Text format     Abstract available


  609. SANIN GN, Benke T
    Bimanual Gesture Imitation in Alzheimer's Disease.
    J Alzheimers Dis. 2017 Feb 7. doi: 10.3233/JAD-160680.
    PubMed     Text format     Abstract available


  610. STOCCORO A, Tannorella P, Salluzzo MG, Ferri R, et al
    The Methylenetetrahydrofolate Reductase C677T Polymorphism and Risk for Late-Onset Alzheimer's disease: Further Evidence in an Italian Multicenter Study.
    J Alzheimers Dis. 2017 Feb 7. doi: 10.3233/JAD-161081.
    PubMed     Text format     Abstract available


  611. CHANG KJ, Hong CH, Lee KS, Kang DR, et al
    Mortality Risk after Diagnosis of Early-Onset Alzheimer's Disease versus Late-Onset Alzheimer's Disease: A Propensity Score Matching Analysis.
    J Alzheimers Dis. 2017 Feb 1. doi: 10.3233/JAD-161181.
    PubMed     Text format     Abstract available


  612. CASTELLANO CA, Paquet N, Dionne IJ, Imbeault H, et al
    A 3-Month Aerobic Training Program Improves Brain Energy Metabolism in Mild Alzheimer's Disease: Preliminary Results from a Neuroimaging Study.
    J Alzheimers Dis. 2017 Feb 1. doi: 10.3233/JAD-161163.
    PubMed     Text format     Abstract available


  613. YU L, Wilson RS, Schneider JA, Bennett DA, et al
    Financial and Health Literacy Predict Incident Alzheimer's Disease Dementia and Pathology.
    J Alzheimers Dis. 2017 Feb 1. doi: 10.3233/JAD-161132.
    PubMed     Text format     Abstract available


  614. JIA J, Wei C, Jia L, Tang Y, et al
    Efficacy and Safety of Donepezil in Chinese Patients with Severe Alzheimer's Disease: A Randomized Controlled Trial.
    J Alzheimers Dis. 2017 Feb 1. doi: 10.3233/JAD-161117.
    PubMed     Text format     Abstract available


  615. GRANHOLM EL, Panizzon MS, Elman JA, Jak AJ, et al
    Pupillary Responses as a Biomarker of Early Risk for Alzheimer's Disease.
    J Alzheimers Dis. 2017 Feb 1. doi: 10.3233/JAD-161078.
    PubMed     Text format     Abstract available


  616. LU Y, Dong Y, Tucker D, Wang R, et al
    Treadmill Exercise Exerts Neuroprotection and Regulates Microglial Polarization and Oxidative Stress in a Streptozotocin-Induced Rat Model of Sporadic Alzheimer's Disease.
    J Alzheimers Dis. 2017 Feb 1. doi: 10.3233/JAD-160869.
    PubMed     Text format     Abstract available


  617. TIMMERS M, Barao S, Van Broeck B, Tesseur I, et al
    BACE1 Dynamics Upon Inhibition with a BACE Inhibitor and Correlation to Downstream Alzheimer's Disease Markers in Elderly Healthy Participants.
    J Alzheimers Dis. 2017 Feb 1. doi: 10.3233/JAD-160829.
    PubMed     Text format     Abstract available


  618. LI L, Xu S, Liu L, Feng R, et al
    Multifunctional Compound AD-35 Improves Cognitive Impairment and Attenuates the Production of TNF-alpha and IL-1beta in an Abeta25-35-induced Rat Model of Alzheimer's Disease.
    J Alzheimers Dis. 2017 Feb 1. doi: 10.3233/JAD-160587.
    PubMed     Text format     Abstract available


    January 2017
  619. SUHONEN NM, Hallikainen I, Hanninen T, Jokelainen J, et al
    The Modified Frontal Behavioral Inventory (FBI-mod) for Patients with Frontotemporal Lobar Degeneration, Alzheimer's Disease, and Mild Cognitive Impairment.
    J Alzheimers Dis. 2017 Jan 20. doi: 10.3233/JAD-160983.
    PubMed     Text format     Abstract available


  620. EBEL DL, Torkilsen CG, Ostrowski TD
    Blunted Respiratory Responses in the Streptozotocin-Induced Alzheimer's Disease Rat Model.
    J Alzheimers Dis. 2017 Jan 20. doi: 10.3233/JAD-160974.
    PubMed     Text format     Abstract available


  621. HORVATH A, Szucs A, Barcs G, Kamondi A, et al
    Sleep EEG Detects Epileptiform Activity in Alzheimer's Disease with High Sensitivity.
    J Alzheimers Dis. 2017 Jan 19. doi: 10.3233/JAD-160994.
    PubMed     Text format     Abstract available


  622. N'SONGO A, Carrasquillo MM, Wang X, Nguyen T, et al
    Comprehensive Screening for Disease Risk Variants in Early-Onset Alzheimer's Disease Genes in African Americans Identifies Novel PSEN Variants.
    J Alzheimers Dis. 2017 Jan 19. doi: 10.3233/JAD-161185.
    PubMed     Text format     Abstract available


  623. GOMEZ-RAMOS A, Picher AJ, Garcia E, Garrido P, et al
    Validation of Suspected Somatic Single Nucleotide Variations in the Brain of Alzheimer's Disease Patients.
    J Alzheimers Dis. 2017 Jan 19. doi: 10.3233/JAD-161053.
    PubMed     Text format     Abstract available


  624. FERRARI L, Huang SC, Magnani G, Ambrosi A, et al
    Optical Coherence Tomography Reveals Retinal Neuroaxonal Thinning in Frontotemporal Dementia as in Alzheimer's Disease.
    J Alzheimers Dis. 2017 Jan 18. doi: 10.3233/JAD-160886.
    PubMed     Text format     Abstract available


  625. LOEWENSTEIN DA, Curiel RE, Wright C, Sun X, et al
    Recovery from Proactive Semantic Interference in Mild Cognitive Impairment and Normal Aging: Relationship to Atrophy in Brain Regions Vulnerable to Alzheimer's Disease.
    J Alzheimers Dis. 2017 Jan 18. doi: 10.3233/JAD-160881.
    PubMed     Text format     Abstract available


  626. SUNDERMANN EE, Biegon A, Rubin LH, Lipton RB, et al
    Does the Female Advantage in Verbal Memory Contribute to Underestimating Alzheimer's Disease Pathology in Women versus Men?
    J Alzheimers Dis. 2017 Jan 18. doi: 10.3233/JAD-160716.
    PubMed     Text format     Abstract available


  627. HADDICK PC, Larson JL, Rathore N, Bhangale TR, et al
    A Common Variant of IL-6R is Associated with Elevated IL-6 Pathway Activity in Alzheimer's Disease Brains.
    J Alzheimers Dis. 2017 Jan 18. doi: 10.3233/JAD-160524.
    PubMed     Text format     Abstract available


  628. KHAN W, Giampietro V, Banaschewski T, Barker GJ, et al
    A Multi-Cohort Study of ApoE varepsilon4 and Amyloid-beta Effects on the Hippocampus in Alzheimer's Disease.
    J Alzheimers Dis. 2017;56:1159-1174.
    PubMed     Text format     Abstract available


  629. IWAHARA N, Hisahara S, Kawamata J, Matsumura A, et al
    Role of Suppressor of Cytokine Signaling 3 (SOCS3) in Altering Activated Microglia Phenotype in APPswe/PS1dE9 Mice.
    J Alzheimers Dis. 2017;55:1235-1247.
    PubMed     Text format     Abstract available



  630. Shi-Jiang Li, PhD, Recipient of 2017 Alzheimer Award.
    J Alzheimers Dis. 2017;59:387-388.
    PubMed     Text format    


  631. LOMBARDI G, Berti V, Tedde A, Bagnoli S, et al
    Low Florbetapir PET Uptake and Normal Abeta1-42 Cerebrospinal Fluid in an APP Ala713Thr Mutation Carrier.
    J Alzheimers Dis. 2017;57:697-703.
    PubMed     Text format     Abstract available


  632. IENCA M, Jotterand F, Elger B, Caon M, et al
    Intelligent Assistive Technology for Alzheimer's Disease and Other Dementias: A Systematic Review.
    J Alzheimers Dis. 2017;60:333.
    PubMed     Text format    



  633. Mini-Forum on Sphingolipids in Alzheimer's Disease and Related Disorders, Guest Editors: Michelle Mielke and Pilar Martinez.
    J Alzheimers Dis. 2017;60:751.
    PubMed     Text format    


  634. SERRA L, Gabrielli GB, Tuzzi E, Spano B, et al
    Damage to the Frontal Aslant Tract Accounts for Visuo-Constructive Deficits in Alzheimer's Disease.
    J Alzheimers Dis. 2017;60:1015-1024.
    PubMed     Text format     Abstract available


  635. AHMED ME, Iyer S, Thangavel R, Kempuraj D, et al
    Co-Localization of Glia Maturation Factor with NLRP3 Inflammasome and Autophagosome Markers in Human Alzheimer's Disease Brain.
    J Alzheimers Dis. 2017;60:1143-1160.
    PubMed     Text format     Abstract available


  636. HUOVINEN J, Helisalmi S, Paananen J, Laitera T, et al
    Alzheimer's Disease-Related Polymorphisms in Shunt-Responsive Idiopathic Normal Pressure Hydrocephalus.
    J Alzheimers Dis. 2017;60:1077-1085.
    PubMed     Text format     Abstract available


  637. REIJS BLR, Ramakers IHGB, Elias-Sonnenschein L, Teunissen CE, et al
    Relation of Odor Identification with Alzheimer's Disease Markers in Cerebrospinal Fluid and Cognition.
    J Alzheimers Dis. 2017;60:1025-1034.
    PubMed     Text format     Abstract available


  638. COSTA AS, Agostini S, Guerini FR, Mancuso R, et al
    Modulation of Immune Responses to Herpes Simplex Virus Type 1 by IFNL3 and IRF7 Polymorphisms: A Study in Alzheimer's Disease.
    J Alzheimers Dis. 2017;60:1055-1063.
    PubMed     Text format     Abstract available


  639. SANCHEZ SM, Abulafia C, Duarte-Abritta B, de Guevara MSL, et al
    Failure to Recover from Proactive Semantic Interference and Abnormal Limbic Connectivity in Asymptomatic, Middle-Aged Offspring of Patients with Late-Onset Alzheimer's Disease.
    J Alzheimers Dis. 2017;60:1183-1193.
    PubMed     Text format     Abstract available


  640. PALMIERI G, Cocca E, Gogliettino M, Valentino R, et al
    Low Erythrocyte Levels of Proteasome and Acyl-Peptide Hydrolase (APEH) Activities in Alzheimer's Disease: A Sign of Defective Proteostasis?
    J Alzheimers Dis. 2017;60:1097-1106.
    PubMed     Text format     Abstract available


  641. CHEN Y, Sillaire AR, Dallongeville J, Skrobala E, et al
    Low Prevalence and Clinical Effect of Vascular Risk Factors in Early-Onset Alzheimer's Disease.
    J Alzheimers Dis. 2017;60:1045-1054.
    PubMed     Text format     Abstract available


  642. VAKALOPOULOS C
    Alzheimer's Disease: The Alternative Serotonergic Hypothesis of Cognitive Decline.
    J Alzheimers Dis. 2017;60:859-866.
    PubMed     Text format     Abstract available


  643. STEVENSON A, Lopez D, Khoo P, Kalaria RN, et al
    Exploring Erythrocytes as Blood Biomarkers for Alzheimer's Disease.
    J Alzheimers Dis. 2017;60:845-857.
    PubMed     Text format     Abstract available


  644. MISE A, Yoshino Y, Yamazaki K, Ozaki Y, et al
    TOMM40 and APOE Gene Expression and Cognitive Decline in Japanese Alzheimer's Disease Subjects.
    J Alzheimers Dis. 2017;60:1107-1117.
    PubMed     Text format     Abstract available


  645. FINGER E, Zhang J, Dickerson B, Bureau Y, et al
    Disinhibition in Alzheimer's Disease is Associated with Reduced Right Frontal Pole Cortical Thickness.
    J Alzheimers Dis. 2017;60:1161-1170.
    PubMed     Text format     Abstract available


  646. DOS SANTOS MATIOLI MNP, Suemoto CK, Rodriguez RD, Farias DS, et al
    Diabetes is Not Associated with Alzheimer's Disease Neuropathology.
    J Alzheimers Dis. 2017;60:1035-1043.
    PubMed     Text format     Abstract available


  647. REIJS BLR, Ramakers IHGB, Kohler S, Teunissen CE, et al
    Memory Correlates of Alzheimer's Disease Cerebrospinal Fluid Markers: A Longitudinal Cohort Study.
    J Alzheimers Dis. 2017;60:1119-1128.
    PubMed     Text format     Abstract available


  648. DAYON L, Wojcik J, Nunez Galindo A, Corthesy J, et al
    Plasma Proteomic Profiles of Cerebrospinal Fluid-Defined Alzheimer's Disease Pathology in Older Adults.
    J Alzheimers Dis. 2017;60:1641-1652.
    PubMed     Text format     Abstract available


  649. FREEZE WM, Jacobs HI, Gronenschild EH, Jansen JF, et al
    White Matter Hyperintensities Potentiate Hippocampal Volume Reduction in Non-Demented Older Individuals with Abnormal Amyloid-beta.
    J Alzheimers Dis. 2017;55:333-342.
    PubMed     Text format     Abstract available


  650. RUSSELL CL, Mitra V, Hansson K, Blennow K, et al
    Comprehensive Quantitative Profiling of Tau and Phosphorylated Tau Peptides in Cerebrospinal Fluid by Mass Spectrometry Provides New Biomarker Candidates.
    J Alzheimers Dis. 2017;55:303-313.
    PubMed     Text format     Abstract available


  651. SHUKLA V, Seo J, Binukumar BK, Amin ND, et al
    TFP5, a Peptide Inhibitor of Aberrant and Hyperactive Cdk5/p25, Attenuates Pathological Phenotypes and Restores Synaptic Function in CK-p25Tg Mice.
    J Alzheimers Dis. 2017;56:335-349.
    PubMed     Text format     Abstract available


  652. ANSTEY KJ, Ashby-Mitchell K, Peters R
    Updating the Evidence on the Association between Serum Cholesterol and Risk of Late-Life Dementia: Review and Meta-Analysis.
    J Alzheimers Dis. 2017;56:215-228.
    PubMed     Text format     Abstract available


  653. WALDRON AM, Wyffels L, Verhaeghe J, Richardson JC, et al
    Longitudinal Characterization of [18F]-FDG and [18F]-AV45 Uptake in the Double Transgenic TASTPM Mouse Model.
    J Alzheimers Dis. 2017;55:1537-1548.
    PubMed     Text format     Abstract available


  654. WANG Y, Zhou Z, Tan H, Zhu S, et al
    Nitrosylation of Vesicular Transporters in Brain of Amyloid Precursor Protein/Presenilin 1 Double Transgenic Mice.
    J Alzheimers Dis. 2017;55:1683-1692.
    PubMed     Text format     Abstract available


  655. HILT S, Tang T, Walton JH, Budamagunta M, et al
    A Metal-Free Method for Producing MRI Contrast at Amyloid-beta.
    J Alzheimers Dis. 2017;55:1667-1681.
    PubMed     Text format     Abstract available


  656. VOYLE N, Patel H, Folarin A, Newhouse S, et al
    Genetic Risk as a Marker of Amyloid-beta and Tau Burden in Cerebrospinal Fluid.
    J Alzheimers Dis. 2017;55:1417-1427.
    PubMed     Text format     Abstract available


  657. RYU HJ, Kim M, Moon Y, Choi Y, et al
    Validation of the Korean Version of the Lewy Body Composite Risk Score (K-LBCRS).
    J Alzheimers Dis. 2017;55:1395-1401.
    PubMed     Text format     Abstract available


  658. BAAZAOUI N, Iqbal K
    Prevention of Amyloid-beta and Tau Pathologies, Associated Neurodegeneration, and Cognitive Deficit by Early Treatment with a Neurotrophic Compound.
    J Alzheimers Dis. 2017;58:215-230.
    PubMed     Text format     Abstract available


  659. BENNYS K, Gabelle A, Berr C, De Verbizier D, et al
    Cognitive Event-Related Potential, an Early Diagnosis Biomarker in Frail Elderly Subjects: The ERP-MAPT-PLUS Ancillary Study.
    J Alzheimers Dis. 2017;58:87-97.
    PubMed     Text format     Abstract available


  660. ESPINOSA A, Alegret M, Pesini P, Valero S, et al
    Cognitive Composites Domain Scores Related to Neuroimaging Biomarkers within Probable-Amnestic Mild Cognitive Impairment-Storage Subtype.
    J Alzheimers Dis. 2017;57:447-459.
    PubMed     Text format     Abstract available


  661. LI Y, Li ZX, Jin T, Wang ZY, et al
    Tau Pathology Promotes the Reorganization of the Extracellular Matrix and Inhibits the Formation of Perineuronal Nets by Regulating the Expression and the Distribution of Hyaluronic Acid Synthases.
    J Alzheimers Dis. 2017;57:395-409.
    PubMed     Text format     Abstract available


  662. MEHTA PD, Blain JF, Freeman EA, Patrick BA, et al
    Generation and Partial Characterization of Rabbit Monoclonal Antibody to Amyloid-beta Peptide 1-37 (Abeta37).
    J Alzheimers Dis. 2017;57:135-145.
    PubMed     Text format     Abstract available


  663. RHEA EM, Humann SR, Nirkhe S, Farr SA, et al
    Intranasal Insulin Transport is Preserved in Aged SAMP8 Mice and is Altered by Albumin and Insulin Receptor Inhibition.
    J Alzheimers Dis. 2017;57:241-252.
    PubMed     Text format     Abstract available


  664. LAMBRACHT-WASHINGTON D, Fu M, Wight-Carter M, Riegel M, et al
    Evaluation of a DNA Abeta42 Vaccine in Aged NZW Rabbits: Antibody Kinetics and Immune Profile after Intradermal Immunization with Full-Length DNA Abeta42 Trimer.
    J Alzheimers Dis. 2017;57:97-112.
    PubMed     Text format     Abstract available


  665. LIU P, Reichl JH, Rao ER, McNellis BM, et al
    Quantitative Comparison of Dense-Core Amyloid Plaque Accumulation in Amyloid-beta Protein Precursor Transgenic Mice.
    J Alzheimers Dis. 2017;56:743-761.
    PubMed     Text format     Abstract available


  666. EMON MA, Kodamullil AT, Karki R, Younesi E, et al
    Using Drugs as Molecular Probes: A Computational Chemical Biology Approach in Neurodegenerative Diseases.
    J Alzheimers Dis. 2017;56:677-686.
    PubMed     Text format     Abstract available


    December 2016
  667. LEE HK, Kwon B, Lemere CA, de la Monte S, et al
    mTORC2 (Rictor) in Alzheimer's Disease and Reversal of Amyloid-beta Expression-Induced Insulin Resistance and Toxicity in Rat Primary Cortical Neurons.
    J Alzheimers Dis. 2016 Dec 30. doi: 10.3233/JAD-161029.
    PubMed     Text format     Abstract available


  668. YARCHOAN M, James BD, Shah RC, Arvanitakis Z, et al
    Association of Cancer History with Alzheimer's Disease Dementia and Neuropathology.
    J Alzheimers Dis. 2016 Dec 30. doi: 10.3233/JAD-160977.
    PubMed     Text format     Abstract available


  669. BRANDSCHEID C, Schuck F, Reinhardt S, Schafer KH, et al
    Altered Gut Microbiome Composition and Tryptic Activity of the 5xFAD Alzheimer's Mouse Model.
    J Alzheimers Dis. 2016 Dec 30. doi: 10.3233/JAD-160926.
    PubMed     Text format     Abstract available


  670. MIELKE MM, Haughey NJ, Han D, An Y, et al
    The Association Between Plasma Ceramides and Sphingomyelins and Risk of Alzheimer's Disease Differs by Sex and APOE in the Baltimore Longitudinal Study of Aging.
    J Alzheimers Dis. 2016 Dec 30. doi: 10.3233/JAD-160925.
    PubMed     Text format     Abstract available


  671. SUGIMOTO T, Yoshida M, Ono R, Murata S, et al
    Frontal Lobe Function Correlates with One-Year Incidence of Urinary Incontinence in Elderly with Alzheimer Disease.
    J Alzheimers Dis. 2016 Dec 30. doi: 10.3233/JAD-160923.
    PubMed     Text format     Abstract available


  672. BERGLAND AK, Dalen I, Larsen AI, Aarsland D, et al
    Effect of Vascular Risk Factors on the Progression of Mild Alzheimer's Disease and Lewy Body Dementia.
    J Alzheimers Dis. 2016 Dec 30. doi: 10.3233/JAD-160847.
    PubMed     Text format     Abstract available


  673. CHIDLOW G, Wood JP, Manavis J, Finnie J, et al
    Investigations into Retinal Pathology in the Early Stages of a Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2016 Dec 30. doi: 10.3233/JAD-160823.
    PubMed     Text format     Abstract available


  674. GARERI P, Castagna A, Cotroneo AM, Putignano D, et al
    The Citicholinage Study: Citicoline Plus Cholinesterase Inhibitors in Aged Patients Affected with Alzheimer's Disease Study.
    J Alzheimers Dis. 2016 Dec 30. doi: 10.3233/JAD-160808.
    PubMed     Text format     Abstract available


  675. SU F, Shu H, Ye Q, Xie C, et al
    Integration of Multilocus Genetic Risk into the Default Mode Network Longitudinal Trajectory during the Alzheimer's Disease Process.
    J Alzheimers Dis. 2016 Dec 30. doi: 10.3233/JAD-160787.
    PubMed     Text format     Abstract available


  676. CAROTENUTO A, Rea R, Traini E, Fasanaro AM, et al
    The Effect of the Association between Donepezil and Choline Alphoscerate on Behavioral Disturbances in Alzheimer's Disease: Interim Results of the ASCOMALVA Trial.
    J Alzheimers Dis. 2016 Dec 30. doi: 10.3233/JAD-160675.
    PubMed     Text format     Abstract available


  677. GAUBERT M, Villain N, Landeau B, Mezenge F, et al
    Neural Correlates of Self-Reference Effect in Early Alzheimer's Disease.
    J Alzheimers Dis. 2016 Dec 30. doi: 10.3233/JAD-160561.
    PubMed     Text format     Abstract available


  678. TAN L, Yang H, Pang W, Li H, et al
    Investigation on the Role of BDNF in the Benefits of Blueberry Extracts for the Improvement of Learning and Memory in Alzheimer's Disease Mouse Model.
    J Alzheimers Dis. 2016 Dec 30. doi: 10.3233/JAD-151108.
    PubMed     Text format     Abstract available


  679. SLOT RE, Van Harten AC, Kester MI, Jongbloed W, et al
    Apolipoprotein A1 in Cerebrospinal Fluid and Plasma and Progression to Alzheimer's Disease in Non-Demented Elderly.
    J Alzheimers Dis. 2016 Dec 30. doi: 10.3233/JAD-151068.
    PubMed     Text format     Abstract available


  680. SQUITTI R, Mendez AJ, Simonelli I, Ricordi C, et al
    Diabetes and Alzheimer's Disease: Can Elevated Free Copper Predict the Risk of the Disease?
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  681. BENUSSI L, Ghidoni R, Dal Piaz F, Binetti G, et al
    The level of 24-Hydroxycholesteryl Esters is an Early Marker of Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  682. MATIAS-GUIU JA, Curiel RE, Rognoni T, Valles-Salgado M, et al
    Validation of the Spanish Version of the LASSI-L for Diagnosing Mild Cognitive Impairment and Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  683. DORAN E, Keator D, Head E, Phelan MJ, et al
    Down Syndrome, Partial Trisomy 21, and Absence of Alzheimer's Disease: The Role of APP.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  684. SABBAGH MN, Schauble B, Anand K, Richards D, et al
    Histopathology and Florbetaben PET in Patients Incorrectly Diagnosed with Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  685. SIEGEL AM, Barrett MS, Bhati MT
    Deep Brain Stimulation for Alzheimer's Disease: Ethical Challenges for Clinical Research.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  686. XIE B, Xu Y, Liu Z, Liu W, et al
    Elevation of Peripheral BDNF Promoter Methylation Predicts Conversion from Amnestic Mild Cognitive Impairment to Alzheimer's Disease: A 5-Year Longitudinal Study.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  687. KOPONEN M, Taipale H, Lavikainen P, Tanskanen A, et al
    Risk of Mortality associated with Antipsychotic Monotherapy and Polypharmacy among Community-Dwelling Persons with Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  688. HO L, Legere M, Li T, Levine S, et al
    Autonomic Nervous System Dysfunctions as a Basis for a Predictive Model of Risk of Neurological Disorders in Subjects with Prior History of Traumatic Brain Injury: Implications in Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  689. SHEN L, Liao L, Chen C, Guo Y, et al
    Proteomics Analysis of Blood Serums from Alzheimer's Disease Patients Using iTRAQ Labeling Technology.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  690. MCLIMANS KE, Willette AA
    Autotaxin is Related to Metabolic Dysfunction and Predicts Alzheimer's Disease Outcomes.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  691. LAW LL, Schultz SA, Boots EA, Einerson JA, et al
    Chronotropic Response and Cognitive Function in a Cohort at Risk for Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


    November 2016
  692. BOCCARDI V, Baroni M, Smirne N, Clodomiro A, et al
    Short-Term Response is not Predictive of Long-Term Response to Acetylcholinesterase Inhibitors in Old Age Subjects with Alzheimer's Disease: A "Real World" Study.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  693. LI X, Westman E, Thordardottir S, Stahlbom AK, et al
    The Effects of Gene Mutations on Default Mode Network in Familial Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  694. SOKOLOW S, Li X, Chen L, D Taylor K, et al
    Deleterious Effect of Butyrylcholinesterase K-Variant in Donepezil Treatment of Mild Cognitive Impairment.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  695. SANCESARIO GM, Toniolo S, Chiasserini D, Di Santo SG, et al
    The Clinical Use of Cerebrospinal Fluid Biomarkers for Alzheimer's Disease Diagnosis: The Italian Selfie.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  696. LAMPELA P, Tolppanen AM, Tanskanen A, Tiihonen J, et al
    Anticholinergic Exposure and Risk of Pneumonia in Persons with Alzheimer's Disease: A Nested Case-Control Study.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  697. SHEN L, Liu L, Ji HF
    Alzheimer's Disease Histological and Behavioral Manifestations in Transgenic Mice Correlate with Specific Gut Microbiome State.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  698. CHONG JR, Chai YL, Lee JH, Howlett D, et al
    Increased Transforming Growth Factor beta2 in the Neocortex of Alzheimer's Disease and Dementia with Lewy Bodies is Correlated with Disease Severity and Soluble Abeta42 Load.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  699. SENNIK S, Schweizer TA, Fischer CE, Munoz DG, et al
    Risk Factors and Pathological Substrates Associated with Agitation/Aggression in Alzheimer's Disease: A Preliminary Study using NACC Data.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  700. MATSUDA T, Hisatsune T
    Cholinergic Modification of Neurogenesis and Gliosis Improves the Memory of AbetaPPswe/PSEN1dE9 Alzheimer's Disease Model Mice Fed a High-Fat Diet.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  701. WANG E, Zhu H, Wang X, Gower A, et al
    Amylin Treatment Reduces Neuroinflammation and Ameliorates Abnormal Patterns of Gene Expression in the Cerebral Cortex of an Alzheimer's Disease Mouse Model.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  702. FUJISHIMA M, Kawaguchi A, Maikusa N, Kuwano R, et al
    Sample Size Estimation for Alzheimer's Disease Trials from Japanese ADNI Serial Magnetic Resonance Imaging.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  703. BOADA M, Anaya F, Ortiz P, Olazaran J, et al
    Efficacy and Safety of Plasma Exchange with 5% Albumin to Modify Cerebrospinal Fluid and Plasma Amyloid-beta Concentrations and Cognition Outcomes in Alzheimer's Disease Patients: A Multicenter, Randomized, Controlled Clinical Trial.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  704. LOUWERSHEIMER E, Cohn-Hokke PE, Pijnenburg YA, Weiss MM, et al
    Rare Genetic Variant in SORL1 May Increase Penetrance of Alzheimer's Disease in a Family with Several Generations of APOE-varepsilon4 Homozygosity.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  705. PANDYA S, Kuceyeski A, Raj A
    The Brain's Structural Connectome Mediates the Relationship between Regional Neuroimaging Biomarkers in Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  706. GLOZMAN T, Solomon J, Pestilli F, Guibas L, et al
    Shape-Attributes of Brain Structures as Biomarkers for Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  707. MORGAN AR, Touchard S, O'Hagan C, Sims R, et al
    The Correlation between Inflammatory Biomarkers and Polygenic Risk Score in Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  708. SLACHEVSKY A, Guzman-Martinez L, Delgado C, Reyes P, et al
    Tau Platelets Correlate with Regional Brain Atrophy in Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  709. KIM M, Nevado-Holgado A, Whiley L, Snowden SG, et al
    Association between Plasma Ceramides and Phosphatidylcholines and Hippocampal Brain Volume in Late Onset Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  710. AMEN DG, Darmal B, Raji CA, Bao W, et al
    Discriminative Properties of Hippocampal Hypoperfusion in Marijuana Users Compared to Healthy Controls: Implications for Marijuana Administration in Alzheimer's Dementia.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  711. BEHESHTI I, Maikusa N, Matsuda H, Demirel H, et al
    Histogram-Based Feature Extraction from Individual Gray Matter Similarity-Matrix for Alzheimer's Disease Classification.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  712. ABU RUMEILEH S, Lattanzio F, Stanzani Maserati M, Rizzi R, et al
    Diagnostic Accuracy of a Combined Analysis of Cerebrospinal Fluid t-PrP, t-tau, p-tau, and Abeta42 in the Differential Diagnosis of Creutzfeldt-Jakob Disease from Alzheimer's Disease with Emphasis on Atypical Disease Variants.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  713. CAGNIN A, Fragiacomo F, Camporese G, Turco M, et al
    Sleep-Wake Profile in Dementia with Lewy Bodies, Alzheimer's Disease, and Normal Aging.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  714. QUARMLEY M, Moberg PJ, Mechanic-Hamilton D, Kabadi S, et al
    Odor Identification Screening Improves Diagnostic Classification in Incipient Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  715. BERGERON D, Vermette A, De La Sablonniere J, Cayer AM, et al
    Finger-to-Nose Test Findings in Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  716. MULLER S, Preische O, Heymann P, Elbing U, et al
    Diagnostic Value of a Tablet-Based Drawing Task for Discrimination of Patients in the Early Course of Alzheimer's Disease from Healthy Individuals.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  717. SZABLEWSKI L
    Glucose Transporters in Brain: In Health and in Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  718. CARMONA-IRAGUI M, Santos T, Videla S, Fernandez S, et al
    Feasibility of Lumbar Puncture in the Study of Cerebrospinal Fluid Biomarkers for Alzheimer's Disease in Subjects with Down Syndrome.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  719. ALVES SARNO T, Leme Talib L, Passarelli Giroud Joaquim H, Farid Gattaz W, et al
    Protein Expression of BACE1 is Downregulated by Donepezil in Alzheimer's Disease Platelets.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  720. ARROYO-ANLLO EM, Boustonb AT, Fargeau MN, Orgaz Baz B, et al
    Self-Consciousness Deficits in Alzheimer's Disease and Frontotemporal Dementia.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  721. MOSS DE, Perez RG, Kobayashi H
    Cholinesterase Inhibitor Therapy in Alzheimer's Disease: The Limits and Tolerability of Irreversible CNS-Selective Acetylcholinesterase Inhibition in Primates.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  722. GAMIR-MORRALLA A, Belbin O, Fortea J, Alcolea D, et al
    Kidins220 Correlates with Tau in Alzheimer's Disease Brain and Cerebrospinal Fluid.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  723. MONACELLI F, Cea M, Borghi R, Odetti P, et al
    Do Cancer Drugs Counteract Neurodegeneration? Repurposing for Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  724. REITER K, Nielson KA, Durgerian S, Woodard JL, et al
    Five-Year Longitudinal Brain Volume Change in Healthy Elders at Genetic Risk for Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  725. CHAU SA, Herrmann N, Sherman C, Chung J, et al
    Visual Selective Attention Toward Novel Stimuli Predicts Cognitive Decline in Alzheimer's Disease Patients.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  726. LUSARDI TA, Phillips JI, Wiedrick JT, Harrington CA, et al
    MicroRNAs in Human Cerebrospinal Fluid as Biomarkers for Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  727. DENGLER-CRISH CM, Smith MA, Wilson GN
    Early Evidence of Low Bone Density and Decreased Serotonergic Synthesis in the Dorsal Raphe of a Tauopathy Model of Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  728. BEESLEY S, Olcese J, Saunders C, Bienkiewicz EA, et al
    Combinatorial Treatment Effects in a Cell Culture Model of Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  729. NUNOMURA A, Zhu X, Perry G
    Modulation of Parkinson's Disease Associated Protein Rescues Alzheimer's Disease Degeneration.
    J Alzheimers Dis. 2016;55:73-75.
    PubMed     Text format     Abstract available


    October 2016
  730. OCHOA JF, Alonso JF, Duque JE, Tobon CA, et al
    Successful Scene Encoding Induces Increased Directed Connectivity in Presymptomatic Early-Onset Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  731. LEE M, Guo JP, Kennedy K, McGeer EG, et al
    A Method for Diagnosing Alzheimer's Disease Based on Salivary Amyloid-beta Protein 42 Levels.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  732. MENDIOLA-PRECOMA J, Padilla K, Rodriguez-Cruz A, Berumen LC, et al
    Theobromine-Induced Changes in A1 Purinergic Receptor Gene Expression and Distribution in a Rat Brain Alzheimer's Disease Model.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  733. DE LA RUBIA ORTI JE, Castillo SS, Benlloch M, Rochina MJ, et al
    Impact of the Relationship of Stress and the Immune System in the Appearance of Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  734. CUMMINGS J, Scheltens P, McKeith I, Blesa R, et al
    Effect Size Analyses of Souvenaid in Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  735. CAI Q, Tammineni P
    Mitochondrial Aspects of Synaptic Dysfunction in Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  736. SERINO S, Riva G
    The Proactive Self in Space: How Egocentric and Allocentric Spatial Impairments Contribute to Anosognosia in Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  737. CEBERS G, Alexander RC, Haeberlein SB, Han D, et al
    AZD3293: Pharmacokinetic and Pharmacodynamic Effects in Healthy Subjects and Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  738. ANDERSON M, Xu F, Ou-Yang MH, Davis J, et al
    Intensive 'Brain Training' Intervention Fails to Reduce Amyloid Pathologies or Cognitive Deficits in Transgenic Mouse Models of Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  739. ZHUANG X, Chen Y, Zhuang X, Xing T, et al
    Impaired Center-Surround Suppression in Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available



  740. Upcoming Meetings Related to Alzheimer's Disease.
    J Alzheimers Dis. 2016;54:1687-1690.
    PubMed     Text format    


  741. LEWCZUK P, Matzen A, Blennow K, Parnetti L, et al
    Cerebrospinal Fluid Abeta42/40 Corresponds Better than Abeta42 to Amyloid PET in Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  742. DE LA MONTE SM, Tong M, Schiano I, Didsbury J, et al
    Improved Brain Insulin/IGF Signaling and Reduced Neuroinflammation with T3D-959 in an Experimental Model of Sporadic Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  743. CRISPOLTONI L, Stabile AM, Pistilli A, Venturelli M, et al
    Changes in Plasma beta-NGF and Its Receptors Expression on Peripheral Blood Monocytes During Alzheimer's Disease Progression.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  744. TONG Z, Wang W, Luo W, Lv J, et al
    Urine Formaldehyde Predicts Cognitive Impairment in Post-Stroke Dementia and Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  745. ANDREOTTI J, Dierks T, Wahlund LO, Grieder M, et al
    Diverging Progression of Network Disruption and Atrophy in Alzheimer's Disease and Semantic Dementia.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  746. MCCLURE R, Ong H, Janve V, Barton S, et al
    Aerosol Delivery of Curcumin Reduced Amyloid-beta Deposition and Improved Cognitive Performance in a Transgenic Model of Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  747. NOGUCHI-SHINOHARA M, Komatsu J, Samuraki M, Matsunari I, et al
    Cerebral Amyloid Angiopathy-Related Microbleeds and Cerebrospinal Fluid Biomarkers in Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  748. MARTINS IV, Rivers-Auty J, Allan SM, Lawrence CB, et al
    Mitochondrial Abnormalities and Synaptic Loss Underlie Memory Deficits Seen in Mouse Models of Obesity and Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  749. LAITERA T, Paananen J, Helisalmi S, Sarajarvi T, et al
    Effects of Alzheimer's Disease-Associated Risk Loci on Amyloid-beta Accumulation in the Brain of Idiopathic Normal Pressure Hydrocephalus Patients.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  750. DRONSE J, Fliessbach K, Bischof GN, von Reutern B, et al
    In vivo Patterns of Tau Pathology, Amyloid-beta Burden, and Neuronal Dysfunction in Clinical Variants of Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  751. COSKUN P, Helguera P, Nemati Z, Bohannan RC, et al
    Metabolic and Growth Rate Alterations in Lymphoblastic Cell Lines Discriminate Between Down Syndrome and Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  752. SHEN Y, Xia Y, Meng S, Lim NK, et al
    SH2B1 is Involved in the Accumulation of Amyloid-beta42 in Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  753. HUEY ED, Lee S, Cheran G, Grafman J, et al
    Brain Regions Involved in Arousal and Reward Processing are Associated with Apathy in Alzheimer's Disease and Frontotemporal Dementia.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  754. ULSTEIN I, Bohmer T
    Normal Vitamin Levels and Nutritional Indices in Alzheimer's Disease Patients with Mild Cognitive Impairment or Dementia with Normal Body Mass Indexes.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  755. DEKENS DW, Naude PJ, Engelborghs S, Vermeiren Y, et al
    Neutrophil Gelatinase-Associated Lipocalin and its Receptors in Alzheimer's Disease (AD) Brain Regions: Differential Findings in AD with and without Depression.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  756. DUGGER BN, Whiteside CM, Maarouf CL, Walker DG, et al
    The Presence of Select Tau Species in Human Peripheral Tissues and Their Relation to Alzheimer's Disease.
    J Alzheimers Dis. 2016;54:1249.
    PubMed     Text format    



  757. Upcoming Meetings Related to Alzheimer's Disease.
    J Alzheimers Dis. 2016;54:1253-1257.
    PubMed     Text format    


  758. MCGEER PL, Rogers J, McGeer EG
    Inflammation, Antiinflammatory Agents, and Alzheimer's Disease: The Last 22 Years.
    J Alzheimers Dis. 2016;54:853-857.
    PubMed     Text format     Abstract available


  759. LIN F, Ren P, Lo RY, Chapman BP, et al
    Insula and Inferior Frontal Gyrus' Activities Protect Memory Performance Against Alzheimer's Disease Pathology in Old Age.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  760. VARMA VR, Watts A
    Daily Physical Activity Patterns During the Early Stage of Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  761. RIVERO-SANTANA A, Ferreira D, Perestelo-Perez L, Westman E, et al
    Cerebrospinal Fluid Biomarkers for the Differential Diagnosis between Alzheimer's Disease and Frontotemporal Lobar Degeneration: Systematic Review, HSROC Analysis, and Confounding Factors.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  762. AN H, Choi B, Park KW, Kim DH, et al
    The Effect of Escitalopram on Mood and Cognition in Depressive Alzheimer's Disease Subjects.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  763. MIRANDA LF, Gomes KB, Tito PA, Silveira JN, et al
    Clinical Response to Donepezil in Mild and Moderate Dementia: Relationship to Drug Plasma Concentration and CYP2D6 and APOE Genetic Polymorphisms.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


    September 2016
  764. WANG R, Reddy PH
    Role of Glutamate and NMDA Receptors in Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  765. LEGER D, Elbaz M, Dubois A, Rio S, et al
    Alzheimer's Disease Severity is Not Significantly Associated with Short Sleep: Survey by Actigraphy on 208 Mild and Moderate Alzheimer's Disease Patients.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  766. DUCLOS H, de La Sayette V, Bonnet AL, Viard A, et al
    Social Cognition in the Frontal Variant of Alzheimer's Disease: A Case Study.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  767. JHA SK, Jha NK, Kumar D, Sharma R, et al
    Stress-Induced Synaptic Dysfunction and Neurotransmitter Release in Alzheimer's Disease: Can Neurotransmitters and Neuromodulators be Potential Therapeutic Targets?
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  768. KEPP KP
    Ten Challenges of the Amyloid Hypothesis of Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  769. CUCCARO D, De Marco EV, Cittadella R, Cavallaro S, et al
    Copy Number Variants in Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  770. XIE B, Liu Z, Jiang L, Liu W, et al
    Increased Serum miR-206 Level Predicts Conversion from Amnestic Mild Cognitive Impairment to Alzheimer's Disease: A 5-Year Follow-up Study.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  771. HAFKEMEIJER A, Moller C, Dopper EG, Jiskoot LC, et al
    A Longitudinal Study on Resting State Functional Connectivity in Behavioral Variant Frontotemporal Dementia and Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  772. SERRA L, Mancini M, Cercignani M, Di Domenico C, et al
    Network-Based Substrate of Cognitive Reserve in Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  773. KITAMURA Y, Inden M, Kimoto Y, Takata K, et al
    Effects of a DJ-1-Binding Compound on Spatial Learning and Memory Impairment in a Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  774. ARNERIC SP, Batrla-Utermann R, Beckett L, Bittner T, et al
    Cerebrospinal Fluid Biomarkers for Alzheimer's Disease: A View of the Regulatory Science Qualification Landscape from the Coalition Against Major Diseases CSF Biomarker Team.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  775. DINKINS MB, Wang G, Bieberich E
    Sphingolipid-Enriched Extracellular Vesicles and Alzheimer's Disease: A Decade of Research.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  776. KIM J, Schweizer TA, Fischer CE, Munoz DG, et al
    The Role of Cerebrovascular Disease on Cognitive and Functional Status and Psychosis in Severe Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  777. DARST BF, Koscik RL, Racine AM, Oh JM, et al
    Pathway-Specific Polygenic Risk Scores as Predictors of Amyloid-beta Deposition and Cognitive Function in a Sample at Increased Risk for Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  778. GUO L, Tian J, Du H
    Mitochondrial Dysfunction and Synaptic Transmission Failure in Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  779. PHILIPPENS IH, Ormel PR, Baarends G, Johansson M, et al
    Acceleration of Amyloidosis by Inflammation in the Amyloid-Beta Marmoset Monkey Model of Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  780. RAHA AA, Henderson JW, Stott SR, Vuono R, et al
    Neuroprotective Effect of TREM-2 in Aging and Alzheimer's Disease Model.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  781. BETHEA CL, Reddy AP, Christian FL
    How Studies of the Serotonin System in Macaque Models of Menopause Relate to Alzheimer's Disease1.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  782. ARDEKANI BA, Bermudez E, Mubeen AM, Bachman AH, et al
    Prediction of Incipient Alzheimer's Disease Dementia in Patients with Mild Cognitive Impairment.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  783. RODRIGUEZ CRUZ Y, Strehaiano M, Rodriguez Obaya T, Garcia Rodriguez JC, et al
    An Intranasal Formulation of Erythropoietin (Neuro-EPO) Prevents Memory Deficits and Amyloid Toxicity in the APPSwe Transgenic Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  784. LEWCZUK P, Lelental N, Lachmann I, Holzer M, et al
    Non-Phosphorylated Tau as a Potential Biomarker of Alzheimer's Disease: Analytical and Diagnostic Characterization.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  785. ZIMETTI F, Caffarra P, Ronda N, Favari E, et al
    Increased PCSK9 Cerebrospinal Fluid Concentrations in Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  786. DAL-PAN A, Dudonne S, Bourassa P, Bourdoulous M, et al
    Cognitive-Enhancing Effects of a Polyphenols-Rich Extract from Fruits without Changes in Neuropathology in an Animal Model of Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  787. MYUNG W, Lee C, Park JH, Woo SY, et al
    Occupational Attainment as Risk Factor for Progression from Mild Cognitive Impairment to Alzheimer's Disease: A CREDOS Study.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  788. DOMINGUEZ-PRIETO M, Velasco A, Vega L, Tabernero A, et al
    Aberrant Co-Localization of Synaptic Proteins Promoted by Alzheimer's Disease Amyloid-beta Peptides: Protective Effect of Human Serum Albumin.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  789. BRUGGENJURGEN B, Andersohn F, Burkowitz J, Ezzat N, et al
    Cohort Study on Predictors of Need for Nursing Care in Alzheimer's Disease: An Analysis of Healthcare Data.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  790. SAINAGHI PP, Bellan M, Lombino F, Alciato F, et al
    Growth Arrest Specific 6 Concentration is Increased in the Cerebrospinal Fluid of Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  791. ROBILLARD JM, Feng TL
    Health Advice in a Digital World: Quality and Content of Online Information about the Prevention of Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  792. TURRO-GARRIGA O, Garre-Olmo J, Rene-Ramirez R, Calvo-Perxas L, et al
    Consequences of Anosognosia on the Cost of Caregivers' Care in Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  793. MUSUNURI S, Khoonsari PE, Mikus M, Wetterhall M, et al
    Increased Levels of Extracellular Microvesicle Markers and Decreased Levels of Endocytic/Exocytic Proteins in the Alzheimer's Disease Brain.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  794. TOMBINI M, Sicari M, Pellegrino G, Ursini F, et al
    Nutritional Status of Patients with Alzheimer's Disease and Their Caregivers.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  795. MUELLER KD, Koscik RL, Turkstra LS, Riedeman SK, et al
    Connected Language in Late Middle-Aged Adults at Risk for Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  796. GOOSSENS J, Laton J, Van Schependom J, Gielen J, et al
    EEG Dominant Frequency Peak Differentiates Between Alzheimer's Disease and Frontotemporal Lobar Degeneration.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available



  797. Upcoming Meetings Related to Alzheimer's Disease.
    J Alzheimers Dis. 2016;54:847-52.
    PubMed     Text format    


  798. CESTARI JA, Fabri GM, Kalil J, Nitrini R, et al
    Oral Infections and Cytokine Levels in Patients with Alzheimer's Disease and Mild Cognitive Impairment Compared with Controls.
    J Alzheimers Dis. 2016;54:845.
    PubMed     Text format    


    June 2016
  799. VAN LANGENHOVE T, Leyton CE, Piguet O, Hodges JR, et al
    Comparing Longitudinal Behavior Changes in the Primary Progressive Aphasias.
    J Alzheimers Dis. 2016;53:1033-42.
    PubMed     Text format     Abstract available


    March 2016
  800. HEFFERNAN M, Mather KA, Xu J, Assareh AA, et al
    Alcohol Consumption and Incident Dementia: Evidence from the Sydney Memory and Ageing Study.
    J Alzheimers Dis. 2016;52:529-38.
    PubMed     Text format     Abstract available


  801. ONTIVEROS-TORRES MA, Labra-Barrios ML, Diaz-Cintra S, Aguilar-Vazquez AR, et al
    Fibrillar Amyloid-beta Accumulation Triggers an Inflammatory Mechanism Leading to Hyperphosphorylation of the Carboxyl-Terminal End of Tau Polypeptide in the Hippocampal Formation of the 3xTg-AD Transgenic Mouse.
    J Alzheimers Dis. 2016;52:243-69.
    PubMed     Text format     Abstract available


  802. LINGLER JH, Butters MA, Gentry AL, Hu L, et al
    Development of a Standardized Approach to Disclosing Amyloid Imaging Research Results in Mild Cognitive Impairment.
    J Alzheimers Dis. 2016;52:17-24.
    PubMed     Text format     Abstract available


  803. FERNANDEZ-BLAZQUEZ MA, Avila-Villanueva M, Maestu F, Medina M, et al
    Specific Features of Subjective Cognitive Decline Predict Faster Conversion to Mild Cognitive Impairment.
    J Alzheimers Dis. 2016;52:271-81.
    PubMed     Text format     Abstract available


  804. JEFFERSON AL, Gifford KA, Acosta LM, Bell SP, et al
    The Vanderbilt Memory & Aging Project: Study Design and Baseline Cohort Overview.
    J Alzheimers Dis. 2016;52:539-59.
    PubMed     Text format     Abstract available


    February 2016
  805. SANDERS C, Behrens S, Schwartz S, Wengreen H, et al
    Nutritional Status is Associated with Faster Cognitive Decline and Worse Functional Impairment in the Progression of Dementia: The Cache County Dementia Progression Study1.
    J Alzheimers Dis. 2016;52:33-42.
    PubMed     Text format     Abstract available


    January 2016
  806. MOHSENI HK, Chettle DR
    A History of In Vivo Neutron Activation Analysis in Measurement of Aluminum in Human Subjects.
    J Alzheimers Dis. 2016;50:913-26.
    PubMed     Text format     Abstract available


  807. KENNEDY RE, Cutter GR, Wang G, Schneider LS, et al
    Post Hoc Analyses of ApoE Genotype-Defined Subgroups in Clinical Trials.
    J Alzheimers Dis. 2016;50:1205-15.
    PubMed     Text format     Abstract available


  808. LEINONEN H, Lipponen A, Gurevicius K, Tanila H, et al
    Normal Amplitude of Electroretinography and Visual Evoked Potential Responses in AbetaPP/PS1 Mice.
    J Alzheimers Dis. 2016;51:21-6.
    PubMed     Text format     Abstract available


  809. GRAMUNT N, Sanchez-Benavides G, Buschke H, Lipton RB, et al
    Psychometric Properties of the Memory Binding Test: Test-Retest Reliability and Convergent Validity.
    J Alzheimers Dis. 2016;50:999-1010.
    PubMed     Text format     Abstract available


  810. KUMFOR F, Teo D, Miller L, Lah S, et al
    Examining the Relationship Between Autobiographical Memory Impairment and Carer Burden in Dementia Syndromes.
    J Alzheimers Dis. 2016;51:237-48.
    PubMed     Text format     Abstract available


  811. ANDRIUTA D, Moullart V, Schraen S, Devendeville A, et al
    What are the Most Frequently Impaired Markers of Neurodegeneration in ADNI Subjects?
    J Alzheimers Dis. 2016;51:793-800.
    PubMed     Text format     Abstract available


  812. GRANGEON L, Paquet C, Bombois S, Quillard-Muraine M, et al
    Differential Diagnosis of Dementia with High Levels of Cerebrospinal Fluid Tau Protein.
    J Alzheimers Dis. 2016;51:905-13.
    PubMed     Text format     Abstract available


  813. SIERKSMA AS, de Nijs L, Hoogland G, Vanmierlo T, et al
    Fluoxetine Treatment Induces Seizure Behavior and Premature Death in APPswe/PS1dE9 Mice.
    J Alzheimers Dis. 2016;51:677-82.
    PubMed     Text format     Abstract available


  814. KRISHNA K, Behnisch T, Sajikumar S
    Inhibition of Histone Deacetylase 3 Restores Amyloid-beta Oligomer-Induced Plasticity Deficit in Hippocampal CA1 Pyramidal Neurons.
    J Alzheimers Dis. 2016;51:783-91.
    PubMed     Text format     Abstract available


  815. RAMANAN S, Flanagan E, Leyton CE, Villemagne VL, et al
    Non-Verbal Episodic Memory Deficits in Primary Progressive Aphasias are Highly Predictive of Underlying Amyloid Pathology.
    J Alzheimers Dis. 2016;51:367-76.
    PubMed     Text format     Abstract available


  816. SON SM, Shin HJ, Byun J, Kook SY, et al
    Metformin Facilitates Amyloid-beta Generation by beta- and gamma-Secretases via Autophagy Activation.
    J Alzheimers Dis. 2016;51:1197-208.
    PubMed     Text format     Abstract available


  817. XU L, Wu X, Li R, Chen K, et al
    Prediction of Progressive Mild Cognitive Impairment by Multi-Modal Neuroimaging Biomarkers.
    J Alzheimers Dis. 2016;51:1045-56.
    PubMed     Text format     Abstract available


  818. MIGLIACCIO R, Gallea C, Kas A, Perlbarg V, et al
    Functional Connectivity of Ventral and Dorsal Visual Streams in Posterior Cortical Atrophy.
    J Alzheimers Dis. 2016;51:1119-30.
    PubMed     Text format     Abstract available


  819. TRAMUTOLA A, Pupo G, Di Domenico F, Barone E, et al
    Activation of p53 in Down Syndrome and in the Ts65Dn Mouse Brain is Associated with a Pro-Apoptotic Phenotype.
    J Alzheimers Dis. 2016;52:359-71.
    PubMed     Text format     Abstract available


  820. RAJI CA, Merrill DA, Eyre H, Mallam S, et al
    Longitudinal Relationships between Caloric Expenditure and Gray Matter in the Cardiovascular Health Study.
    J Alzheimers Dis. 2016;52:719-29.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Alzheimer's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: